Improving enzyme properties through directed evolution by Porter, Joanne Loren
  
 
 
Improving Enzyme Properties Through 
Directed Evolution 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy of 
The Australian National University 
 
 
 
Joanne Loren Porter 
 
 
 
 
 
Research School of Chemistry 
 
 
February 2015 
 3 6 . 6  < : ,  . < 0 + , 3 0 5 , :   4 ( 9 * /     ; / ,  ( < : ; 9 ( 3 0 ( 5  5 ( ; 0 6 5 ( 3  < 5 0 = , 9 : 0 ; @ 
;OL(5<SVNVPZHJVU[LTWVYHY`
YLÅLJ[PVUVMV\YOLYP[HNL
0[JSLHYS`WYLZLU[ZV\YUHTL
V\YZOPLSKHUKV\YTV[[V!
-PYZ[[VSLHYU[OLUH[\YLVM[OPUNZ
;OL(5<SVNVYLTHPUZWYVWLY[`VM[OL<UP]LYZP[ `;VWYLZLY]L
[OLH\[OLU[PJP[`VMV\YIYHUKPKLU[P[ `[OLYLHYLY\SLZ[OH[
NV]LYUOV^V\YSVNVPZ\ZLK
7YLMLYYLKSVNV
;OLWYLMLYYLKSVNVZOV\SKIL\ZLKVUH^OP[LIHJRNYV\UK
;OPZ]LYZPVUPUJS\KLZISHJR[L_[^P[O[OLJYLZ[PU+LLW.VSKPU
LP[OLY74:VY*4@2
)SHJR
>OLYLJVSV\YPZUV[H]HPSHISL[OLISHJRSVNVJHUIL\ZLKVUH
^OP[LIHJRNYV\UK
9L]LYZL
;OLSVNVJHUIL\ZLK^OP[LYL]LYZLKV\[VMHISHJR
IHJRNYV\UKVYVJJHZPVUHSS`HUL\[YHSKHYRIHJRNYV\UK
3VNVHUKHWWYV]HSZJHUILVI[HPULKMYVTIYHUK'HU\LK\H\
+LLW.VSK
*4@2
9.)
74:4L[HSSPJ
74:
)SHJR
*4@2
9.)
74:7YVJLZZ)SHJR
7YLMLYYLKSVNV )SHJR]LYZPVU
9L]LYZLK]LYZPVU
Any application of the ANU logo on 
a coloured background is subject 
to approval by the Marketing Of!ce. 
Please send to brand@anu.edu.au
(5<3VNV<ZL.\PKLSPULZ
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! "!
 
Declaration 
 
To the best of my knowledge, the work presented in this thesis does not contain material that has 
been previously published, except for publications arising from this work that have been referenced 
within the text. 
 
The work contained in this thesis, except where due acknowledgement has been made, is 
original work that I carried out during my PhD candidature and has not been submitted previously 
in whole or in part for any other degree or diploma in any university or tertiary institution. 
 
 
 
                
                                                                                                Joanne Loren Porter                   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
!""!
 
Acknowledgements 
 
First and foremost I wish to thank my supervisor Prof. David Ollis who has offered guidance, 
support and friendship in perfect measure throughout the course of my candidature. I am 
immensely grateful to have had such a knowledgeable and enthusiastic mentor.  
 
A huge thank you to Assoc. Prof. Charles Collyer from the University of Sydney and Dr. 
Paul Carr for their patience when introducing me to X-ray crystallography and for sharing their 
experience and vast knowledge in this field. Also to Ms. Tracy Murray for her constant support but 
most especially for her invaluable guidance in the laboratory during the early part of my 
candidature. 
   
Thanks to Prof. Thomas Huber, Dr. Bradley Stevenson and Dr. Colin Jackson for providing 
advice and insight during many helpful discussions. I would also like to thank my colleagues at the 
Research School of Chemistry and especially fellow members of the Ollis Group for providing 
encouragement and helping to make this an enjoyable experience.  
  
Finally, to my family and to Sam thank you for your unconditional support. I couldn’t have 
done this without you. 
 
 
     
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
! """!
 
Abstract 
 
Enzymes are specific and economical biocatalysts and as such are highly desirable synthetic tools. 
While there are many examples of successful applications of enzymes into industrial or commercial 
processes, the vast potential of enzyme technology is yet to be reached. Protein engineering, 
specifically directed evolution, is a powerful tool for generating enzymes tailored for specific 
industrial tasks. The ease of this process dictates the availability of enzymes and their diversity as 
biocatalysts. This thesis is concerned with the use of directed evolution to enhance the physical and 
catalytic properties of the enzyme dienelactone hydrolase. This is a small monomeric enzyme with a 
simple !/" hydrolase fold which provides a catalytic core shown by nature to be capable of 
fulfilling a wide variety of functions.  
 
Solubility is an important property dictating the suitability of enzymes as industrial 
biocatalysts in terms of both cost and functional utility. This thesis describes the adaption and use of 
the dihydrofolate reductase fusion reporter system to select for more soluble dienelactone hydrolase 
variants, an enzyme that already possesses a good level of solubility. The selection system was 
modified to incorporate a pre-culturing period, then used to identify mutations in solvent accessible 
locations that appeared to offer increased solubility. While the original system was capable of 
selecting for improvements to the solubility of inherently insoluble proteins, the modified system 
can be used to select for further improvements. This work provides a solid foundation for the 
continued and future use of the modified dihydrofolate reductase fusion reporter system. 
 
This thesis also discusses linked directed evolution experiments that were designed to 
rapidly alter and enhance the substrate specificity of dienelactone hydrolase in favour of non-
physiological p-nitrophenyl ester substrates. The culmination of three sequential directed evolution 
experiments were a series of enzyme variants with increased activity, stability and altered substrate 
specificity. The best variants possessed in excess of 2000-fold improvements in kcat/Km compared to 
the native enzyme. Active site mutations were able to accumulate rapidly, despite most being 
detrimental to the overall stability of the enzyme, due to constant monitoring and maintenance of 
enzyme stability through compensatory surface mutations. The roles of six of the seven active site 
mutations were elucidated with the use of substrate docking and a comprehensive structural 
analysis. Additional work focused on the surface mutations that seemed to provide compensatory 
stabilising effects. These mutations were made individually and in combination to determine the 
roles they served in the directed evolution process. Two of the three mutations were shown to be 
thermally and chemically stabilising while the third was destabilising individually but exhibited 
epistasis when present in combination with the former mutations. This work is of interest due to the 
evolutionary strategy but more importantly for the insight into the evolution and relationship 
between sequence, structure and function of !/" hydrolase fold enzymes.  
 
!"#!
 Work investigating and improving the stability of dienelactone hydrolase in the presence of 
organic co-solvents is also discussed. Eight rounds of directed evolution yielded a variant with 7 
surface mutations that provided increased thermal and chemical (organic solvents and urea) 
stability. These experimental results corroborated with computational predictions, which provide 
promise for an alternative method to rapidly engineer chemical stability. Additional work analysing 
the effects of crystal packing on protein structure is also discussed. It was found that the crystalline 
environment caused small changes to side chain orientation, mostly at crystallographic interfaces 
and flexible surface loops, with only minor changes to the protein backbone.   
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Introduction 
 
Proteins are complex macromolecules serving important roles in virtually every cellular function. 
They are made from unique linear sequences of amino acids that dictate the way in which the 
protein will fold into a unique three-dimensional structure. The folding process is aided by the 
formation of local structural elements such as !-helices, "-sheets and turns and often the presence of 
folding co-factors or metal ions. The specific amino acid sequences provide great diversity in 
protein structure enabling a vast variety of functions. Proteins are classified into types based on 
their function. Types include: transport, structural, storage, defence, regulatory and signalling or 
receptor proteins but perhaps the most numerous are enzymes.1  
 
 
1.1. Enzymes 
Enzymes are biological catalysts that facilitate the majority of reactions in nature and at any one 
time are responsible for more chemistry than the combined chemical industry.2 They facilitate many 
processes fundamental in sustaining life; without enzymes these reactions would not occur on a 
useful timescale. Enzymes are classified into six classes based on the type of chemical reaction they 
catalyse (Figure 1.1).1 
 
 
Figure 1.1 Enzyme classification 
!"#$%&'()*'+,-./*/# 0"#1).2/3*)./*/# 4"#56')(7./*/# 8"#96./*/# :"#;/(<*)./*/# ="#9&>./*/#
!"#$%&'(
!%!
Like all catalysts, enzymes work by lowering the activation energy of a reaction thereby 
increasing the rate of product formation and enabling reactions to reach their equilibrium state 
more rapidly. However where non-biological catalysts often require extreme reaction conditions 
and generate undesired side products, enzymes operate at mild biologically compatible 
temperatures. More importantly they have the potential to promote a specified and controlled 
reaction on a target substrate with greatly enhanced reaction rates. Although the catalytic properties 
of enzymes make them highly desirable synthetic tools, the number in use commercially is 
somewhat modest.3, 4  
 
 
1.1.1. Enzyme Applications 
Examples of the utilisation of enzymes in various commercial and industrial processes are given in 
Table 1.1. The different industrial applications have different requirements on the enzyme. For 
example, the chemical, medicinal and pharmaceutical industries generally take full advantage of the 
high substrate and reaction specificity typically associated with enzyme catalysis in order to 
produce fine chemicals and pharmaceutical compounds of enantiomeric purity.5 However, enzymes 
such as those utilised in cleaning products, the production of oils and biofuels as well as pulp and 
textile manufacturing, are required to have broad substrate specificity. In these industries it is 
advantageous for the enzymes to have this broad specificity since they act upon a range of materials 
(e.g. various stains, crude oils etc.). In the enzymatic refinement of oils and fats, enzymes are 
usually added to crude oils to catalyse the transesterification or hydrolysis of triacylglycerols and 
phospholipids, as such the enzymes need to have broad substrate specificity.6  
 
Table 1.1 Examples of industrial applications of enzymes 
Industry Application(s) Enzymes (class or specific) References 
Biofuel production Interesterification of fats and oils Lipases 7-9 
Bioremediation Degradation of toxic pesticides and pollutants Hydrolases, oxidoreductases 10-14 
Biotechnology DNA manipulation, proteolysis etc. 
Proteases, polymerases, ligases 
etc. 15-18 
Chemical industry Synthesis of natural products and fine chemicals Various 5, 12, 14, 19 
Cleaning products Stain removal Proteases, lipases, amylases, cellulases 20, 21 
Food and oil 
processing 
Tenderising, thickening, 
stabilising, emulsifiers Esterases and lipases etc. 13, 22-24 
Leather processing Cleaning and degreasing Proteases and lipases 25 
Medicine Therapeutic treatments Esterases 14, 26-28 
! &!
Pulp and paper 
industry Deinking, processing 
Amylases, cellulases, lipases, 
xylanases etc. 13 
Pharmaceutics Synthesis of pharmaceutical products and intermediates Various 5, 12, 29 
Textile manufacturing Scouring, finishing Amylases, cellulases, proteases etc. 13, 30 
 
The most common use of enzymes in everyday life is in household cleaning products and 
most especially in laundry detergents and washing powders. Enzyme technology was first 
introduced to this industry in the 1960’s and use is now widespread with most brands on the 
market containing enzymes.21 Proteases, lipases and amylases can provide a means of breaking 
down a variety of stains including grease, wine, grass, soil and food stains. In order for enzymes to 
be suitably utilised in this way, there are certain criteria they need to satisfy. Since the detergents 
themselves need be inexpensive, perform well and have a long shelf life, the enzymes in them must 
also be stable, suitably active and cheap to produce meaning they must express well. 
  
In medicine the use of enzyme technology can be sub-categorised into the areas of 
diagnostics and therapeutics. In diagnostics enzyme concentration can be used as an indicator for 
disease.31-33 For example, clinical tests for myocardial infarction are based on the detection of 
enzymes.34-36 Myocardial infarction is the interruption of blood supply to the heart causing death of 
cardiac muscle cells. Detection of enzymes such as creatine kinase and troponin that leak from the 
damaged tissue into the blood stream can be used for diagnosis. Certain isozymes of creatine kinase 
and troponin (cardiac I and T) are unique to the heart muscle and their respective concentrations 
temporarily increase following an infarction.  
 
In therapeutics the most successful applications of enzymes are extracellular, including 
topical uses for skin diseases and lacerations, removal of toxic substances and treatment of 
disorders that manifest within the blood circulation. The enzyme L-asparaginase is often used for 
the treatment of acute lymphoblastic leukemia in combination with other anticancer drugs.28, 37, 38 
Certain tumour cells lack the ability to synthesise the essential amino acid L-asparagine and are 
dependant on external supply. Administration of L-asparaginase causes rapid depletion of the L-
asparagine by hydrolysing it to aspartic acid and ammonia. Depletion of the external supply causes 
growth suppression and induced apoptosis in tumour cells that lack L-asparaginase synthase.38 
 
Enzymes can be specific and efficient biological catalysts and as such are highly desirable 
therapeutic agents,26, 39, 40 although unfortunately there are some severe limitations to the use of 
enzymes in this field. When administered, the effective lifetime of the enzyme is often not sufficient 
due to inactivation or degradation. Additionally the use of proteins foreign to the body can elicit 
immune responses with the potential for severe allergic reactions. On a broader scale, the practical 
limitations to the versatility of enzymes in catalysing non-biological processes in any industry 
include: the level of expression, solubility in desired media, stability and specificity. This is because, 
although enzymes have evolved over millions of years, nature has optimised their functionality to 
!'!
align purely with the needs of the host organism. For example, if the organism requires small 
quantities of a particular compound then the enzyme responsible for its production may have poor 
activity or low levels of expression. Additionally the high level of substrate and reaction specificity 
associated with enzyme catalysis means finding an appropriate enzyme for an industrial process is 
not always possible. Techniques in protein engineering have the capability of expanding and 
improving the current state of enzyme technology as applied to industrial and commercial 
practices. 41-50 
 
 
1.2. Protein Engineering 
The properties and characteristics of proteins have been studied for well over a century. However, 
in more recent times the focus has shifted to improving enzyme properties. The technology and 
knowledge in the field of genetic engineering has advanced significantly in recent years, such that 
mutations can be incorporated into target genes with relative ease.51 However, the effect of these 
respective mutations is not easy to predict. Consequently the modification of enzymes at a 
molecular level to improve properties of interest is not a trivial task. Pre-existing knowledge of a 
candidate enzyme is highly beneficial. This ideally includes: 
 
 Sequence and structural information !
 Information on close ancestral and evolutionary relations !
 An understanding of the active site and reaction mechanism !
 
 The key approaches to protein engineering are rational design and directed evolution. 
Rational design uses prior knowledge of the candidate protein to predict – manually or 
computationally – amino acid substitutions that will yield the desired properties. In contrast, 
directed evolution harnesses the power of natural selection to generate proteins with the desired 
traits.  
 
 
1.2.1. Directed Evolution 
The concept of directed or laboratory evolution of proteins is essentially survival of the fittest.52, 53 It 
has become a powerful tool not only in engineering enzymes suitable for industrial use but also in 
highlighting the relationship between protein structure, sequence and function.47-49, 54-56 The overall 
concept of directed evolution is a relatively simple one; a library of variants is created and those 
possessing the chosen trait are identified using an appropriate selection or screening method. The 
cycle is carried out a number of times until an enzyme possessing the desired properties is obtained 
(Figure 1.2).49, 52, 53, 57 
 
! (!
 
Figure 1.2 General strategy for the directed evolution of enzymes 
  
 The benefit of directed evolution over rational design is that it does not require any 
forethought to the mutation sites so prior detailed knowledge of the enzyme, although useful, is not 
essential. Any lack of knowledge is offset by the ‘power in numbers’ approach to library screening. 
These two quite different approaches are not incompatible and often a hybrid approach will be 
used, particularly in more recent years. For example, site saturation mutagenesis or randomised 
mutagenesis but only over a portion of the enzyme rather than the entire enzyme.58 
 
 
1.2.1.1. Library Generation 
The overall process of introducing mutations and the subsequent selection of desirable traits has 
been well established. It is the development of the polymerase chain reaction (PCR), a relatively 
simple laboratory technique that is capable of creating significant genetic diversity that has 
revolutionised the field.51 Routine methods for library generation include error-prone PCR, site-
saturation mutagenesis and DNA shuffling (Figure 1.3). 
 
 
Figure 1.3 Common methods of library generation for directed evolution 
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 PCR was originally designed to amplify lengths of DNA but has been adapted, in the form 
of error-prone PCR, to serve as a tool for library generation. DNA polymerases usually have 
proofreading activity to ensure DNA is replicated with high fidelity. However, as the name 
suggests, error-prone PCR is intended to introduce random mutations during replication by 
reducing the fidelity of the DNA polymerase. One approach to reducing the fidelity is to use a 
polymerase lacking the domain responsible for editing (i.e. Taq polymerase).59, 60 However, the 
absence of an editing domain does not give rise to a high error rate and additional agents must be 
considered. Protocols established to further increase the rate of nucleotide misincorporation include 
simply varying the nucleotide ratio, increasing the concentration of MgCl2 or the addition of 
MnCl2.60  
  
 DNA shuffling, otherwise referred to as genetic recombination, involves the fragmentation 
and subsequent recombination of multiple DNA sequences with the aim of combining beneficial 
mutations.61 Shuffling is typically performed on a set of naturally occurring homologous sequences 
using Deoxyribonuclease I to fragment the genes and self-priming PCR to reassemble the 
fragments. Site-saturation mutagenesis (SSM) allows the systematic substitution of the wild-type 
amino acid at a particular position to all twenty possible amino acids.62-64! This technique can be 
considered a compromise between rational design and the rigours of directed evolution. In contrast 
to error-prone PCR, when using SSM, it is highly beneficial to have the relevant prior knowledge of 
the enzyme in order to target the appropriate residues.  
  
 The properties of DNA are not highly sequence dependant so these well established 
methods of library generation can be applied across many different directed evolution experiments 
with little alteration. However, the properties of the resulting enzymes can differ dramatically, as 
such the methods employed to effectively screen these enzyme libraries need to be carefully 
considered.  
 
 
1.2.1.2. Selection or Screening of Libraries 
The selection or screening stage is arguably the most difficult step in a directed evolution 
experiment. A poorly chosen or carelessly executed screen could result in variants with the desired 
properties remaining unidentified. Recent advances allow for rapid library screening with the 
compartmentalisation of individual samples or single cells into microdroplets and the use of 
fluorescence-activated cell sorters (FACS).65-68 However these methods require specialised 
equipment and were not used for the work presented in this thesis so will not be discussed further. 
 
 Selection techniques are higher-throughput than screening but are not always possible to 
implement (Table 1.2). They are agar plate based and rely on a direct correlation between cell 
survival and the desired enzyme function. Cells are transformed with an enzyme library and plated 
on selective media where only cells containing a viable variant will survive. Selections are typically 
limited to antibiotic resistant enzymes (i.e. "-lactamases) or enzymes involved in the synthesis of 
! *!
nutrients essential for cell growth.69 However, the activity of these enzymes can also be utilised as a 
marker to evolve improved physical properties for an unrelated target enzyme. For example, 
systems such as the Dihydrofolate reductase (DHFR) fusion reporter system can be used to improve 
the solubility or stability of an enzyme.70 This is achieved by fusing its gene to that of an enzyme so 
that the fused entity has antibiotic resistance. The DHFR reporter system has been used during the 
course of this work and is described in greater detail in Chapter 3. Typically selection-based assays 
are followed up by a secondary screen since the information gained from selection is one-
dimensional (i.e. cells that survive selection are known to have the desired property but the degree 
of improvement is not known).  
 
Table 1.2 Comparison of selection and screening techniques 
Technique Library Size Adaptability Dynamic Range Simplicity 
Selection 105 ! ! !!!!! 
Microtiter plate screen 104 !!!!! !!!!! ! 
Agar plate screen 104 - 105 !!! !!! !!! 
 
 Microtiter plate screening is more laborious than selection based assays but the information 
obtained is often more useful. Cells transformed with an enzyme library are grown in microtiter 
plates – usually single transformants per well. Cells are normally, although not always, lysed and 
the library is assayed for the desired property. If the reaction involves the formation or degradation 
of a coloured or fluorescent substance then it can be easily visualised by eye or monitored using a 
microplate spectrophotometer.71 Alternatively the reaction products can be screened by gas/liquid 
chromatography or mass spectrometry. Although microtiter plate screening is versatile and offers 
great dynamic range, the screenable library size is limited due to practical aspects such as plate 
preparation and reaction time.   
  
 A compromise between the ease of selection and the benefits yielded with a microtiter plate 
screen is an agar plate screen. These screens offer a robust method of colony assessment, as with 
selection, while also allowing some measure of the quality of the variants, as with mircotiter plate 
screening. The critical aspect of agar plate screening is the need for a visual signal to identify 
colonies expressing an enzyme variant with the desired property. Ideally the catalysis product 
would be coloured or the reaction would be coupled with a dye and substrate turnover monitored 
indirectly. The speed that colonies are stained with the indicator colour is used as measure of the 
catalytic activity. These screening techniques are simpler than microtiter plate screening and larger 
libraries can be screened but differentiating between catalytic rates is not very precise.  
  
 
1.3. Esterases 
A crucial aspect of any protein engineering project is the selection of an appropriate candidate 
enzyme to use as a starting point. It is very difficult to evolve a completely new function rather an 
!+!
existing weak promiscuous activity can be exploited, so the candidate enzyme should have some 
level of the desired activity.72, 73 Additionally the candidate enzyme should be relatively stable, 
soluble and express well in a recombinant system especially if it is to be used commercially.  
 
Of the six classes of enzymes, hydrolases are the most abundant and are often targets of 
protein engineering studies since they are the most commonly utilised biocatalysts (Section 1.1.1). 
These enzymes catalyse the breaking of a single bond through the addition of water. There are a 
vast variety of hydrolase enzymes and they are further classified into subclasses including 
carboxylesterases, glycosylases and peptidases. Carboxylesterases include non-specific esterases 
and lipases, both of which hydrolyse ester bonds. They are distinguished based on substrate 
specificity; esterases preferentially catalyse the hydrolysis of water-soluble short chain esters while 
lipases prefer longer chain fatty acids (i.e. lipids).74 Most lipases are either phospholipases (EC 
3.1.1.4/5/32) or triacylglycerol lipases otherwise referred to as true lipases (EC 3.1.1.3) that catalyse 
the conversion of triglycerides to monoglycerides and free fatty acids. True lipases are mostly serine 
hydrolases belonging to the !/" hydrolase fold superfamily. 
 
 
1.4. The !/" Hydrolase Fold 
The domain folds most frequently found in nature are !/" domains consisting of a ,-sheet 
surrounded by - helices. The !/" hydrolase fold is a subclass of this fold and is common to a range 
of enzymes from highly differing phylogenetic origin and catalytic function (Table 1.3).75  
 
Table 1.3 Enzymes of the -/, hydrolase fold family 
Hydrolase Subclass Number of Genes Substrate 
Carboxylesterases 1649 
 
Dehalogenases 42  
Lipases 2194 
 
Peptidases 1566 
 
Thioesterases 668 
 
Other 4689 Various 
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In contrast to what the name suggests, the !/" hydrolase fold does not contain purely 
hydrolytic enzymes, although they were the first discovered and are the most numerous. Enzymes 
with this characteristic fold can include: proteases, hydrolases, esterases, peroxidases, lipases and 
dehalogenases. Additionally, there are also a small number of binding proteins that exhibit the -/, 
hydrolase fold.75-78 The functional diversity of this fold makes it an ideal framework for protein 
engineering studies. These enzymes do not necessarily share any significant sequence similarity. 
They do, however, share remarkably similar tertiary structure and a preserved arrangement of 
catalytic residues, suggesting evolution from a common ancestor.  
 
 
1.4.1. Characteristic Features  
The canonical !/" hydrolase fold has eight strands forming a central "-sheet, surrounded by six !-
helices. The strands of "-sheet are highly twisted, such that the first and last are orthogonal to each 
other. Helices connect all but strands one and two, where strand two is anti-parallel to the rest.75 
The strand order is 12435678 and topology of the central ,-sheet is +1, +2, -1x, +2x, (+1x)3 (Figure 
1.4).79, 80  
 
 
Figure 1.4 Schematic of the !/" hydrolase canonical fold 
 
The catalytic residues constitute a highly conserved triad, consisting of a nucleophile 
(serine, cysteine or aspartic acid), an acid and a histidine. The nucleophile is positioned after strand /"#0, the acidic residue is positioned after strand 10#02 and the histidine residue is located after the 
last strand. Although the nature of the nucleophile differs, it is always the central residue of a sharp 
# turn connecting 134526!/"#0 to an !-helix. A highly conserved sequence motif of SR–X–Nu–X–SR–
SR (SR = Small Residue, X = Any Residue and Nu = Nucleophile), where the small residue is 
usually glycine, surrounds the nucleophile and forms the # turn – known as ‘the nucleophile elbow’. 
This maximises exposure of the nucleophile into the active site cleft and minimises crowding by 
neighbouring residues. The position of the # turn at the N-terminal end of an !-helix, increases the 
net reactivity and stabilisation of the nucleophile side chain during catalysis.  
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1.4.2. Structural Variation and Functional Diversity 
The most significant variation between these enzymes is in the substrate binding region or 
domain.76, 78 Such that it appears as if nature has taken a highly effective catalytic core and altered 
the substrate binding residues to cater for a large variety of substrates (Figure 1.5). 
 
 The inherent structural similarity but vast functional diversity exhibited by enzymes of the 
!/" hydrolase fold family makes them ideal subjects for protein engineering studies. The 
framework this fold provides has been adapted by nature enabling it to facilitate many catalytic 
processes. In relation to the overall structure, dienelactone hydrolase from Pseudomonas knackmussii 
is one of the simplest of known -/, hydrolase fold enzymes. It has been used to provide the -/, 
hydrolase fold scaffold that has been used as a basis for the protein engineering and directed 
evolution experiments presented in this thesis.  
 
Figure 1.5 Additional secondary structural elements exhibited by !/" hydrolase fold enzymes 
 
 
 
1.5. Dienelactone Hydrolase 
Dienelactone hydrolase (DLH) is 25.5 kDa monomeric protein that was first identified in 
Pseudomonas knackmussii as part of the ,-ketoadipate pathway. This pathway is found in certain 
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strains of bacteria and fungi where it is responsible for the degradation of toxic and stable aromatic 
compounds. 81, 82  
 
 
1.5.1. The "-ketoadipate Pathway 
Although there are many natural aromatic compounds – i.e. aromatic amino acids, vitamins and 
melanins – the most abundant is lignin, a natural aromatic polymer.83 Lignin is a constituent of the 
plant cell wall. Therefore, it is not surprising that the ,-ketoadipate pathway is found almost 
exclusively in soil microorganisms, especially bacterial groups associated with plants. Organisms 
with the capacity to biodegrade these aromatic compounds have the ability to utilise them as a 
source of energy for growth and replication. 
  
In addition to their natural induction into the environment, large quantities of synthetic 
aromatic compounds are also introduced through industry. Chlorinated aromatic compounds, such 
as those found in paints, pesticides and herbicides are the most prevalent of these and are highly 
toxic to living systems. The ,-ketoadipate pathway consists of three main branches – catechol, 
protocatechuate and gentisate – and unaltered is unable to degrade haloaromatic compounds. This 
is likely due to steric constraints or to the electron withdrawing effect of the respective halogen.84 
Therefore microorganisms that have evolved pathways for the degradation of these haloaromatics, 
play an important role in their elimination from the biosphere.  
 
DLH is the third of four enzymes in the modified ortho-cleavage branch that is responsible 
for the degradation of toxic chloroaromatic compounds (Figure 1.6).85, 86 Organisms that degrade 
chloroaromatics using this modified branch, otherwise referred to as the chlorocatechol branch, also 
co-express the enzymes of the unmodified ,-ketoadipate pathway. The modified branch produces ,-ketoadipate as the final product. This is fed into the unmodified pathway for subsequent thiol 
cleavage and processing to acetyl-CoA and Succinyl-CoA. These tricarboxylic acid (TCA) cycle 
intermediates are in turn fed into the TCA cycle to produce metabolic energy. Comparison of the 
enzymes from the ortho-cleavage and modified ortho-cleavage branches of the ,-ketoadipate 
pathway present an interesting evolutionary study. While the corresponding enzymes muconate 
cycloisomerase and chloromuconate cycloisomerase II are almost identical structurally,87-90 that is 
not the case for enol lactone hydrolase and dienelactone hydrolase.91 Furthermore a second enzyme 
(maleylacetate reductase) is required to produce ,-ketoadipate to feed into the TCA cycle. 
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Figure 1.6 The ortho-cleavage and modified ortho-cleavage catechol branches of the ,-ketoadipate 
pathway 
 
 DLHs from various chlorobenzoate utilizing bacteria have been classified into three groups. 
These groups have been assigned based on their specificity toward the Z- (cis-) and E- (trans-) 
dienelactone substrates. Type I DLHs preferentially catalyse the conversion of the E isomer to 
maleylacetate and are magnesium dependant. Type II DLHs have the opposite preference from type 
I in that they hydrolyse only the Z isomer, while type III DLHs – such as the one from P. knackmussii 
– can catalyse the hydrolysis of both isomers. 
 
 
1.5.2. Structure 
The initial structure of type III DLH from P. knackmussii was determined at 2.8 Å resolution then 
further refined at 1.8 Å from orthorhombic crystals in space group P212121.92, 93 It consists of 236 
amino acids forming seven helices and eight strands of "-sheet (Figure 1.7). Seven of the stands are 
parallel but as is characteristic of !/" hydrolase fold enzymes strand two is anti-parallel to the rest. 
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Six of the helices lie on the outer solvent-accessible domains surrounding the "-sheet at the core of 
the enzyme, the final helix also lies within the inner core.93  
 
 
Figure 1.7 The !/" hydrolase fold exhibited by DLH shown in (A) three-dimensional form and (B) 
in schematic representation with the substrate binding residues in green and residues comprising 
the oxyanion hole in orange 
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 Unlike other !/" hydrolase fold enzymes (Figure 1.5), DLH has a minimal stretch of peptide 
responsible for substrate binding. In DLH sections of helix B and loop 14 contain residues involved 
in substrate binding while in other enzymes, such as acetylcholinesterase, whole domains serve the 
same purpose.94 Figure 1.7 also shows the residues comprising the oxyanion hole – Q35, E36, I37 
and L124. The oxyanion hole creates a hydrophilic region of the active site and is responsible for 
stabilisation of the enzyme-substrate tetrahedral intermediate during catalysis (discussed later in 
Section 1.5.3). 
  
 The catalytic triad of DLH comprises a nucleophilic cysteine (C123), an aspartic acid (D171) 
and a histidine (H202).95 The active site pocket extends from a region on the surface of the enzyme 
to the central "-pleated sheet. The nucleophile lies at the bottom of this pocket and is the central 
residue of a sharp # turn that links strand five to helix C. The histidine is in loop 14 between strand 
eight and helix C, this loop acts as a cover for the active site creating a crevice inaccessible to bulk 
solvent. The carboxylic acid side chain of D171 is hydrogen bonding distance from H202 forming a 
charge relay system ensuring de-protonation of the nucleophile for catalysis. Figure 1.8 shows 
residues of the DLH active site with an inhibitor dienelactam in complex, a complex that mimics the 
Michaelis complex of the native dienelactone substrates. 
 
 
Figure 1.8 Active site residues of DLH with the inhibitor dienelactam bound 
 
 During crystal structure analysis, it was observed that the side chain of C123 exhibited two 
distinct conformations. The C123 thiol can rotate about the C- – C, bond, so that it is positioned 
either into the active site or away from it in a seemingly inactive conformation. The crystal structure 
showed C123 to be partially oxidised to sulfonic acid, disabling rotation and holding it in the active 
state.93, 95 It has been suggested that prior to oxidation, the nucleophile exists predominantly in the 
inactive conformation, although it is not able to initiate catalysis, it is more energetically favourable. 
It is thought that upon substrate binding the nucleophile will shift into the active conformation 
through ionic rearrangements in the active site involving R206 and E36.96, 97 
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Mutation of the nucleophile to a serine (C123S) produces an enzyme with altered 
functionality toward its physiological substrates the E- and Z-dienelactones.95 Changing the 
nucleophile from cysteine to serine causes the enzyme to become an isomerase catalysing the 
interconversion of the substrate isomers.98, 99 Both the native and C123S variant have low level 
promiscuous hydrolytic activity toward non-physiological ester substrates such as p-nitrophenyl 
acetate and !-naphthyl acetate. The DLH C123S variant has been used for the work contained 
within this thesis since unlike cysteine, serine is not prone to oxidation, so use of this variant 
prevents potential loss of activity during expression and purification stages due to irreversible 
oxidation. Throughout the subsequent chapters of this thesis the DLH C123S is variant is referred as 
native.  
 
 
1.5.3. Mechanism 
The DLH catalysed hydrolysis of its physiological substrates the E- and Z-dienelactones is a variant 
of the serine protease mechanism.100-102 The DLH catalysed hydrolysis of the non-physiological 
substrate p-nitrophenyl acetate does follow this known serine protease mechanism (Scheme 1.1).  
 
 
Scheme 1.1 DLH C123S catalysed hydrolysis of p-nitrophenyl acetate 
 
The nucleophile attacks the carbonyl carbon of the substrate, leading to formation of the 
covalent enzyme-substrate tetrahedral intermediate, which is stabilised in the oxyanion hole. 
Following release of the first product (p-nitrophenol) H202 de-protonates a water molecule, the 
resulting hydroxide then acts as a nucleophile toward the carbonyl carbon of the enzyme bound 
ester. The enzyme is eliminated from the second tetrahedral transition state, producing the second 
product (acetic acid) and regenerated enzyme active site.     
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The proposed mechanism for DLH catalysed hydrolysis of the native dienelactone 
substrates differs due to positional constraints within the active site (Scheme 1.2). The nucleophile 
attacks the carbonyl carbon of the lactone ring belonging to the substrate forming a covalent 
enzyme-substrate tetrahedral intermediate. Deviating from the serine protease mechanism, it is 
suggested that H202 does not protonate the leaving group or deprotonate water for deacylation. 
Instead it is proposed that the enolate anion acts as a base to de-protonate a water molecule itself 
generating the hydroxide necessary to facilitate release of the product (maleylacetate) and 
regeneration of the enzyme active site. 103 
 
 
Scheme 1.2 DLH C123 catalysed hydrolysis of Z-dienelactone 
 
 
 
1.6. Research Objectives  
This project aimed to take a versatile catalytic framework in the !/" hydrolyse fold and engineer it 
for new and improved catalytic functions as well as enhanced physical properties. Multiple sets of 
directed evolution experiments were performed to alter the specificity of DLH and to enhance 
physical properties such as solubility, thermal stability and stability in organic solvent (Figure 1.9).  
 
 An initial aim of this project was to separately evolve DLH to have improved solubility and 
improved stability. Although protein solubility and stability are distinct features, the properties 
governing them are often considered to be highly correlated. That is to say, a stable protein likely 
also possesses good solubility, while unstable proteins generally lose their structure and form 
insoluble inclusion bodies and aggregates. There are of course exceptions to this, for example 
intrinsically disordered proteins (IDPs) are often highly soluble but lack three-dimensional 
structure.104-106 It was envisaged that side-by-side evolutions for improved solubility and stability 
would yield sets of mutations that could provide insight into the more intricate differences between 
these two properties. Problems were encountered that delayed progress in both the solubility 
(discussed in Chapter 3) and stability evolutions. The stability evolution was hindered by lack of 
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activity to the easily assayable p-nitrophenyl esters, which were used to monitor residual activity of 
the enzyme following heat exposure. Thus focus shifted to evolving and altering the catalytic 
properties of DLH, which opened new avenues of research (Chapters 4, 5 and 6) that were pursued 
in favour of the solubility and stability comparison. 
 
 
Figure 1.9 Directions for the evolution of DLH 
 
Overall several selection and screening methods were developed or optimised for the 
directed evolution experiments discussed in this thesis. These can now subsequently be employed 
to evolve other enzymes – in particular more complex and less well characterised !/" hydrolase 
fold enzymes. Additionally and perhaps more interestingly these studies aim to contribute to the 
global understanding of evolutionary biology, by observing how DLH evolves under different 
selection pressures.  
 
 
1.7. Thesis Outline 
Three publications arose from the work contained within this thesis. They are reproduced in 
Chapters 4, 5, and 7 respectively.  
 
Chapter 2. Description of routine experimental procedures used during completion of the work 
presented in this thesis. 
 
Chapter 3. Using the DHFR fusion reporter system to select for DLH variants with improved 
solubility. This comprises initial testing and modification of the system to enable it to be used to 
select for enzymes with high solubility, previously it had only been used to select for improvements 
in natively insoluble enzymes. The results presented in this Chapter, although only preliminary, 
provide a solid foundation for the future continuation of this work.  
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Chapter 4. Enhancing the activity and substrate specificity of DLH through directed evolution using 
a three-stage process. This chapter is about Publication 1. 
 
Chapter 5. Investigating of the role of compensatory surface mutations during the directed 
evolution of DLH. This chapter is focused on Publication 2.  
 
Chapter 6. Assessment of the solubility, stability and activity of DLH in the presence of organic 
solvents. This focuses on the evolution of DLH for greater stability in the presence of ethanol with 
the eventual aim of evolving a transesterase, whether DLH itself can become capable of catalysing a 
transesterification or the methods can be used to more efficiently evolve other candidate enzymes in 
the future.  
 
Chapter 7. Differences in protein structure caused by changes in the crystalline environment 
assessed by crystallisation of DLH in the space group P212121 and C2. This chapter is about 
Publication 3. 
 
Chapter 8. Brief summary and concluding remarks. 
 
 
 
 
! $.!
Experimental Methods 
 
This chapter is designed to provide details on the routine experimental procedures used throughout 
the course of this research. Information on specific and developed protocols is given in the relevant 
chapters. All chemicals were purchased from Sigma-Aldrich unless otherwise specified and water 
was purified using a Milli-Q purification system (Millipore). 
 
 
2.1. Cell Strains and Expression Vectors 
Throughout the course of this work, enzymes were synthesised using the native cellular machinery 
of bacteria. The requirements for cell based protein expression are a vector incorporating the DNA 
sequence for the protein of interest and a host cell. Escherichia coli is one of the most widely used 
hosts and DNA is most commonly introduced using a plasmid expression system. 
 
 
2.1.1. DH5! E.coli Strain 
The E. coli strain of choice for all aspects of this work was the DH5! (supE44 ∆lac169 80 lacZ∆M15 
hsdR17 recA1 endA1 gyrA96 thi -1 relA1) strain. It is known for its high transformation efficiency, is 
relatively simple to prepare and is easily stored. The endA1 mutation reduces non-specific 
endonuclease digestion, thereby increasing plasmid yield and quality during plasmid preparations. 
Wild-type E. coli strains contain the gene for a functioning recA protein that is responsible for DNA 
repair and homologous recombination. The recA1 mutation is especially advantageous for directed 
evolution experiments since it eliminates the possibility of plasmid recombination or the occurrence 
of insertions/deletions and creates a more stable insert.  
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2.1.2. The pCY76 Expression Vector 
A plasmid must be able to produce desired target variants with ease and in high quality for it to be 
an effective carrier of a gene library. The vector pCY76 (par+, bla+, lacZpro, T7!10tir+) is a constitutive 
protein expression system under the control of the lac promoter. It was developed in-house and its 
construction has been previously described.107 The pCY76 vector contains a partition element (par) 
that aids in maintenance of plasmid copy numbers (stability). It also contains the bla gene encoding 
ampicillin resistance. The clcD gene encoding DLH was cloned into the multi-cloning site of pCY76 
using NdeI and EcoRI unique restriction sites.  
  
The pCY76 expression system was utilised for the expression of native and variant DLH 
enzymes during the process of library screening and preliminary testing. However, it was not 
suitable for purification, since the co-expressed "-lactamase – responsible for conference of 
ampicillin resistance – possesses a similar isoelectric point (pI) and is of similar molecular weight to 
DLH. Separation of these enzymes during the purification process proved a difficult task. As such, 
pJWL1030 a kanamycin selective expression vector was employed for this purpose.  
 
 
2.1.3. The pJWL1030 Expression Vector 
The pJWL1030 expression vector was engineered from pCY76, with only one significant difference. 
Where pCY76 is encoded with an ampicillin resistance gene, pJWL1030 contains the gene for an 
aminoglycoside 3’-phosphotransferase enzyme conferring kanamycin resistance.  
 
 
2.2. Molecular Biology 
 
2.2.1. Bacterial Transformation 
Plasmid DNA was transformed into bacterial cells by electroporation. In this process, an electric 
field is applied to the cells, weakening the phospholipid bilayer of the cell membrane. This creates 
temporary pores in the cell wall through which DNA and other charged molecules can permeate.  
  
 DNA was added to thawed electro-competent DH5! cells and transferred to a 0.2 cm 
electroporation cuvette. An electroporator (Bio-Rad MicroPulser) was used to subject the cells to a 
2.5 kV electrical pulse. YenB media (1 mL) was immediately added and the recovered cells were 
incubated for 30 minutes at 37 °C, before being plated on agar plates supplemented with an 
appropriate antibiotic and grown overnight.  
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2.2.2. Polymerase Chain Reaction 
The polymerase chain reaction (discussed in Section 1.2.1.1) was used routinely for both general 
amplification and mutant library generation. Two models of thermocyler were used: an MJmini 
(Bio-Rad) and a Veriti® 96-well Veriflex™ PCR system (Applied Biosystems). General amplification 
was carried out using Phusion high fidelity polymerase (Thermo Scientific) in accordance with the 
manufacturer’s protocol. The PCR conditions were 20 cycles of 98 °C for 10 s, 55 °C for 15 s and 72 
°C for 30 s or 2 minutes depending on whether the gene alone or full plasmid were being amplified.   
 
 
2.2.2.1. Error-Prone and StEP PCR 
Perhaps the most common method of introducing genetic diversity for the directed evolution of 
enzymes is by random mutagenesis in the form of error-prone PCR. For error-prone PCRs carried 
out during the course of this work a combination of increased MgCl2 concentration and addition of 
MnCl2 were used to control the error-rate. Taq polymerase (Bioline) lacking 3’-5’ exonuclease 
proofreading ability was used with an increased number of cycles. A typical error-prone PCR set-up 
is outlined in Table 2.1.  
 
Table 2.1 Reaction set up for Error-prone PCR 
Component Volume (µL) 
Plasmid DNA (20 – 50 ng/µL) 1 
Forward primer (10 µM) 5 
Reverse primer (10 µM) 5 
PCR buffer (without additional MgCl2) 5 
MgCl2 (50 mM) 5 
MnCl2 (5 mM) 1-2 
dNTPs (40 µM combined) 1 
Taq polymerase (5 U µL-1) 0.5 
Water 25.5-26.5 
Total 50 
 
 The PCR conditions were 30 cycles of 96 °C for 10 s, 55 °C for 10 s and 72 °C for 20 or 5 s. 
The longer extension time (20 s) was used for first round library generation in the directed evolution 
process. For subsequent rounds when shuffling was required, error-prone PCR was combined with 
a staggered extension process (StEP). The shorter extension time (5 s) was used to generate small 
gene fragments that anneal to different templates based and extend further during each cycle.108  
  
 There are several reasons leading to bias in the composition of a library created by error-
prone PCR. Firstly, some types of error are more common than others due to the preferences of the 
polymerase. Secondly there is codon bias, resulting from the nature of the genetic code. For 
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example, a single point mutation to a CCU proline codon can alter it to encode for serine, threonine, 
alanine, leucine, histidine or arginine. In order to access codons for other amino acids, two point 
mutations (F, Y, C, Q, I, N, V, D and G) or even three (W, M, K, R and E) are required. Although this 
genetic bias is optimised toward the substitution of amino acids with those less likely to cause loss 
of function, it does dictate library size and diversity. The third bias is caused by the exponential 
nature of the amplification process. A mutation introduced in the first amplification cycle of an 
error-prone PCR will be significantly more abundant in the product molecules than mutations 
introduced in later stages. To partially combat this third bias, four separate error-prone PCRs were 
carried out at every stage (i.e. reactions were run in four separate tubes), then combined to construct 
the final working library. 
 
 
2.2.2.2. Site Saturation Mutagenesis 
Site saturation and site directed mutagenesis were performed using a method adapted from 
Stratagene’s Quickchange® protocol. Primers containing the desired nucleotide change or 
randomisation were employed in a PCR to replicate the entire plasmid (Figure 2.1). 
 
 
Figure 2.1 Schematic of the site saturation mutagenesis protocol adapted from Stratagene 
 
 The mutagenic primers used for site saturation mutagenesis experiments in this thesis 
utilised the NNK codon (where N = A, C, G or T and K = G or T). The genetic code is made up of 
sixty-four possible codons. For creation of a site saturated library, randomising the first two bases in 
the codon and limiting the third to either G or T, is more practical than complete randomisation of 
all three bases. Complete randomisation produces a theoretical library size of sixty-four. Use of the 
NNK codon reduces the library size by half to thirty-two, while still representing all twenty amino 
acids. Although for practical purposes an excess of the theoretical library needs to be screened to 
ensure almost complete coverage (discussed in Chapter 4, Section 4.4.2).  
 
A typical site saturation or site directed PCR was performed in 200 µL PCR tubes as outlined in 
Table 2.2. 
 
 
 
 
 
 
Template Plasmid DNA 
Mutagenic Primers 
Mutated Plasmid DNA 
Target Mutation 
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Table 2.2 Reaction set up for site-saturation mutagenesis PCR 
Component Volume (µL) 
Plasmid DNA (20 – 50 ng/µL) 1 
Forward mutagenic primer (10 µM) 2.5 
Reverse mutagenic primer (10 µM) 2.5 
Phusion high fidelity buffer 10 
dNTPs (40 µM combined) 1 
Phusion high fidelity polymerase (2 U µL-1) 0.5 
Water 32.5 
Total 50 
  
 The PCR thermocycling conditions were 30 cycles of 98 °C for 10 s, 55 °C for 15 s and 72 °C 
for 2 minutes. This was followed by a final extension at 72 °C for 10 minutes at the end of the 
cycling period. 
 
 
2.2.3. Restriction Enzyme Digestion 
Plasmid expression vectors or PCR products were digested with 10 U of the appropriate restriction 
enzymes (New England Biolabs) in a solution (50 µL) with the manufacturer’s recommended buffer. 
The restriction endonuclease DpnI was added to the digestion of PCR products for the purpose of 
cleaving initial methylated template DNA. Digestion mixtures were incubated for three hours at 
37 °C, then gel purified. To prevent recircularisation, digested plasmid expression vectors were 
treated with calf intestinal alkaline phosphatase (CIP) (New England Biolabs) for sixty minutes 
before purification. 
 
 
2.2.4. DNA Ligation 
Ligation of the DLH genes into expression vectors was performed with 100 ng of vector and a 3-fold 
molar excess of insert. Ligation reactions were on the 20 µL scale with 0.5 U of T4 DNA ligase 
(Fermentas) in the supplied buffer. The reactions were carried out at 18 °C for 12 – 18 hours.   
 
 
2.2.5. DNA Purification 
Plasmid DNA was routinely purified from overnight cultures (5 mL) using the Qiagen Miniprep® 
kit. The Promega® PCR purification kit was used to purify PCR products and digested or ligated 
DNA. Gel purification was performed by first subjecting the DNA sample to gel electrophoresis on 
a 1% agarose gel using RedSafeTM nucleic acid staining solution (iNtRON Biotechnology). The 
region of gel containing the desired DNA was extracted while visualising under a blue LED with an 
orange filter. DNA was purified from the fragment of gel according to the Promega® PCR 
purification kit protocol. 
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2.2.6. DNA Sequencing 
The native and mutant DLH genes were sequenced on a AB 370xI DNA Analyzer (Applied 
Biosystems) at the ACRF Biomolecular Resource Facility at the JCSMR at the Australian National 
University. Samples were prepared by PCR using BigDye terminator (Applied Biosystems) as 
recommended by the facility (Table 2.3). 
 
Table 2.3 Sample preparation for DNA sequencing  
Component Volume (µL) 
Plasmid DNA (200 – 300 ng/µL) 1 
BigDye terminator 1 
Sequencing buffer (10 mM MgCl2, 400 mM Tris, pH 9.0) 3.5 
Primer (32 pM) 1 
Water 13.5 
Total 20 
 
 Thermocycling conditions were 96 °C for 5 mins, followed by 50 cycles of 96 °C for 10 s, 50 
°C for 5 s and 60 °C for 4 minutes. The PCR extension products were prepared for analysis by 
mixing with a precipitation solution consisting of ethanol (62.5 µL), sodium acetate (3 µL) and water 
(14.5 µL). The combined precipitation mixture and sequencing products were incubated at room 
temperature for 15 minutes and then centrifuged at 3700 rpm (eppendorf 5804) for 30 minutes. After 
removal of the supernatant, the pellet was washed with 70 % (v/v) ethanol and centrifuged for a 
further 15 minutes. The supernatant was removed and the pellet air-dried in a BSB12 laminar flow 
hood (Gelaire) for 10 minutes before sequencing.  
 
 
2.3. Directed Evolution 
A general introduction to the directed evolution of enzymes was provided in Chapter 1. Any 
directed evolution experiment can be divided into two main stages. The first stage is the 
introduction of genetic diversity, whether randomly or targeted. The second stage is selection or 
screening for the desired traits. 
  
 Both random (error-prone PCR combined with StEP for shuffling) and targeted (SSM) 
methods of library generation have been used in this work, although random mutagenesis has been 
the main focus. Following mutagenic PCR (Section 2.2.2.1) the DLH gene libraries were digested at 
the NdeI and EcoRI restriction sites and ligated into the pCY76 expression vector (Section 2.1.2 and 
2.2.3). The cloned genes are transformed into DH5! E. coli cells prior to library screening (Section 
2.2.1). DNA sequencing of ten randomly selected colonies was performed before the start of a 
directed evolution experiment to determine the nucleotide and resulting amino acid mutation rates.  
! %(!
  
 After library generation the screening or selection stages take place. Multiple screening 
methods have been employed during this course of this work depending on the desired trait and 
library size. These methods are described in the relevant subsequent chapters (Chapter 3, 4 and 6).  
 
 
2.4. Protein Analysis by SDS-PAGE 
Polyacrylamide gels were used to evaluate solubility and expression in cell lysate and to test FPLC 
fractions during enzyme purification. The gels contained a 5 % (w/v) stacking region and a 15 % 
(w/v) separating region,109 both prepared from a 37.5:1 ratio of acrylamide to N,N-methylene-
bisacrylamide (Amresco). The gels were run using a SE250 Mighty Small II Mini Vertical 
Electrophoresis Unit (Hoefer) and visualised using Bio-Safe Coomassie Blue G250 stain (Bio-Rad).  
 
 
2.5. Enzyme Expression and Purification 
Proteins were expressed constitutively from the pJWL1030 vector in LB media supplemented with 
kanamycin. Single colonies were inoculated into a 10 mL starter culture and grown for 8 hours 
before being used to seed a 1 L expression culture that was grown overnight at 37 °C. Cells were 
lysed either using a French Pressure Cell Press (SLM Aminco) or using rLysozyme (Novagen).  
 
 Two methods of purification were used and these are described in full in Publications 1 and 
2 (Chapters 4 and 5). The first consisted of anion exchange chromatography followed by size 
exclusion chromatography and was used to obtained protein of crystallisation grade purity. The 
second method used just anion exchange chromatography. Examples of the elution profiles and 
SDS-PAGE of column fractions are given below for the anion exchange and size exclusion 
separations (Figure 2.2), where Buffer A is 1 mM EDTA, 20 mM Hepes at pH 7.5 and Buffer B is 1 
mM EDTA, 1 M NaCl, 20 mM Hepes at pH 7.5.   
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Figure 2.2 Purification of DLH C123S (A) elution profile using DEAE anion exchange and (B) 
corresponding SDS-PAGE of selected fractions (C) elution profile using Sephadex G75 size 
exclusion and (D) corresponding SDS-PAGE 
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2.6. X-Ray Crystallography 
X-ray crystallography can provide a detailed description of the atomic and molecular structure of a 
crystalline material.110 This is an especially valuable tool for the study of large and complex 
macromolecules such as proteins, where mechanisms and responses to stimuli are often hard to 
predict. During the course of this work X-ray crystallography was used to visualise and compare 
the structure of evolved DLH variants with the native enzyme.  
  
 X-ray crystallography is a well-established technique and has been successfully 
implemented for protein structure determination countless times since the later half of last 
century.111 The following introduction to X-ray crystallography is intended to outline the basic 
methods of protein crystallisation and structure determination as relevant to this work.  
 
 
2.6.1. Crystallisation 
The fundamental characteristic of the crystalline state is an extremely high degree of internal 
order.110 In other words, the molecules or atoms that comprise a crystal are arranged in an ordered 
lattice that extends in all directions, where equivalent lattice points have identical environments.  
  
 Proteins can generally be encouraged to form crystals when combined with the appropriate 
reagents – i.e. buffers, salts, precipitants – and transitioned into a supersaturated solution. Since the 
theory of protein crystallisation is not fully understood, finding the appropriate conditions for 
crystallisation of a particular protein is typically a trial and error process.110 However, there are now 
many commercially available protein crystallisation screens that enable rapid systematic searches to 
aid in this process.112 
  
 Techniques such as dialysis and free interface diffusion have been established for the 
crystallisation of proteins. However by far the most common is the vapour diffusion method in the 
form of a hanging drop.110 In these experiments, the protein is mixed with a precipitating solution in 
a small drop and allowed to equilibrate with a reservoir of a larger volume in a sealed environment. 
This means that the concentration of protein in the drop increases until its vapour pressure matches 
that of the reservoir. The design of the experiment should be such that initially the protein is soluble 
but when allowed to equilibrate it becomes supersaturated (Figure 2.3). When supersaturation 
occurs, there are typically two possibilities: the protein can come out of solution as precipitate or as 
an ordered crystal. For the second option to eventuate, equilibration needs to result in conditions 
suitable for crystal nucleation. As protein crystals form, the concentration of soluble protein will 
decrease, ideally in line with conditions suitable for growth.  
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Figure 2.3 Phase diagram showing the changes in protein and precipitant concentration over the 
course of a protein crystallisation experiment (adapted from similar figures110, 113-115) 
 
 DLH readily crystallises in space group P212121 space group with unit cell dimensions 49 x 
71 x 77 Å.92, 93, 116 This is a common space group for protein crystals, especially for monomeric 
proteins like DLH. 
  
 The native and variant DLH enzymes were crystallised using hanging drop vapour 
diffusion. The conditions used for crystallisation of the native protein in space group P212121 
differed only slightly to those previously reported.117 The hanging drop was 8 µL in size with a 5:3 
ratio of protein to precipitant, where the precipitant consisted of 0.1 M sodium citrate, 1.2 M 
ammonium sulphate at pH 5.8. The variants crystallised under similar conditions with some 
requiring microseeding and slightly altered precipitant concentration (0.8 – 1.2 M ammonium 
sulphate). Crystals were harvested after 10-30 days growth at 4 °C and stored in a solution with 
elevated concentration of precipitant, 15 % (w/v) glucose and 2.5 % (v/v) glycerol were added for 
cryoprotection. Specific crystallisation conditions for the proteins crystallised as part of the work 
presented in the publication reproduced in Chapter 4 are detailed in Table 2.4. 
 
Table 2.4 Conditions for crystallisation of native and evolved DLH variants 
Condition Native A-6 S-2 S-3 B-1 B-4 
Sodium citrate (M) 0.1 0.1 0.1 0.1 0.1 0.1 
pH 5.8 5.8 5.8 5.8 5.8 5.8 
Ammonium sulphate (M) 1.2 1.2 0.8 1.0 1.2 1.0 
Temperature (C) 4 4 4 4 4 4 
Micro seeding no yes no no no yes 
Drop ratio (protein : precipitant) 5:3 3:1 3:1 3:1 5:3 3:1 
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 Separate structures of the native enzyme in the space groups P212121 and C2 were solved 
and are the subject of the publication reproduced in Chapter 7. The conditions for crystallisation are 
given in the same publication.   
 
 
2.6.2. Data Collection and Structure Determination 
Structures were solved as part of the work in Chapters 4 and 7, data collection and structure 
determination were performed as described in the publications reproduced in the respective 
chapters. All structures have been deposited in the PDB and the codes are listed in Table 2.5. 
  
Table 2.5 Structures and their corresponding PDB codes 
 Enzyme Space group PDB Code 
Chapter 4 DLH-C123S P212121 4U2B 
 A-6 P212121 4U2C 
 S-2 P212121 4U2D 
 S-3 P212121 4U2E 
 B-1 P212121 4U2F 
 B-4 P212121 4U2G 
Chapter 7 DLH-C123S P212121 4P92 
 DLH-C123S C2 4P93 
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Improving Enzyme Solubility 
 
3.1. Introduction 
Protein solubility along with stability is a major limiting factor when considering enzymes for 
utilisation in industrial or commercial practices. A protein that is soluble when expressed in its 
native cellular environment will not necessarily be soluble when expressed in a recombinant 
system. The cell may only require a small amount of protein, such that the protein never reaches its 
solubility limit within the cell. In many cases proteins receive assistance in folding (by chaperones) 
and will be less soluble in their absence. Often recombinant proteins – particularly those expressed 
at very high levels – will fail to fold correctly and insoluble protein will accumulate resulting in 
aggregates or inclusion bodies (Figure 3.1).118  
 
 
Figure 3.1 Conformational changes and protein inactivation pathways 
 
Codon substitution, reduction of growth temperature, addition of fusion partners and co-
expression of chaperones are just some of the methods used to obtain higher yields of soluble 
protein.119 However success is far from guaranteed and new methods of improving protein 
Folded Molten Globule Unfolded 
Aggregated 
Degraded 
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solubility are still being pursued. Protein engineering – especially directed evolution – present ways 
to enhance the intrinsic solubility of target proteins without the need for additives.71, 120, 121 
 
 
3.1.1. Evolving Soluble Enzymes 
Enhancing the solubility of enzymes directly is an attractive alternative to coaxing the formation of 
soluble enzymes through controlled expression or addition of co-expression partners. Several 
methods to evolve proteins for high levels of solubility exist. One of the most commonly used and 
accepted methods is the green fluorescent protein (GFP) fusion reporter method.122-124 The target 
protein is expressed as a fusion product at the N-terminus of GFP. The fluorescence of GFP is 
measured to transduce information about the folding of the fused target protein. Cells expressing 
GFP fused to a soluble and correctly folded target protein fluoresce, whereas if the target protein is 
insoluble then GFP will fluoresce weakly or not at all.  
  
The dihydrofolate reductase (DHFR) fusion reporter system has been previously developed 
in the Ollis laboratory.70 In principle it is similar to the GFP fusion reporter method in that both 
methods use a fusion partner to indicate the folded state of the target protein. The advantage of the 
DHFR system is that it offers a method of selection rather than a screen and can significantly 
increase the level of throughput. 
 
 
3.1.2. The DHFR Fusion Reporter System 
The DHFR fusion reported system has been developed as a method for the selection of soluble 
proteins.70 It is based on the observation that Escherichia coli can become resistant to the antibiotic 
trimethoprim (TMP) if DHFR – a highly soluble protein – is expressed at a sufficiently high level, 
such that the concentration of DHFR exceeds that of the antibiotic. TMP exerts its antibiotic effect by 
preventing bacteria from producing folate, which is required for the synthesis of purine nucleotides, 
thymidine and certain amino acids. Without this, bacteria cannot produce DNA and are unable to 
replicate. DHFR catalyses the reduction of dihydrofolate (DHF) to tetrahydrofolate (THF) – the 
biologically active derivative of folate – using NADPH as an electron donor. Therefore DHFR is 
crucial for the survival of growing cells since inhibition will disrupt DNA synthesis, so by 
expressing high levels of DHFR cells can overcome the effects of TMP.  
  
The recombinant plasmid pJWL1030folA (Figure 3.2) was constructed to express DHFR – 
encoded by the folA gene – at very high levels so that cells containing the plasmid can survive levels 
of TMP that would otherwise be lethal. Within the plasmid the gene for DHFR is fused to the 3’ end 
of the gene encoding the target protein. If the target protein is insoluble, then the resulting fusion 
protein will form aggregates or inclusion bodies, DHFR will be inactive and hence the host cells will 
be susceptible to TMP. If the target protein is soluble, then DHFR will be active and the host cell will 
be TMP resistant. Mutations to the target protein improving its solubility will in turn make the 
fusion protein more soluble and DHFR will be at least partially active giving the cells a degree of 
!&%!
resistance to TMP. Starting at low concentrations of TMP and increasing the concentration by round 
as more soluble variants are generated and shuffled, significant improvements in solubility have 
been observed.70 
 
 
Figure 3.2 The DHFR fusion vector  
 
The DHFR fusion reporter system has been used to successfully improve the solubility of 
small and naturally insoluble proteins. DLH is relatively small but it is not insoluble, it was hoped 
that the DHFR fusion system could be applied to further increase the solubility of DLH, however 
there was no precedent for this type of experiment. It was envisaged that the mutations obtained 
while evolving DLH for a very high level of solubility could provide insight into the properties 
governing protein solubility. Of particular interest was the correlation between solubility and 
stability, i.e. would the evolved variants also be more stable or would the evolution increase the 
solubility of the denatured or partially folded states? 
 
 
3.2. Experimental Methods 
General experimental protocols such as bacterial transformations, ligations and typical PCR are 
described in Chapter 2. Given here are specific details relating to the work presented in this chapter 
using the DHFR fusion system to evolve DLH to a higher level of solubility.  
 
 
3.2.1. The ClcDopt Gene 
The clcDopt gene encodes DLH but was codon optimised for expression in E.coli by DNA 2.0 
(California, USA) with an overall nucleotide similarity of 76.9 % (Figure 3.3).  
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Figure 3.3 DNA sequence alignment of clcDopt and clcD genes encoding DLH 
 
 Expression of clcDopt using pCY76 was lower than the native gene and produced almost 
exclusively insoluble protein (Figure 3.4). Initial work and set-up of the DHFR fusion reporter 
system used both the optimised and native genes. Originally it was envisaged that evolving the 
same enzyme independently from genes with different levels of solubility and expression would 
provide insight into the properties governing expression and solubility as well as exploring the 
difference in evolutionary pathways. However, due to insoluble expression of clcDopt using pCY76 
and limited expression in the fusion vector (Figure 3.4), it was felt there was little benefit to the 
continued use of this gene. Subsequently only the native gene was used during the directed 
evolution experiments for improved solubility. 
 
 
 
    The optimised gene (clcDopt) aligned with the native gene (clcD) 
 
 
  1   ATGCTGACCGAAGGCATCTCGATCCAAAGCTACGACGGCCACACCTTTGGCGCGTTGGTG  60 
      ||||||||||||||||| ||||| |||   || ||||| || || || |||||| | ||| 
  1   ATGCTGACCGAAGGCATATCGATTCAATCGTATGACGGGCATACATTCGGCGCGCTCGTG  60 
 
 61   GGTAGCCCAGCTAAGGCTCCGGCTCCGGTGATTGTCATTGCGCAAGAGATTTTCGGTGTT  120 
      ||    || || || || || ||||| |||||||| || || ||||| || || |||||  
 61   GGCTCGCCGGCCAAAGCGCCCGCTCCCGTGATTGTGATCGCTCAAGAAATATTTGGTGTG  120 
 
121   AACGCGTTCATGCGCGAAACGGTGAGCTGGCTGGTGGACCAGGGTTACGCTGCCGTTTGT  180 
      |||||||||||||| |||||||||   |||||||| |||||||| || || || |||||  
121   AACGCGTTCATGCGAGAAACGGTGTCATGGCTGGTCGACCAGGGGTATGCGGCAGTTTGC  180 
 
181   CCGGACCTGTATGCGCGTCAAGCACCAGGTACCGCGTTGGATCCGCAGGATGAAGCCCAG  240 
      || || ||||| ||||| || || |||||||| ||  | |||||||||||||| || ||| 
181   CCTGATCTGTACGCGCGCCAGGCGCCAGGTACAGCACTCGATCCGCAGGATGAGGCGCAG  240 
 
241   CGTGAGCAGGCCTATAAACTGTGGCAGGCATTCGATATGGAGGCGGGTGTGGGTGACCTG  300 
       | ||||| ||||| || || |||||||| ||||| |||||||| || ||||| || ||| 
241   AGAGAGCAAGCCTACAAGCTCTGGCAGGCCTTCGACATGGAGGCCGGCGTGGGCGATCTG  300 
 
301   GAGGCGGCAATCCGCTACGCGCGTCACCAGCCGTACAGCAATGGTAAAGTTGGCCTGGTC  360 
      ||||| || |||||||| ||||| ||||| || |||||||| || || || ||  ||||  
301   GAGGCTGCTATCCGCTATGCGCGACACCAACCCTACAGCAACGGCAAGGTGGGATTGGTG  360 
 
361   GGTTATTGCCTGGGTGGTGCACTGGCGTTTCTGGTGGCAGCGAAGGGTTACGTCGATCGT  420 
      || ||||||||||| ||||| || || ||||| ||||| || || || ||||| |||||  
361   GGGTATTGCCTGGGCGGTGCGCTTGCCTTTCTAGTGGCCGCCAAAGGATACGTGGATCGC  420 
 
421   GCGGTCGGCTACTATGGCGTCGGCCTGGAGAAACAACTGAAGAAAGTGCCGGAGGTTAAA  480 
      || || |||||||| || || || |||||||| || || || || || ||||| || ||  
421   GCCGTAGGCTACTACGGTGTTGGACTGGAGAAGCAGCTCAACAAGGTCCCGGAAGTCAAG  480 
 
481   CATCCTGCCTTGTTCCACATGGGTGGCCAGGATCACTTTGTTCCGGCACCGAGCCGCCAA  540 
      ||||| || ||||| |||||||| ||||| || ||||| || || || || ||||||||  
481   CATCCGGCGTTGTTTCACATGGGCGGCCAAGACCACTTCGTGCCCGCGCCAAGCCGCCAG  540 
 
541   CTGATCACTGAAGGTTTCGGCGCCAATCCGCTGCTGCAGGTTCATTGGTACGAGGAAGCG  600 
      ||||| |||||||| ||||| ||||||||  ||||||| || || |||||||| || ||  
541   CTGATTACTGAAGGCTTCGGTGCCAATCCATTGCTGCAAGTGCACTGGTACGAAGAGGCC  600 
 
601   GGTCATAGCTTTGCGCGTACGTCCTCTAGCGGTTATGTTGCCTCCGCAGCGGCCCTGGCG  660 
      || ||    || ||  | |||  |  |   || ||||| ||    || |||||  ||||  
601   GGACACTCGTTCGCCAGGACGAGCAGTTCGGGCTATGTGGCGAGTGCCGCGGCGTTGGCC  660 
 
661   AACGAACGCCGTTTGGACTTTCTGGCACCGCTGCAAAGCAAGAAGCCGTGATAA  714 
      ||||||||     |||| || ||||| ||  |||| ||||||||||| | |||| 
661   AACGAACGTACACTGGATTTCCTGGCGCCCTTGCAGAGCAAGAAGCCATAATAA  714 
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Figure 3.4 Comparison of the expression of DLH from the native and optimised genes  
 
 
 
3.2.2. The pJWL1030folA-DLH fusion construct 
The clcD and clcDopt genes encoding DLH were cloned into the pJWL1030folA fusion vector by Dr. 
Jian-Wei Liu and Ms. Tracy Murray. The clcD gene was PCR amplified then digested with DpnI, 
NdeI and PstI restriction enzymes then ligated into pJWL1030folA at the latter two sites. Cloning of 
the clcDopt gene differed out of necessity since it contained an internal PstI restriction site. An NsiI 
restriction site was inserted at the 3’ end of the clcDopt gene, which was subsequently digested with 
NdeI and NsiI. The NsiI and PstI restriction enzymes create complementary 3’ overhangs, enabling 
ligation of the clcDopt gene into pJWL1030folA at the NdeI and NsiI/PstI restriction sites. 
 
 
3.2.2.1. Deletion C-terminal DLH residues 
For reasons explained later (Section 3.3.2.1), the nucleotides encoding the three C-terminal residues 
were removed. This was done by PCR (Section 2.2.2) using mutagenic reverse primers (Table 3.1) 
coupled with a forward vector primer (Table 3.2). Amplified products were either digested with 
NdeI and EcoRI and ligated into pCY76 or digested with NdeI and HindIII and ligated into 
pJWL1030folA. Constructs were confirmed with DNA sequencing prior to use.  
  
 The original cloning method saw the four amino acid stretch of linker differ between the 
native (-LQKL-) and optimised DLH (-MQKL-) fusion constructs. Hence the clcDopt 234Del-1 
mutagenic primer also encoded a single nucleotide mutation to change the methionine (ATG) to 
leucine (CTG) making the linker the same in both constructs.  
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Table 3.1 Primers for deletion of KKP sequence from the C-terminus of DLH 
Primer Sequence 
4pCY76 5’- GCC GGC GAT ATC GGA TCC G -3’ 
clcD 234Del-1 5’- GA TTC TTA AAG CTT CTG CAG GCT CTG CAA GGG CGC -3’ 
clcD 234Del-2 5’- GAT AAG CTT CTG GAA TTC TTA TTA GCT CTG CAA GGG CGC -3’ 
clcDopt 234Del-1 5’- GA TTC TTA AAG CTT CTG CAG GCT TTG CAG CGG TGC -3’ 
clcDopt 234Del-2 5’- GAT AAG CTT CTG GAA TTC TTA TTA GCT TTG CAG CGG TGC -3’ 
 Note: The nucleotides encoding the linker are shown in bold and the underlined codon encodes 
   the methionine to leucine mutation. 
 
Table 3.2 Template DNA, forward and reverse mutagenic primers for PCR amplification 
Template DNA Forward Primer 
Reverse  
Primer 
(Mutagenic) 
Final Construct 
pCY76/clcD 4pCY76 clcD 234Del-1 pJWL1030folA/clcD $KKP 
pJWL1030folA/clcD 4pCY76 clcD 234Del-2 pCY76/clcD $KKP 
pCY76/clcDopt 4pCY76 clcDopt 234Del-1 pJWL1030folA/clcDopt $KKP 
pJWL1030folA/clcDopt 4pCY76 clcDopt 234Del-2 pCY76/clcDopt $KKP 
pCY76/clcD C123S 4pCY76 clcD 234Del-1 pJWL1030folA/clcD C123S $KKP 
 
  
3.2.3. Original DHFR Fusion System Selection Protocol 
The original protocol for the improvement of protein solubility using the DHFR fusion reporter 
system protocol has been previously published.70 Transformed cells were washed with sterilized 
water then plated on Mueller Hinton (MH) Agar supplemented with 50 µg mL-1 kanamycin and the 
appropriate concentration of TMP. Plates were incubated at 37 °C for up to 5 days or until colonies 
developed. The use of MH agar rather than LB agar was important. TMP exhibits its antibacterial 
properties by inhibiting DHFR and thus preventing thymidine production (Section 3.1.2). LB 
contains large quantities of thymidine and would therefore neutralise the effect of TMP. MH media 
lacks thymidine so was a suitable substitute for LB in these experiments.   
  
 
3.2.4. Characterisation 
Preliminary characterisation of evolved DLH variants was conducted to assess solubility, activity 
and stability. These assessments were done using the variants as fused entities with DHFR and also 
unfused to DHFR expressed using the pJWL1030folA and pCY76 expression vectors respectively. 
!&)!
Solubility was evaluated from SDS-PAGE analysis (Section 2.4). Methods for activity and stability 
analysis are described below as well as preparation of the unfused variant constructs.  
 
 
3.2.4.1. Preparation of the Unfused Constructs in pCY76 
The genes encoding the native and evolved DLH variants were PCR amplified out of pJWL1030folA 
using the 4pCY76 forward primer and a reverse mutagenic primer encoding insertion of an EcoRI 
restriction site at the 3’ end of the DLH gene. The previously used clcD 234Del-2 reverse mutagenic 
primer was used for the 1-1 and 3-5 variants. However, the 2-4 variant required design of the S233N 
234Del-2 primer to accommodate the S233N mutation (Table 3.3), which would otherwise have been 
lost using the clcD 234Del-2 primer. The amplified genes were then digested and ligated into pCY76 
at the NdeI and EcoRI restriction sites (Section 2.2.3 and 2.2.4). 
 
Table 3.3 Primers for deletion of KKP sequence from the C-terminus of DLH 
Primer Sequence 
clcD 234Del-2 5’- GAT AAG CTT CTG GAA TTC TTA TTA GCT CTG CAA GGG CGC -3’ 
S233N 234Del-2   5’- G CTT CTG GAA TTC TTA TTA GTT CTG CAA GGG -3’ 
Note: The codon in bold encodes reside 233 and the underlined nucleotide shows the mutation to 
facilitate retention of the S233N mutation in the evolved 2-4 DLH variant. 
 
 
3.2.4.2. Lysate Activity and Residual Activity 
The activity of the native DLH and evolved variants was assessed with enzyme expressed unfused 
using pCY76 and expressed fused using pJWL1030folA. The cells were grown in 96 well microtitre 
plates for 24 hours in 200 µL of LB media supplemented with ampicillin when using pCY76 and 
kanamycin when using pJWL1030folA. The cells were pelleted then resuspended and lysed with 
200 µL of 20 mM HEPES, 1 mM EDTA at pH 7.5 with 2 % (v/v) BugBuster (Novagen). Lysed cells 
were assayed for activity using 250 µM p-nitrophenyl acetate as substrate and monitoring the 
formation of p-nitrophenolate at 405 nm. Assays were performed in triplicate and the errors are the 
standard deviation between the triplicates. 
  
 Stability was evaluated only for the unfused enzyme and was done by monitoring residual 
enzyme activity following heat treatment. Cells were grown for 24 hours in 96-well mictrotitre 
plates then pelleted and lysed as previously. Lysed cells were pelleted and the supernatant was 
divided equally between three PCR plates and heated using the gradient function on a C1000 
thermal cycler (Bio-Rad). Samples were heated for 15 min followed by 15 min at 4 °C to allow for 
possible refolding then activity was measured as detailed above. Data was collected in duplicate 
with 20 data points for each and melting temperatures were determined by fitting the following 
equation125 to the data: 
! &*!
a = a0 – (a0 x Th)/(Th + Th1/2) 
 
 
3.2.5. Determination of Solvent Accessible Surface Area 
The solvent accessible surface area (ASA) for each residue in DLH was determined using the 
AreaIMol application in the CCP4 suite of programs.126, 127 The relative ASA was calculated for each 
residue by expressing the values as a percentage compared to the ASA of the same residue type in a 
Gly-X-Gly tripeptide.128 
 
 
3.3. Results and Discussion 
 
3.3.1. Preliminary Results 
Prior to commencement of the directed evolution experiments to improve the solubility of DLH 
using the DHFR fusion vector, preliminary testing was carried out. The TMP resistance of native 
DLH-DHFR was determined using unfused DHFR as a positive control and an insoluble protein 
(C11) fused to DHFR as a negative control (Table 3.4).  
 
Table 3.4 TMP resistance conferred by native DLH fused to DHFR 
TMP 
(µg/mL) 
DHFR (control) DLH – DHFR C11* – DHFR (control) 
1 day 3 days 5 days 1 day 3 days 5 days 1 day 3 days 5 days 
0 +++++ +++++ +++++ +++++ +++++ +++++ +++++ +++++ +++++ 
10 +++++ +++++ +++++ +++++ +++++ +++++ - - - 
20 +++++ +++++ +++++ +++++ +++++ +++++ - - - 
50 + ++++ +++++ + +++ +++++ - - - 
100 - ++ ++ - + +++ - - - 
150 - + + - - ++ - - - 
200 - - - - - - - - - 
* C11 is an insoluble protein serving as a negative control  
 
 Based on these initial TMP resistance assays, there were two concerns affecting the 
reliability of the selection. The first was the indistinguishable difference in TMP resistance conferred 
by DLH fusion product and unfused DHFR. The second was the poor growth of the positive control 
at high TMP concentrations (>100 µg/mL) – i.e. when E.coli containing unfused DHFR were grown 
on agar plates without TMP there were thousands of colonies but when the same cells were plated 
on agar containing high levels of TMP, only a handful of colonies developed. In the original 
experiments, the maximum TMP concentration used during the directed evolution of 
acetyltransferase was 100 µg/mL.70 It was deduced that at moderate to high concentrations of TMP 
!&+!
the cells cannot express protein fast enough to confer resistance. In other words at high 
concentrations of TMP, large amounts are needed to bind the TMP and this is not achievable fast 
enough to ensure survival of the cell. Whereas at low concentrations of TMP, relatively small 
amounts of DHFR are required so resistance is conferred and growth is uninhibited.  
 
 
3.3.2. Modifying the System 
It was thought that the inconsistencies with cell growth at high TMP concentrations could be 
overcome by pre-culturing the cells prior to TMP selection. Thus, this was investigated in the design 
of a modified system suitable for the directed evolution of proteins with moderate to high levels of 
existing solubility. 
 
 
3.3.2.1. Re-construction of the Target-Fusion Linker 
In addition to addressing the previous concerns outlined above, a pre-emptive change was first 
made to the construct. A previous evolution using the existing system, conducted in the Ollis 
laboratory by Dr. Amalia Mohd Hashim, encountered an unexpected problem.129 During the 
evolution a fused variant was identified conferring TMP resistance matching that of unfused DHFR. 
DNA sequencing showed this was due to the evolution of a ribosome binding site (RBS) in the 
linker, such that DHFR was being expressed freely conferring the high resistance.  
  
 DLH has a RBS encoded at the end of the gene (discussed in Publication 1). To prevent 
issues from arising due to the RBS, the nucleotide sequence encoding the three C-terminal residues 
was removed (Section 3.2.2.1). This had the additional effect of essentially shortening the peptide 
linker (Figure 3.5) since these residues are highly flexible and do not form part of any secondary or 
tertiary structure.   
 
Figure 3.5 Removal of three C-terminal residues and the resulting fusion products 
Native DLH fused to DHFR 
DLH with three C-terminal residues deleted 
   DLH … L Q S K K P L Q K L I S L … DHFR 
DLHopt … L Q S K K P M Q K L I S L … DHFR 
 
   DLH … L Q S . . . L Q K L I S L … DHFR 
DLHopt … L Q S . . . L Q K L I S L … DHFR 
Linker 
! &.!
  
 The solubility and TMP resistance of the fusion product was re-evaluated upon removal of 
the three C-terminal residues ($KKP). SDS-PAGE analysis was used to assess the solubility and 
expression of the fusion product (expressed using pJWL1030folA, Figure 3.6) and the free enzyme 
(expressed using pCY76, Figure 3.7). TMP resistance assays were carried out as previously using 
unfused DHFR and C11-DHFR as the positive and negative controls respectively (Table 3.2). 
 
 
Figure 3.6 Expression and solubility of DLH expressed fused to DHFR using pJWL1030folA 
 
 
 
Figure 3.7 Expression and solubility of DLH expressed unfused using pCY76 
 
 Expression and solubility of DLH $KKP was very similar to the full-length enzyme when 
expressed unfused using pCY76 in E. coli. When expressed fused to DHFR using pJWL1030folA, 
there was a reduction in overall expression resulting in the production of less soluble protein. This 
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was reflected in the significant decrease in TMP resistance exhibited by cells expressing the DLH 
$KKP-DHFR fusion product (Table 3.5). As such, the previous concern regarding the 
indistinguishable resistance conferred to cells by free DHFR and fused DLH-DHFR was overcome 
by deletion of these three C-terminal DLH residues. 
 
Table 3.5 TMP resistance conferred by DLH $KKP fused to DHFR 
TMP 
(µg/mL) 
DHFR (control) DLH $KKP – DHFR C11* – DHFR (control) 
1 day 3 days 5 days 1 day 3 days 5 days 1 day 3 days 5 days 
0 +++++ +++++ +++++ +++++ +++++ +++++ +++++ +++++ +++++ 
10 +++++ +++++ +++++ - ++ +++ - - - 
20 +++++ +++++ +++++ - - + - - - 
50 + ++++ +++++ - - - - - - 
100 - ++ ++ - - - - - - 
150 - + + - - - - - - 
200 - - - - - - - - - 
* C11 is an insoluble protein serving as a negative control 
 
 
3.3.2.2. Modified DHFR Fusion Vector Selection Protocol 
Modification of the system was based on the premise that at high TMP concentrations, protein was 
not expressed at a fast enough rate to confer resistance. Thus, use of a pre-culturing period was 
utilised, allowing cells to begin expression of the necessary fusion product before plating on TMP 
supplemented agar plates.  
  
 Transformed cells (50 µL) were inoculated into 5 mL MH broth and incubated for 24 hours 
before being plated onto TMP supplemented MH agar plates. The plates were incubated for 40-48 
hours before colony growth was assessed. TMP resistance conferred by DLH $KKP-DHFR, C11-
DHFR and unfused DHFR using the new protocol showed distinct differences and more rapid 
colony growth (Table 3.6). This modified approach to the DHFR fusion reporter selection system 
was successfully implemented and used to select for more soluble DLH variants. 
 
 
 
 
 
 
 
 
! '$!
 
Table 3.6 TMP resistance conferred by the truncated DLH fused to DHFR 
TMP (µg/mL) DHFR (control) DLH $KKP – DHFR C11* – DHFR (control) 
0 +++++ +++++ +++++ 
10 +++++ +++++ - 
20 +++++ +++++ - 
30 +++++ ++++ - 
40 +++++ ++++ - 
50 +++++ - - 
60 +++++ - - 
* C11 is an insoluble protein serving as a negative control 
 
 
3.3.3. Directed Evolution 
Three rounds of library generation and selection were carried out using the modified DHFR 
selection system. Random mutagenesis libraries were generated by error-prone PCR (with 0.2 mM 
MnCl2) across the entire coding region (Section 2.2.2.1). The TMP concentration for selection was 
increased in each round (50, 70 then 80 µg mL-1). Colonies that grew during the initial plating were 
streaked onto a second plate with an identical TMP concentration and grown overnight to confirm 
resistance (Figure 3.8, Table 3.7). 
 
 
Figure 3.8 Experimental workflow for the directed evolution of DLH using the modified DHFR 
fusion reporter system 
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Table 3.7 Amino acid variations over three rounds of directed evolution for improved solubility 
 
 
 
 Three selected variants from generations one and two and five variants from generation 
three (! Table 3.7) were selected for further testing and characterisation. The window of TMP 
resistance was determined by plating transformed cells onto agar plates supplemented with a range 
of TMP concentrations (Table 3.8). Inconsistencies with colony growth were observed, the exact 
reason for this was unknown as it was thought that this was rectified by addition of the pre-
culturing step. Regardless, the TMP resistance of cells expressing native or variant DLH fusion 
products could still be accurately compared.   
  
Table 3.8 TMP resistance of cell expressing the evolved variants fused to DHFR 
 Time (days) 
TMP (µg/mL) 
0 40 50 60 70 80 90 100 
Native 
1 +++++ - - - - - - - 
2 +++++ + - - - - - - 
3 +++++ ++ + - - - - - 
4 +++++ +++ + + + - - - 
1-1 
1 +++++ + - - - - - - 
2 +++++ ++ + + + - - - 
3 +++++ +++ ++ + + + - - 
4 +++++ +++ +++ + + + + - 
1-2 
1 +++++ - - - - - - - 
2 +++++ + + - - - - - 
3 +++++ + + + + - - - 
4 +++++ ++ + + + - - - 
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1-4 
1 +++++ - - - - - - - 
2 +++++ - - - - - - - 
3 +++++ + + + + - - - 
4 +++++ ++ + + + + + - 
2-2 
1 +++++ - - - - - - - 
2 +++++ + - - - - - - 
3 +++++ + + - - - - - 
4 +++++ + + + + + - - 
2-4 
1 +++++ - - - - - - - 
2 +++++ +++ + - - - - - 
3 +++++ ++++ ++ + + + - - 
4 +++++ +++++ +++ +++ ++ + + + 
2-5 
1 +++++ - - - - - - - 
2 +++++ + - - - - - - 
3 +++++ + - - - - - - 
4 +++++ + + + - - - - 
3-1 
1 +++++ - - - - - - - 
2 +++++ + + - - - - - 
3 +++++ ++ + - - - - - 
4 +++++ ++ + + + + - - 
3-2 
1 +++++ - - - - - - - 
2 +++++ + - - - - - - 
3 +++++ + - - - - - - 
4 +++++ + + - - - - - 
3-3 
1 +++++ - - - - - - - 
2 +++++ + + + - - - - 
3 +++++ ++ + + - - - - 
4 +++++ ++ + + + - - - 
3-4 
1 +++++ - - - - - - - 
2 +++++ + - - - - - - 
3 +++++ + - - - - - - 
4 +++++ ++ + + - - - - 
3-5 
1 +++++ - - - - - - - 
2 +++++ ++ + - - - - - 
3 +++++ +++ ++ ++ + + - - 
4 +++++ ++++ +++ +++ ++ + + - 
Note: Underlined variants are those that have been further characterised 
 
 
3.3.4. Characterisation 
Native DLH and the best variants (1-1, 2-4 and 3-5) based on observed TMP resistance limit (Table 
3.8) were selected for further characterisation (all $KKP). This included assessment of solubility, 
expression, stability and activity of the variants as fused entities with DHFR expressed using 
pJWL1030folA and also unfused to DHFR expressed using pCY76.  
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3.3.4.1. Solubility 
SDS-PAGE was used to assess the expression and solubility of the fusion products and the free 
enzymes expressed using pCY76 (Figure 3.9).  
 
 
Figure 3.9 SDS-PAGE of native and evolved DLH variants expressed (A) fused to DHFR using 
pJWL1030folA and (B) unfused using pCY76 
 
 In pJWL1030folA, the 1-1 and 3-5 variant fusion products appear to be marginally more 
soluble while the 2-4 variant forms an insoluble fusion product. However SDS-PAGE gives only a 
gross estimate of expression and solubility therefore it is difficult to compare these minor changes 
with absolute accuracy.  
  
 The insoluble expression of the 2-4 was unsurprising based on the amino acid mutations 
(H14R, E36G, G121R, F173Y, Y197R and S233N). Residue 36 is located in the active site where it is 
involved in substrate binding, substitution of the charged glutamic acid to glycine would interfere 
with interaction in the active site during catalysis. Moreover residue 121 is in the core of the enzyme 
and forms part of a conserved sequence motif around the nucleophile C123S (SR–X–Nu–X–SR–SR, 
section 1.4.1), where in the case of DLH the small residues (SR) are glycines. Mutation of glycine to a 
large, positively changed arginine residue would undoubtedly cause clashes and disrupt packing in 
the hydrophobic core. In addition the G121R mutation would likely distort formation of the tight # 
turn necessary to maximise exposure of the nucleophile into the active site during catalysis. 
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Expression of free DHFR was not observed for the native or any of the variants in the fusion system, 
so it is unknown why the insoluble 2-4 variant confers the highest level of TMP resistance. 
  
 When expressed unfused using pCY76 the same trend can be seen, the 1-1 and 3-5 variants 
are soluble with a probable slight improvement over the native enzyme. They also appear to have 
better overall expression that the native enzyme, while again the 2-4 variant was insoluble.   
  
 
3.3.4.2. Activity and Stability 
The activity of the variants was tested in a crude lysate assay with enzyme expressed unfused using 
pCY76 and expressed fused to DHFR using pJWL1030folA (Figure 3.10). The cells were grown 
overnight then lysed and assayed for activity toward p-nitrophenyl acetate. 
 
 
Figure 3.10 Lysate activity of native and selected variants as free enzyme and fusion product 
 
 Activity of the native enzyme and the 1-1 and 3-5 variants when expressed unfused was 
very similar and within error. As expected, and consistent with the observed insoluble expression, 
the 2-4 variant was inactive. Expression of the fused constructs using pJWL1030folA was lower than 
overexpression of the free enzymes (Figure 3.9). As such the quantity of enzyme obtained from 24 
hours expression in 96-well plates was insufficient to accurately measure and compare activity.  
  
 The stability of native DLH and the 1-1 and 3-5 variants was assessed using residual activity 
(Figure 3.11). The 2-4 variant was not subjected to this testing since it had already been proven to be 
unstable through lack of activity and solubility.  
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Figure 3.11 Stability of native and evolved variants (A) residual activity plots and (B) extracted 
melting temperatures 
 
 The 1-1 variant contains only a single amino acid mutation (Q170R) and the 3-5 variant 
contains only two mutations (N154S and Q170R). Single or double mutations to the surface of an 
enzyme that do not change the activity but do give modest improvements to solubility should not 
significantly alter stability. 
 
 The error associated with the stability measurements was relatively high since crude lysate 
was used in these assessments rather than purified protein. Slight differences in melting 
temperature between native DLH (Tm = 55 ± 1 °C) and the 1-1 (Tm = 53 ± 2 °C) and 3-5 (Tm = 56 ± 
2 °C) evolved variants could not be distinguished since all were within error. However, the data 
was sufficient to conclude that, as expected, there was no significant change in stability. 
 
 
3.3.5. Location of Mutations 
It was anticipated that most mutations would be at the surface of the enzyme since solubility was 
the targeted property. Figure 3.12 shows the relative solvent accessible surface area (ASA) for sites 
where mutations occurred during the three rounds of directed evolution. The relative ASA gives the 
percentage ASA of each residue in the protein compared to the ASA of the same residue side chain 
in a Gly-X-Gly tripeptide (Section 3.2.5).128 
 
 Most mutations that occurred during the directed evolution of DLH from improved 
solubility were at sites at least partially solvent accessible. Only seven sites – E36, Y56, L63, G121, 
V138, L164 and Y197 – had less than 10 % relative ASA and of these only one (Y197) occurred more 
than once. Residue Y197 has an ASA of 10.8 Å2 in the crystal structure of native DLH and a relative 
ASA of 4.7 % when the ASA of a tyrosine side chain in a Gly-Tyr-Gly tripeptide is taken into 
account.  
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Figure 3.12 Relative solvent accessible surface area of mutation sites in DLH 
 
 Figure 3.13 shows the location of the mutations from the variants that conferred increased 
TMP resistance compared to the native enzyme when tested on a range of TMP concentrations 
following the directed evolution (Table 3.8). Residue 197 is on the surface of the enzyme but the side 
chain is orientated towards the interior of the enzyme. It is possible that the Y197H mutation causes 
the side chain to change orientation and interact with the solvent on the surface of the enzyme. 
However, a crystal structure would be required to validate this speculation. 
  
 
Figure 3.13 Location of amino acid mutations found during the directed evolution of DLH or 
improved solubility where mutation text colour corresponds to the relative ASA 
 
 None of the mutations are in the internal hydrophobic centre of the enzyme, all are on the 
surface in solvent exposed positions or positions with the potential for exposure upon side chain 
rotation (Y197). The most prominent mutations from the evolution were the N154S and Q170R 
H1
4 
K2
5 
E3
6 
Y5
6 
L6
3 
G9
8 
E1
01
 
Y1
06
 
Q1
10
 
K1
16
 
G1
21
 
V1
38
 
G1
48
 
K1
51
 
N1
54
 
L1
64
 
Q1
70
 
H1
72
 
F1
73
 
Q1
93
 
Y1
97
 
L2
25
 
S2
33
 
N - - C 
!  Buried residue (<10 % relative ASA) 
!  Partially solvent exposed residue (10 – 40 % relative ASA) 
!  Solvent exposed residue (40 – 70 % relative ASA) 
!  Highly solvent exposed residue  (>70 % relative ASA) 
* * * * * * 
suspected false positive mutations 
!'+!
mutations that were present in the characterised 1-1 and 3-5 variants and also the E101K mutation 
that was present in several variants across all three generations. 
 
 
3.4. Conclusion 
The DHFR fusion reporter system was adapted and used to evolve DLH variants possessing a 
higher level of solubility than the native enzyme. Three rounds of library generation and selection 
were carried out to yield a variant (3-5: N154S and Q170R) that when fused to DHFR, conferred 
TMP resistance at 80 µg/mL after 3 days growth compared to 50 µg/mL for the native enzyme 
(Table 3.8). 
  
 Although the modified method was implemented with relative success, the evolution was 
limited to three generations due to time constraints and priority being given to other projects 
(Chapters 4 - 6). Additionally the presence of false positives was of concern and this would have 
needed to be addressed before continuation of the evolution. Nevertheless, several variants and 
mutations were identified. The 1-1 (Q170R) and 3-5 (N154S and Q170R) variants appeared to show 
increased expression and solubility by SDS-PAGE while showing no appreciable change in stability 
or activity. The 2-4 variant, although it unexplainably conferred the highest TMP resistance, was 
insoluble. Several promising mutations (E101K, Y106H, G148E, H172R, Y197H and L225P) were 
identified in other variants that should the evolution have been continued would have likely 
featured.  
 
 These were preliminary results and although not complete, they provide a platform for 
future work. Be this through the continuation of the directed evolution of DLH or through 
implementation of the modified DHFR fusion reporter system protocol for the evolution of other 
enzymes with some level of pre-existing solubility.  
 
 
3.5. Future Work 
Future work on this project involves purification of the native enzyme and the best evolved variants 
(1-1 and 3-5) for more accurate characterisation. To accurately measure and compare protein 
solubility, the concentration of protein can be measured when there is equilibrium between soluble 
and precipitated protein. This must be done at a known and constant pH, since protein solubility is 
also pH dependent. Crystal structures of the evolved variants would also be useful in order to 
assess possible structural changes resulting from the mutations. 
  
 In order to continue use of the DHFR fusion system for selection of highly soluble DLH 
variants, the high TMP resistance of the 2-4 DLH fusion product should ideally be investigated. 
Understanding why this variant conferred a high level of TMP resistance when little or no soluble 
protein was expressed would aid in the early identification or prevention of future false positive 
results. 
! '.!
 With further small modifications to the system, the directed evolution could be successfully 
continued in the future to produce DLH variants with very high levels of solubility. Insertion of a 
tertiary screen monitoring for changes in activity would ensure insoluble variants and variants with 
unfavourable active site mutations were eliminated. This screen would need to be performed on a 
larger scale than provided by a 96-well microtitre plate, since activity is not detectable on this small 
scale (Section 3.3.4.2). However, addition of such a tertiary screen – although helping to eliminate 
false positives – would also eliminate variants with improved solubility in the denatured state. 
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Altering Substrate Specificity 
 
The article “Directed evolution of new and improved enzyme functions using an evolutionary 
intermediate and multi-directional search” published in ACS Chemical Biology forms the basis for 
this chapter. 
 
 
4.1. Introduction and Chapter Outline 
In the publication presented in this chapter (Section 4.2) we used three sequential directed evolution 
experiments to alter and enhance the activity of DLH toward a range of p-nitrophenyl esters. 
Stability was continually monitored throughout the course of the evolution and was selectively 
improved when substantial losses were observed. A range of evolved variants from different stages 
of the evolution were characterised kinetically and studied structurally to elucidate the roles of the 
active site mutations.  
  
 Our immediate aims in carrying out this work and in using DLH, a simple and well 
characterised !/" hydrolase fold enzyme, was to: 
 
1. Take the proven !/" hydrolase fold catalytic framework and broaden the substrate range – as 
nature has done over millions of years – and in doing to alter DLH from an enzyme with very low 
levels of activity toward simple esters to an enzyme capable of hydrolysing ester and lipid 
substrates. 
 
2. Highlight, as has been done before, the importance of stability in a directed evolution experiment. 
! ($!
 
3. Complete a thorough structural and mechanistic analysis of evolved variants to deduce the 
specific roles of individual mutations and contribute to our understanding of enzyme evolution and 
more globally to evolutionary biology.  
 
4. Develop assays and a standard for which the evolution of more complex and less well 
characterised enzymes could be compared (particularly for use in the Ollis Laboratory).   
 
 Following the article reproduced in this chapter (Section 4.2) some additional comments and 
experimental results are presented. This includes comments on the motivation behind the use of 
random mutagenesis over site-saturation mutagenesis (SSM) as the main library generation 
technique. An expanded account of some SSM work that was mentioned only briefly in the 
published article is also included. Lastly the long-term goals leading to the work in the publication 
and the future work required to achieve them is outlined.  
 
 
4.2. Reproduction of Published Article 
The following article is reproduced with permission. Copyright 2014 American Chemical Society. 
(http://pubs.acs.org/doi/abs/10.1021/cb500809f) 
 
J. L. Porter, P. L. S. Boon, T. P. Murray, T. Huber, C. A. Collyer, D. L. Ollis (2014) Directed evolution 
of new and improved enzyme functions using an evolutionary intermediate and multi-directional 
search. ACS Chem. Biol. doi:10.1021/cb500809f 
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ABSTRACT: The ease with which enzymes can be adapted from their native
roles and engineered to function speciﬁcally for industrial or commercial
applications is crucial to enabling enzyme technology to advance beyond its
current state. Directed evolution is a powerful tool for engineering enzymes with
improved physical and catalytic properties and can be used to evolve enzymes
where lack of structural information may thwart the use of rational design. In this
study, we take the versatile and diverse α/β hydrolase fold framework, in the form
of dienelactone hydrolase, and evolve it over three unique sequential evolutions
with a total of 14 rounds of screening to generate a series of enzyme variants. The
native enzyme has a low level of promiscuous activity toward p-nitrophenyl
acetate but almost undetectable activity toward larger p-nitrophenyl esters. Using p-nitrophenyl acetate as an evolutionary
intermediate, we have generated variants with altered speciﬁcity and catalytic activity up to 3 orders of magnitude higher than the
native enzyme toward the larger nonphysiological p-nitrophenyl ester substrates. Several variants also possess increased stability
resulting from the multidimensional approach to screening. Crystal structure analysis and substrate docking show how the
enzyme active site changes over the course of the evolutions as either a direct or an indirect result of mutations.
Although enzymes are remarkable catalysts, their use inmany practical applications is limited by the availability
of large quantities of stable enzyme with appropriate catalytic
properties. Directed evolution can be usefully employed to
enhance enzyme stability and alter substrate speciﬁcity to
engineer tailored biocatalysts.1−4 Mutations are introduced at
the genetic level yielding a library of variant enzymes that are
screened for a desired trait. It is extremely diﬃcult to evolve an
enzyme to have a completely new catalytic function; rather an
existing and weak promiscuous activity can be exploited and
greatly enhanced. Here we report the multistep process by
which the substrate speciﬁcity of the enzyme dienelactone
hydrolase (DLH) has been altered so that it can act upon ester
and lipase substrates with long alkyl chains (C4−C12), while
turnover of these substrates by the native enzyme is virtually
undetectable.
DLH is one of the many hydrolytic enzymes that has an α/β
hydrolase fold. While these enzymes do not necessarily share
any signiﬁcant sequence similarity, they do share remarkably
similar tertiary structures and a preserved arrangement of
catalytic residues, suggesting possible evolution from a common
ancestor.5,6 The catalytic residues include a highly conserved
triad, consisting of a nucleophile (serine, cysteine, or aspartic
acid), an acid, and a histidine. The most signiﬁcant variations
among these enzymes are in the residues responsible for
substrate binding. As well as hydrolases, enzymes exhibiting this
characteristic fold can include proteases, esterases, peroxidases,
lipases, and dehalogenases.7 It appears as if nature has taken an
eﬀective catalytic core and altered the substrate binding domain
to cater to a variety of substrates. We have set out to do the
same with DLH from Pseudomonas knackmussii one of the
simplest of known α/β hydrolase fold enzymes.8−10
DLH is 25.5 kDa monomeric protein and is the third of
four enzymes that constitute the chlorocatechol branch of the
β-ketoadipate pathway.11−14 It consists of 236 amino acids that
form eight strands of β-sheet in the core of the enzyme with
one buried α-helix and six others on the solvent accessible
surface.9 The catalytic triad consists of a cysteine (C123), an
aspartic acid (D171), and a histidine (H202).15 Previous
studies have shown that mutation of the nucleophile to a serine
(C123S) gives an enzyme with altered isomerase activity
toward the physiological substrate.16,17 The DLH C123S
variant was the starting point for the present study, referred
to as native DLH in the remainder of this report, since unlike
the native cysteine, serine is not prone to oxidation. It has
low but detectable activity toward simple substrates like p-
nitrophenyl acetate and α-naphthyl acetate but almost
nonexistent activity toward p-nitrophenyl butyrate and longer
chain p-nitrophenyl esters, too low to detect in crude lysates
during library screening.
We set out to generate DLH variants that have good activity
toward long chain p-nitrophenyl esters and in doing so alter the
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activity of the enzyme from a simple hydrolase to an esterase or
lipase. These are the most highly utilized biocatalysts where
they are commonly found in cleaning products and have appli-
cations in industries such as food processing and pharmaceu-
tics.18,19 Our intention was to ﬁrst increase the activity toward
p-nitrophenyl acetate with the understanding that this would
also give increased activity toward esters with longer chains
so that large libraries could then be screened for activity toward
p-nitrophenyl butyrate. At various stages in this process, we
monitored DLH expression and solubility. These latter
experiments were done because we were aware that increased
activity in crude lysates could be achieved through improve-
ments in expression or solubility. Additionally, we were aware
that active site mutations could compromise the overall stability
of the protein and thus hinder attempts to evolve for further
increases in activity; thus we also monitored changes in
stability.
■ RESULTS AND DISCUSSION
Overview. Three sequential directed evolution experiments
were carried out, each consisting of multiple rounds of
mutagenesis and screening (Figure 1). The method of library
screening was diﬀerent for each evolution, reﬂecting the aims of
the experiment. The ﬁrst evolution selected for improvements
in activity toward p-nitrophenyl acetate, a small ester substrate
to which the native enzyme possesses a low level of pro-
miscuous activity. Although only one property was targeted,
due to the nature of the screens, improvements in other
physical properties would also give rise to improvements in the
targeted property, termed coselectable properties. For example,
when we select for improved activity, a mutation improving
protein expression, even a silent mutation, would manifest as a
positive variant since the presence of more enzyme would increase
substrate turnover rate. Hence, improvements in expression,
solubility, or stability would provide positive results under the
screening conditions for improved enzymatic activity (see
Methods). Over the course of this evolution, especially during
the later rounds, several surface mutations were accumulated.
These mutations were assumed to be stabilizing since SDS-
PAGE analysis (Supporting Figure S1, Supporting Information)
showed no signiﬁcant changes in expression or solubility, although
SDS-PAGE gives only a gross estimate of these properties so
slight changes may have occurred.
It is widely acknowledged that a more stable protein has a
greater capacity to evolve.20−22 The additional stability confers
the ability to accommodate the often destabilizing mutations
that are required for the acquisition of new and improved
enzyme functions. Given that stabilizing mutations were
acquired during the ﬁrst set of evolution experiments and the
proven importance of protein stability on evolvability, a second
set of evolution experiments were conducted to produce a
variant with increased thermal stability. This variant was then
used as the starting point for the third and ﬁnal set of evolution
experiments to increase the activity and speciﬁcity of DLH
toward longer chain p-nitrophenyl esters. At this point, the level
of activity toward the longer chain esters was adequate for high-
throughput library screening.
Like the ﬁrst evolution, the second and third also had
coselectable properties that gave rise to improved variants
under the primary selection pressure. The stability of mutants
during the second evolution was determined based on residual
activity after incubation at an elevated temperature; therefore
more active variants could also be identiﬁed under this screen.
The coselectable traits for the third evolution toward p-
nitrophenyl butyrate were the same as the p-nitrophenyl acetate
evolution. As with the ﬁrst evolution, there appeared to be
minimal change to expression or solubility based on SDS-
PAGE analysis (Supporting Figures S2 and S3, Supporting
Information). To summarize, the following study presents a
three-dimensional search along three consecutive evolutionary
trajectories to evolve DLH for improved activity, substrate
speciﬁcity, and stability.
Directed Evolution toward an Evolutionary Inter-
mediate. Six rounds of directed evolution were carried out to
improve the activity of DLH toward p-nitrophenyl acetate
(Supporting Table S1, Supporting Information). Random
mutagenesis in the form of error-prone PCR was used to
generate genetic diversity, and libraries of 5000 variants were
screened. Library and screening details for all three evolutions
are given in Table 1. Three important active site mutations,
Q35H, F38L, and Y145C, were found individually in genera-
tion one and combined through shuﬄing in generation two
(Figure 2). The combined mutations in the generation two
variant (A-2) gave a 16-fold improvement in catalytic activity
compared with the native enzyme but reduced the stability of
the enzyme as shown by the 5.0 ± 0.4 °C decrease in melting
temperature. Melting temperature was determined from the
residual activity of the enzymes following heat treatment; Sup-
porting Figure S4, Supporting Information, shows the residual
activity plots, and Figure 3 shows the melting temperatures
determined by analysis based upon a Hill type equation (see
Methods).
Mutations and kinetic constants for the characterized variants
from this and following evolutions are shown in Tables 2 and 3.
The kcat of the best variants from generations 2, 4, and 6 (A-2,
A-4, and A-6) increased steadily, but absence of the F38L
mutation in the A-4 variant caused an increase in Km and
consequential drop in kcat/Km. The F38L mutation returned in
the A-6 variant, alongside the E199G and S208G mutations, all
of which were fully conserved in the ﬁnal generation. Residues
199 and 208 are on the loop containing H202 of the catalytic
triad, and mutation of these residues to glycine gives improved
activity. Over the subsequent generations, stabilizing surface
Figure 1. Strategy for the directed evolution of DLH.
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mutations compensated for the loss of stability introduced by
the active site changes enabling the enzyme to accommodate
and combine the activity enhancing mutations, which were fully
conserved in the ﬁnal round of evolution. Several mutations
(S7T, A24V, G17D, D53N, A65G, and Q110L) thought to
provide neutral or stabilizing eﬀects appeared multiple times
over the generations, of these the only one to be fully con-
served was Q110L. The best variant after six generations (A-6)
of evolution had a 45-fold increase in kcat/Km for the hydrolysis
of p-nitrophenyl acetate. It also showed improved activity
toward the larger p-nitrophenyl butyrate substrate with an
85-fold improvement in kcat/Km. Modest increases in substrate
speciﬁcity were indicated for both substrates with Km values
of 34 ± 2 and 146 ± 16 μM for p-nitrophenyl acetate and
butyrate compared with 40 ± 2 and 175 ± 4 μM for the native
enzyme.
Site saturation mutagenesis (SSM) was conducted on the A-6
variant at sites 38 and 145 individually and at sites 85 and 88
jointly. It was suspected that alternative residues could better
ﬁll the role of the F38L and Y145C mutations obtained during
evolution one. Residues Y85 and W88 were chosen because
they are involved in substrate binding. None of these sites
yielded beneﬁcial mutations; a scarce number of neutral
mutations were found, but most were detrimental (data not
shown).
Improving the Thermostability and Evolvability of
DLH. Three rounds of evolution were carried out to improve
the stability of DLH before we attempted to evolve activity
toward larger substrates (Supporting Table S2, Supporting
Information). The A-6 variant from the p-nitrophenyl acetate
evolution (Tm = 51.5 ± 0.2 °C) was used as a template for
library generation. Libraries with sizes in excess of 10000
variants were screened for each round with an average of 1−2
amino acid mutations per variant. The best variants from the
second and third generations (S-2 and S-3) had improved
thermal stability and improved activity toward both substrates.
These variants both contained the mutations Y137C, N154D,
and G211D. The latter mutation is to the loop containing the
histidine of the catalytic triad and contributed to the increased
Figure 2. Location of mutations accumulated over three sequential evolutions shown (A) in 3-D and (B) as a 2-D schematic.
Figure 3. Melting temperature of native and evolved DLH variants
calculated from residual activity.
Table 1. Experimental Details for Library Generation and Screening
mutation rate
number
of rounds
base
pairs
amino
acids
theoretical
library size primary screen method
primary
screen
sizea secondary screen method
secondary
screen size
evolution one 6 2 1 1400 activity assay (96-well plates) 5000 activity assay (96-well plates) 250
evolution two 3 3 1−2 3500 activity after heat treatment
(ﬁlter paper)
10000 residual activity after heat
treatment (96-well plates)
350
evolution three 5 stage 1: rounds 1−3 4 2 8500 activity assay (ﬁlter paper) 24000 activity assay (96-well plates) 350
stage 2: rounds 4−5 2 1 1400 activity assay (96-well plates) 5000 activity assay (96-well plates) 250
aTriple the theoretical library size should be screened in order the achieve 95% library coverage.
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activity. The only diﬀerence between the S-2 and S-3 variants
was the addition of a single mutation K234N at the C-terminus
of the S-3 variant. From crude lysate assays during screening, it
appeared the S-3 variant had approximately 2 °C higher melting
temperature than the S-2 variant (data not shown). This turned
out not to be the case when melting temperature was measured
more accurately using puriﬁed protein; the melting temper-
atures were in fact very similar and within error. The melting
temperatures determined from residual activity after 15 min
heat exposure using puriﬁed protein were 55.1 ± 0.5 and
55.5 ± 0.4 °C giving improvements of 3.6 ± 0.7 and 4.0 ±
0.6 °C, respectively (Figure 3).
Residues K234, K235, and P236 are highly ﬂexible and as a
result have always been disordered in crystal structures;
therefore determination of their inﬂuence on the properties
of the enzyme is diﬃcult.9,23,24 In response to the K234N muta-
tion that initially appeared to give increased activity, a variant
was engineered with these terminal residues deleted (S-Δ).
Characterization of this enzyme showed it had greater stability
(Tm 56.5 ± 0.2 °C) and solubility (Supporting Figure S2,
Supporting Information) than the full-length enzyme while
retaining similar kinetic properties.
Altering Substrate Speciﬁcity. Screening for improved
activity toward p-nitrophenyl butyrate was done in two stages
(Supporting Table S3, Supporting Information). Variants from
generations one and four were characterized. The generation
one variant (B-1) contained a single mutation additional to the
mutations conserved from the S-2 variant that was used as a
template for this evolution. The Y64H mutation was fully
conserved throughout ﬁve rounds of directed evolution; it is
located in the core of the enzyme separated from the active site
by residues of the oxyanion hole (A34, Q35(H), E36, and I37).
The B-1 variant had improved substrate speciﬁcity toward
p-nitrophenyl butyrate with a Km of 59 ± 2 μM compared with
175 ± 4 μM for the native enzyme. The Y64H mutation gave
an increase in kcat for both substrates, but the increase was more
signiﬁcant for the hydrolysis of p-nitrophenyl butyrate with a
kcat/Km value of (2.1 ± 0.1) × 104 M−1 s−1, which is 3 orders of
magnitude greater than the native rate of 21 ± 1 M−1 s−1.
The best variant from the fourth generation (B-4) contained
the additional mutations Q76L, A141V, and S233G and
incorporation of glutamine (237Q) at the C-terminus replacing
the ﬁrst of two stop codons in the DNA sequence. These
mutations were thought to be primarily stabilizing; however
they also caused a change in the kinetic proﬁle of the enzyme.
The Q76L mutation was thought to be responsible for this since
it is solvent exposed at the opening of the active sight. It caused
a slight decrease in substrate speciﬁcity but a 20% increase in kcat
for the hydrolysis of p-nitrophenyl butyrate compared with the
B-1 variant and an overall 400-fold increase compared with
the native enzyme. These mutations were conserved in the ﬁfth
generation where the evolution appeared to converge.
Addition of 237Q to the C-terminus of the enzyme was
unexpected since the terminal three residues are highly ﬂexible
and do not form part of any secondary or tertiary structural
elements. It is likely that these residues are the consequence
of a nucleotide sequence necessary for the translation of
the following enzyme in the operon. The genes (clcA, clcB,
clcD, and clcE) encoding the four enzymes of the modiﬁed
ortho-cleavage branch of the β-ketoadipate pathway are located
together in an operon (Supporting Figure S5, Supporting
Information). The clcE gene encoding maleylacetate reductase
is immediately after the clcD gene encoding DLH; consequentlyT
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there is a ribosome binding site and suspected proteolytic
cleavage site at the end of the DLH gene.25 We suspected that
the nucleotides encoding the three C-terminal DLH residues
are inconsequential to the function of DLH but are necessary
for translation of maleylacetate reductase. Deletion of the three
C-terminal residues, as in the S-Δ variant, did in fact improve
the stability and solubility (Supporting Figure S2, Supporting
Information) of the enzyme lending credence to this
hypothesis.
Enzymatic Activity toward Longer Acyl Chain p-
Nitrophenyl Esters. The native enzyme has low activity
toward both p-nitrophenyl acetate and butyrate with kcat/Km
values of 320 ± 10 and 21 ± 1 M−1 s−1, respectively (Figure 4).
All characterized variants have improved activity compared
with the native enzyme for these two substrates. The activity
of the native enzyme along with B-1 and B-4 variants
from the third evolution were measured toward the larger
p-nitrophenyl hexanoate (C6), octanoate (C8), decanoate
(C10), and dodecanoate (C12) substrates (Table 3b). This
was done in the presence of 0.2% Triton X-100 and 4%
dimethyl sulfoxide (DMSO) to bolster substrate solubility.
Kinetic parameters of the enzymes with the smaller C2 and
C4 substrates were measured in both buﬀer compositions for
consistency.
The addition of Triton X-100 and DMSO to the assay buﬀer
changed the Km values for the smaller substrates quite
drastically, especially in the case of p-nitrophenyl butyrate. In
aqueous buﬀer, the Km values for the native, B-1, and B-4
variants were 175 ± 4, 59 ± 2, and 80 ± 3 μM, while in the
presence of the detergent and organic solvent, the Km values
increased to 530 ± 90, 227 ± 16, and 402 ± 24 μM,
respectively. The native enzyme had the best activity toward
p-nitrophenyl acetate and almost negligible activity toward the
larger p-nitrophenyl ester substrates (C6−C12). The B-1 and
B-4 variants had good enzymatic activity toward all substrates
tested. The B-1 variant had kcat/Km of (1.3 ± 0.1) × 103 M−1 s−1
for the hydrolysis of p-nitrophenyl dodecanoate, a 2205-fold
improvement for this substrate and a 3.8-fold improvement
compared with the activity of the native enzyme toward its
favored p-nitrophenyl acetate substrate.
Structural Changes to the DLH Active Site over
Multiple Evolutions. The mutations Q35H, F38L, Y64H,
E199G, S208G, and G211D are either in or immediately
surrounding the enzyme active site. Singularly the Q35H
mutation gave the largest improvement in activity. In the native
enzyme Q35 hydrogen bonds with the backbone of E36 and
L63, these hydrogen bonds make the local structure more rigid
and stabilize the active site. The mutation of glutamine to
histidine is subtle in relation to size so the packing and
hydrophobic interactions of the surrounding residues remain
undisturbed. However, even with the crystal structures and
substrate docking simulations (see Methods), it was hard to
decipher the exact role played by the Q35H mutation in
facilitating the observed increased activity.
Mutations F38L and Y145C enlarge the enzyme active site in
favor of the larger nonphysiological substrates rather than the
smaller and more polar dienelactones. The substitution of
phenylalanine to leucine at position 38 is not drastic because
both residues are hydrophobic, but leucine is smaller so the
change increased the size of the active site. The substitution of
tyrosine to cysteine at position 145 was also exchanging a large
residue for a smaller one, thereby increasing the size of the
active site. Site-saturation mutagenesis (SSM) was performed at
this position with the belief that other residues such as serine or
alanine could ﬁll this role better than cysteine, especially since
in the A-6 variant it was oxidized. However, SSM yielded no
variants with activity equal to or better than the cysteine found
in the ﬁrst evolution (data not shown). Interestingly during
evolution two, the G211D mutation appeared, and in the
crystal structure of this variant and all subsequent variants, the
cysteine was not oxidized (Figure 5a). Mutation of glycine to
aspartic acid at position 211 caused the amide nitrogen of S203
to ﬂip in order to avoid a clash between the carboxylic acid of
G211D and the backbone carbonyl oxygen of H202. The new
position of the H202 carbonyl oxygen would cause a clash with
the oxidized cysteine at position 145 and therefore prevents
oxidation.
Other mutations important in enhancing the activity of DLH
are the mutations to loop 14 (residues 198−212) containing
H202 of the catalytic triad (Figure 5a). Loop 14 functions as a
cover for the active site, and mobility of this loop is important
to facilitate substrate binding and subsequent release of product
but more importantly to allow the crucial accessibility of H202
during catalysis. The proposed mechanism for the DLH
catalyzed hydrolysis of the native dienelactone substrates sees
the enolate−enzyme intermediate deprotonate the water
molecule itself to generate the nucleophile needed for release
of the product and regeneration of free enzyme.26 The
mechanism for the hydrolysis of p-nitrophenyl esters is thought
to follow that of the serine proteases whereby the catalytic
Figure 4. Speciﬁc activity toward two substrates over three evolutions and the ratio of kcat/Km for p-nitrophenyl butyrate to p-nitrophenyl acetate.
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histidine is responsible for generation of the hydroxide
nucleophile during the catalysis and not the substrate itself.27
This diﬀerence in mechanism explains the accumulation of
mutations on loop 14 and the evolution of increased ﬂexibility
allowing H202 more freedom where it was not required before.
The mutations E199G and S208G see the replacement of
larger residues for smaller and more ﬂexible glycine residues,
with one either side of H202. The substitution of two glycine
residues into the loop increased its ﬂexibility and subsequently
made the histidine more accessible during catalysis. The
normalized B-values for the H202 side chain of 0.77 and 1.01
for the native and generation A-6 variant represent a 30%
increase in relative thermal motion in the crystallographic
environment, which is consistent with increased mobility.
The mutation of tyrosine to histidine at position 64 gave
improved activity toward both substrates but an overall loss in
speciﬁc activity toward p-nitrophenyl acetate due to an increase
in Km. However, for the larger substrate, the Km decreased with
an improved kcat giving 3 orders of magnitude improvement in
kcat/Km for the hydrolysis of p-nitrophenyl butyrate. Residue 64
is separated from the active site by the residues of the oxyanion
hole. Both the original tyrosine and substituted histidine form
hydrogen bonds with the carbonyl oxygen of residue I37.
During catalysis, the enzyme−acyl tetrahedral intermediate is
stabilized by the backbone amide of I37 and L124 in the
oxyanion hole.26 In the crystal structures, the I37 side chain
protrudes into the active side in a decidedly similar position for
the native and evolved enzymes. Substrate docking experiments
showed that the substrate is prevented from binding tightly in
this pocket due to the position of this side chain. Mutation of
tyrosine to histidine at position 64 in the B-1 variant creates
space behind residue 37 enabling the side chain to rotate upon
substrate binding (Figure 5b). This rotation opens the active
site creating more space for the bulkier nonphysiological
p-nitrophenyl ester substrates allowing the carbonyl oxygen of
the substrate to hydrogen bond with residues I37 and L124 in
the oxyanion hole. The proximity of the polar part of the
substrate to the oxyanion hole will aid in stabilization of the
Figure 5. Evolution of the DLH active site showing (A) changes in the ﬂexibility of the active site loop and (B) change in substrate positioning
caused by the Y64H mutation.
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enzyme−substrate intermediate during catalysis and facilitate
release of products and regeneration of free enzyme thereby
increasing the catalytic rate. Although this mutation gave the
B-1 variant an increased kcat for all tested substrates, the
speciﬁcity is lowered for the smaller p-nitrophenyl acetate
substrate but signiﬁcantly increased for the larger p-nitrophenyl
butyrate substrate.
Overall Structural Changes. The overall structure of
native DLH and the evolved variants for which crystal
structures were obtained are decidedly similar. The RMS
displacements for the superposition of variant structures with
the native are 0.84, 0.86, 0.81, 0.81, and 0.84 Å for the A-6, S-2,
S-3, B-1, and B-4 variants. When the superposition was limited
to main-chain atoms, the RMS displacements were 0.40, 0.41,
0.40, 0.41, and 0.39 Å respectively. The RMS displacement plot
for residues of the native enzyme superimposed with the B-4
variant highlights structural regions with the most variation
(Figure 6). Unsurprisingly the most signiﬁcant change to the
protein backbone occurs at loop 14 where the previously
discussed mutations (E199G, S208G, and G211D) around the
catalytic H202 alter the local structure and increase the
ﬂexibility. Other regions showing slight change in structure
include the oxyanion hole where mutations Q35H and F38L
occur and loop 8 and 9 featuring mutations Q110L and Y137C.
■ CONCLUSIONS
Three consecutive sets of directed evolution experiments have
been used to successfully improve and alter the speciﬁcity of
DLH. The low level of promiscuous activity exhibited toward
p-nitrophenyl acetate has been increased such that the kcat/Km
of evolved variants approaches values typically observed in
enzymes, with the best variant showing a 175-fold improvement
over native DLH. The target substrate of the third evolution
can be hydrolyzed by variants at a rate 3 orders of magnitude
greater than the native enzyme. Additionally the evolved
variants have signiﬁcant activity toward a range of larger
p-nitrophenyl esters, while the native enzyme has virtually
undetectable levels of activity toward substrates with acyl chains
longer than C4. The kcat and kcat/Km of the best variants from
evolution three (B-1 and B-4) toward the C10 and C12
substrates were in excess of 2000-fold greater than the native
enzyme, with the best being a 2370-fold improvement in
kcat/Km for the hydrolysis of p-nitrophenyl decanoate (C10) by
the B-4 DLH variant.
The combination of seven active site mutations gave rise to
the changes in kinetic parameters. The mutations Q35H, F38L,
and Y145C gave improved activity toward all p-nitrophenyl
ester substrates, while the Y64H mutation was speciﬁc for larger
p-nitrophenyl esters. These mutations are in or around the
oxyanion hole, which is responsible for stabilization of the
enzyme−substrate intermediate complex. It is clear from the
magnitude of the observed increase in catalytic rate and
the position of these mutations that the oxyanion hole is better
able to serve its purpose in the evolved enzymes. Three
important mutations were accumulated in the loop containing
the histidine of the catalytic triad, E199G, S208G, and G211D.
These mutations increase the ﬂexibility of the loop resulting in
increased movability of H202 and therefore improved
accessibility during catalysis for its role in generation of the
nucleophile leading to release of the second product and
regeneration of free enzyme. Although most of the esterases
and lipases of the α/β hydrolase fold family have rather
elaborate substrate binding domains,6 DLH has a minimal
stretch of peptide responsible for substrate binding. Stretches of
helix B (Figure 2) and sections of loop 14 are involved in
substrate binding in DLH while in acetylcholinesterase a large
domain serves the same purpose.28 We have evolved DLH to
be capable of hydrolyzing esterase and lipase substrates even
though the residues responsible for substrate binding are
minimal. This may account for the evolved broad substrate
speciﬁcity.
Additional to the signiﬁcant activity improvements and
altered speciﬁcity of the evolved variants, the stability was
maintained throughout the three evolutions allowing the rapid
accumulation of active site mutations. Furthermore, the three
C-terminal residues have been shown to be superﬂuous to the
structure and function of DLH and are actually a source of
instability and most likely contribute to the initiation of protein
unfolding. Deletion of these residues increased not only the
stability but also the solubility of the enzyme.
The ease with which enzymes can be modiﬁed is crucial to
see the continued use of enzyme technology in roles outside
of those nature intended. This study conﬁrms the position
of directed evolution as a premier approach to engineering
enzymes tailored for speciﬁc industrial or commercial appli-
cations. The use of DLH, a simple and well-characterized
enzyme, has enabled a thorough structural and mechanistic
investigation of the mutations accumulated over three
sequential evolutions. This multidirectional approach has
displayed the rapid evolution of improved and altered catalytic
properties while maintaining a stable and evolvable protein.
This work presents the evolutionary pathway of an enzyme
under multiple selection pressures, activity, stability, and
speciﬁcity, and is of value to our global understanding of
evolutionary biology as well as setting a benchmark for the
Figure 6. RMS displacement plot for the superimposition of the native and B-4 DLH variant for both main-chain and side-chain atoms.
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future evolution of more complex and less well characterized
enzymes.
■ METHODS
Library Generation. Error-prone PCR with the addition of
manganese (0.1−0.2 mM) was used to introduce mutations into the
DLH gene (Supporting Table S5, Supporting Information). The PCR
product was digested at NdeI and EcoRI restriction sites and cloned
into the constitutive expression vector pCY7629 and then transformed
into electrocompetent DH5a Escherichia coli cells. DNA sequencing
was performed to test the mutation rate during library construction
and following screening for selected individual variants. This was done
on an AB 3730xI DNA analyzer (Applied Biosystems) at the ACRF
Biomolecular Resource Facility, JCSMR, at the Australian National
University.
Screening for Improved p-Nitrophenyl Acetate Activity. The
transformed cells carrying the library of DLH variants were diluted
with ampicillin supplemented LB media and distributed into 96-well
plates with 2−3 colony forming units (CFU) per well and grown for
24 h. The mutation rate of this library was one to two base changes per
gene leading to an average of one amino acid change per enzyme. For
the primary screen, cells were lysed using BugBuster (Novagen)
and then assayed for p-nitrophenyl acetate activity with monitoring at
405 nm. The top 3−4% of wells from the primary screen were streaked
onto ampicillin supplemented LB agar plates and grown overnight to
isolate the individual variants comprising the wells. Six single colonies
from each streaked well were inoculated into 96-well plates and
subjected to a similar secondary screen. The variants with the highest
activity from the secondary screen were isolated, and the DNA was
sequenced and used as template for the subsequent round.
Screening for Improved Thermal Stability. The transformed
cells were plated on ampicillin supplemented agar plates with
approximately 200 colonies per plate and grown overnight at 37 °C.
Colonies were blotted onto ﬁlter paper (Whatman) and incubated at
elevated temperature for 30 min, while the original agar plates were
returned to 37 °C incubation. Following heat treatment, the ﬁlter
paper with blotted cells was sprayed with a solution containing
0.25% (w/v) Fast Blue BB, 2% acetonitrile, 2 mM α-naphthyl acetate,
1 mM ethylenediaminetetraacetic acid (EDTA), and 20 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.0.
Variants with greater activity stained the fasted, and the corresponding
colonies were selected from the original plates, inoculated into 96-well
plates, and grown overnight before being subjected to a secondary
screen. The overnight cultures were assayed twice for p-nitrophenyl
acetate activity, once with prior heat treatment and once with no heat
treatment as described above. Heat treatment consisted of 15 min
incubation at elevated temperature followed by 15 min on ice allowing
time for the enzyme to refold before measurement of residual activity.
Two aspects were considered when selecting the best variants, those
with the greatest residual activity after the heat treatment, providing
they also had equal or greater activity at ambient temperature
compared with the parent enzyme. DNA from these selected variants
was sequenced then used as template for the following round. Three
rounds were carried out in this manner with the temperature of heat
treatment increased for each round (52, 53, and 55 °C).
Screening for Improved p-Nitrophenyl Butyrate Activity.
Screening of variant libraries for improved activity toward p-
nitrophenyl butyrate was carried out in two stages (rounds 1−3 and
rounds 4−5). Rounds 1−3 were done in a similar manner to the
thermal stability screening. The amino acid mutation rate of the library
was increased from an average of one mutation per enzyme used in the
previous evolution to an average of two amino acid changes.
Consequently, to achieve 95% library coverage when screening, the
target number of colonies per agar plate was increased to 400 with a
total library size of approximately 24000. Blotted colonies were
sprayed with the same solution as before only with α-naphthyl
butyrate as substrate and the addition of 2% methanol. The best
variants were assayed for p-nitrophenyl butyrate activity in a secondary
screen, the best 10−20 variants were isolated, and the DNA was
sequenced and used as template for subsequent rounds. The libraries
for rounds 4 and 5 were screened using the same method as the
p-nitrophenyl acetate screening only with the larger substrate.
Enzyme Expression and Puriﬁcation. An identical method of
expression and puriﬁcation was used for the native and variant
enzymes closely resembling a method previously described.23 Consult
the Supporting Information for further detail.
Stability Assays. Enzyme melting temperature was determined by
measuring the residual activity of puriﬁed protein after 15 min incuba-
tion at elevated temperature followed by 15 min at 4 °C. Enzyme
samples were heated using the gradient function on a C1000 thermal
cycler (Bio-Rad); 18 data points were collected in triplicate between
30 and 70 °C for each sample. The melting temperature was
determined by ﬁtting the following equation,30 derived from the Hill
equation, to the data:
= − +a a a T T T( )/( )0 0 h 1/2h h
Kinetic Characterization. Enzyme kinetics was done using two
sets of conditions due to diﬀering solubility of p-nitrophenyl ester
substrates. The DLH catalyzed hydrolysis of the substrates in both
cases was measured by monitoring the release of p-nitrophenolate at
405 nm. The substrate concentration was varied, while the enzyme
concentration remained constant throughout. Activity toward the
more water-soluble p-nitrophenyl acetate (C2) and butyrate (C4)
substrates was measured in cuvettes (1 mL) using a Cary1E spectro-
photometer (Varian) equipped with thermal control at 25 °C.
Substrates were dissolved in acetonitrile and used at 1% (v/v) in the
ﬁnal assay buﬀer containing 20 mM HEPES and 1 mM EDTA at
pH 7.5. Activity toward the larger more hydrophobic p-nitrophenyl
hexanoate (C6), octanoate (C8), decanoate (C10), and dodecanoate
(C12) substrates was measured in a 96-well microtiter plate using a
SpectraMax M2e plate reader (Molecular Devices) at 25 °C.
Substrates were dissolved in a 1:4 ratio of acetonitrile to DMSO
such that the ﬁnal assay buﬀer consisted of 1% (v/v) acetonitrile and
4% (v/v) DMSO in addition to 0.2% (v/v) TritonX-100, 20 mM
HEPES, and 1 mM EDTA at pH 7.5. For consistency, kinetics for the
C2 and C4 substrates were also measured in this manner. Extinction
coeﬃcients used were 12790 and 11869 M−1 cm−1, respectively with a
path length of 0.55 cm when the reactions were done in 96-well plates.
Kinetic constants Vmax and Km were obtained by ﬁtting the
experimental data to the Michaelis−Menten equation.31 All kinetic
data was obtained in triplicate; the errors are the standard deviation of
the data sets but could be underestimated since the data was from the
same sample preparation.
Crystallization. Crystallization of native DLH was done using
conditions already reported.24 The variants crystallized under similar
conditions, although some required microseeding or slightly altered
precipitant concentration (0.8−1.2 M ammonium sulfate).
Data Collection and Processing. Diﬀraction data was collected
using Cu Kα radiation at a temperature of 100 K. Data were recorded
as a contiguous sequence of half-degree rotations using a MAR345
image plate detector mounted on a rotating anode Rigaku RA Micro 7
HFM X-ray generator with cooling supplied by an Oxford Cryostream
700 series. Between 225 and 480 frames were collected for each crystal
with 180 s exposure time per frame for all except the S-3 and B-4
variant crystals, which required 300 s exposure time per frame. Data
collection statistics are listed in Table S6, Supporting Information.
Structure Determination and Reﬁnement. The native structure
was determined by reﬁning it against a known DLH structure (PDB
entry 1ZI6).23 All variant structures were ﬁrst subjected to a rigid body
cycle, followed by a cyclical manual inspection of electron density maps
using COOT,32 and then further reﬁned using REFMAC533 in the
CCP4 suite of programs.34 The average error in the native coordinates
was found to be 0.09 Å as determined by the diﬀraction-component
precision index (DPI) value for the model, while the corresponding
errors for the A-6, S-2, S-3, B-1, and B-4 variant structures are 0.13, 0.08,
0.09, 0.10, and 0.12 Å respectively.35 Structures were superimposed
using SUPERPOSE.36
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Substrate Docking. The crystal structures of the native and
variant enzymes were ﬁrst relaxed using the ROSETTA 3.5 relax
application to minimize internal clashes and further reﬁne the
structure.37 Twenty structures were generated for each enzyme,
and the lowest total scoring structure was used as input into the
docking protocol. Rotamers were generated for p-nitrophenyl acetate
and p-nitrophenyl butyrate using balloon version 1.4.1.1068.38 The
ligands were constrained in the active site with distance and angle
restraints. Substrate docking was done using Rosettascripts 3.5 and
ligand_dock.xml ﬁle with commands -no_optH, -ex1, -ex1aro, and
-ex2.39 Five hundred structures were generated from the docking
protocol, and the structures were ﬁltered by ligand RMSD and
interface energy. The top 10% of lowest scoring structures were
analyzed visually using PyMol.40
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4.3. Additional Comments 
We used random mutagenesis in the form of error-prone PCR as the primary technique to introduce 
genetic diversity. SSM was used only in an attempt to expand on the findings from random 
mutagenesis. During the review process preceding publication, one of the reviewers queried our 
used of random mutagenesis over SSM and the screening of targeted libraries. This was not 
addressed in the revised article due to space constraints but is addressed below. 
 
 
4.3.1. Random vs. Targeted Mutagenesis 
Protein engineering and in particular directed evolution (Section 1.2.1) is an important tool for not 
only engineering enzymes suitable for industrial applications but also for aiding our understanding 
of how enzymes evolve. This information can be used to further develop and automate techniques 
in this field as well as contributing to a more global understanding of evolutionary biology and the 
dynamics of enzyme evolution.55, 130 
  
 The screening of smaller targeted or focused libraries created by SSM has become a 
preferred approach to directed evolution (Section 1.2.1.1).64, 131 This is generally used when 
engineering the catalytic properties of an enzyme, such as substrate, stereo- or regioselectivity. 
These tasks invariably require multiple active site mutations and therefore randomisation at only 
specific active site residues that are in direct contact with the substrate can yield a smaller but 
higher quality library. This approach has been used successfully to expand substrate profiles and 
improve existing functions.62 However there are still many benefits to be gained from traditional 
directed evolution using error-prone PCR to create random mutations across the entire coding 
sequence.  
 
 Perhaps the most important benefit to using random mutagenesis over SSM is the 
compensatory stabilising mutations that are often obtained alongside active site mutations when 
using random mutagenesis. The importance of stability and its high correlation to protein 
evolvability has been well established.132, 133 A stable protein can more readily accommodate the 
often destabilising mutations that are necessary to facilitate the gain of new or improved catalytic 
functions. Thus, the accumulation of stabilising surface mutations during the directed evolution of 
enzymes is crucial to enable the continual acquisition of multiple active site mutations without 
stability as a limiting factor. 
 
 Additionally, SSM relies on the correct identification of appropriate residues to target 
within the active site. Although our understanding of enzyme structure, function and evolution is 
continually advancing, this can still be a difficult task. Enzymes do not always evolve in a 
predictable way and mis-selection of targeted residues can limit the prosperity of the evolution 
before it even commences. Random mutagenesis ensures a more thorough exploration of the 
sequence space and allows discovery of unexpected or unintuitive mutations. The information 
gained from this type of experiment can not only yield enzymes with new and improved functions 
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but also contribute to our understanding of enzyme evolution.55 More so than SSM, which is 
inherently restricted in respect to possible mutation sites, and is therefore also restricted in the 
number of available evolutionary pathways.  
 
 So while random mutagenesis and SSM both have distinct advantages and disadvantages, a 
conscious decision was made to use random mutagenesis as the main form of library generation. 
However SSM was used, albeit sparingly, to complement and further expand on the results 
obtained by random mutagenesis. 
 
 
4.4. Site-Saturation Mutagenesis 
SSM was mentioned only briefly in the published article due to a need to be concise. The saturated 
sites were 38 and 145 individually and 85 and 88 jointly. This work is discussed in further detail 
below.  
 
 
4.4.1. Choice of Sites for Mutagenesis 
SSM was performed at the end of evolution one, prior to commencement of evolution two, using 
the DLH A-6 variant as a template. Positions 38 and 145 which were mutated during evolution one, 
were chosen for saturation as it was suspected other amino acids could better fill the role of the 
F38L and Y145C mutations. Residues 85 and 88 are involved in substrate binding and these sites 
were saturated jointly (Figure 4.1). 
 
 
Figure 4.1 Location of residues selected for SSM in the DLH A-6 variant 
 
 The F38L mutation opened the active site more favourably for p-nitrophenyl acetate, a larger 
substrate than the native dienelactones. It was thought that smaller amino acids such as valine or 
alanine could further open the active site and enhance the rate of catalysis. The Y145C mutation in 
the A-6 variant (prior to coupling with the G211D mutation in the S-2 variant) was initially 
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perplexing. In exposed positions such as protein surfaces or in active sites, cysteine residues are 
prone to oxidation and indeed this was the case in the A-6 variant (evident from electron density 
maps during structure determination). The Y145C mutation was deduced to aid catalysis by 
removal of the bulky tyrosine residue, allowing more space for movability of H202 during catalysis. 
Thus, it was thought likely that other small residues such as serine or alanine could replace cysteine 
in this position. Residues R81, Y85 and W88 are substrate binding residues located on helix B 
(residues 77 – 87). R81 binds the carboxylic acid of the dienelactone substrates (Figure 1.8) and it 
was anticipated it would similarly bind the nitro group of p-nitrophenyl acetate. Therefore rather 
than saturate all three sites, which would require screening a library of almost 105 variants, only 
residues Y85 and W88 were saturated. These sites were saturated in combination to allow for 
possible complementary mutations. 
 
 
4.4.2. Experimental  
The SSM libraries were generated using the DLH A-6 variant as template. Sets of offset NNK 
mutagenic primers (Table 4.1) were used to PCR amplify the entire gene and plasmid sequence 
(Section 2.2.2.2). The product was digested with DpnI (Section 2.2.3) then purified and transformed 
into DH5! E.coli (Section 2.2.1).  
 
Table 4.1 Mutagenic NNK primers for SSM mutagenesis 
Primer Sequence 
38 F                 5’- CAA GAA ATA NNK GGT GTG AAC GCG -3’ 
38 R             3’- CGA GTT CTT TAT NNM CCA CAC TTG -5’ 
145 F                 5’- GTA GGC TAC NNK GGT GTT GGA CTG -3’ 
145 R              3’- GG CAT CCG ATG NNM CCA CAA CCT G -5’ 
85+88 F           5’- GAG CAA GCC NNK AAG CTC NNK CAG GCC TTC GAC -3’ 
85 + 88 R     3’- C TCT CTC GTT CGG NNM TTC GAG NNM GTC CGG AAG -5’ 
Note: The underlined codon encodes the mutation site 
 
 Ten variants were sequenced to determine quality of each library, where the quality 
referrers to the percentage of variants in the experimental library containing a mutation at the 
desired site(s). This quality was then used to calculate the library size needed to be screened to 
achieve 95 % library coverage (Table 4.2). For example, a library comprised of 100% variants with 
no native enzymes would require the screening of 96 variants (NNK = 32 codons, 32 x 3 = 96). 
However, the more common amino acids (A, V, S etc.) would be over represented and these are the 
ones of interest in the 38 and 145 libraries, as such a library size of 64 would be adequate (codons for 
these amino acids are represented 2-3 times within the 32 codons obtained using NNK primers).  
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Table 4.2 SSM library quality and screening statistics 
Library Quality Library size required for 95 % total coverage 
Actual size of library 
screened 
38 70 % 124 64 
145 100 % 96 88 
85 + 88 80 % 3680 3080 
 
 
 For the 38 and 145 SSM libraries, transformed colonies were individually inoculated into 96-
well microtitre plates and grown overnight. For the 85 + 88 SSM library, the transformed library 
was distributed into 96-well microtitre plates with and average of 3-4 CFU per well (see supporting 
information for Publication 1 in Appendix A). This library required a primary and secondary screen 
(see methods for evolution one in Publication 1) while the 38 and 145 SSM libraries only required a 
single screen. 
 
 
4.4.3. Results and Discussion 
Three SSM libraries were screened covering four sites within (38 and 145) and immediately 
surrounding (85 and 88) the DLH active site. The activity distributions for variants within each 
library are listed in Table 4.3. It is important to note the quality of the libraries (Table 4.2) differed 
and is therefore reflected in the activity distributions. For example, library 38 was the lowest quality 
library with 30 % of the ten randomly sequenced variants with no mutation at residue 38. 
Correspondingly this library had a high proportion of variants with activity equal to the DLH A-6 
variant – the starting point for creation of the SSM libraries 
 
Table 4.3 Library distributions  
Library Percentage activity compared to the DLH A-6 variant  < 10 %  10 – 80 % 80 – 100 % > 100 %  
38 38 % 34 % 28 % 0 % 
145 75 % 17 % 8 % 0 % 
85 + 88* 38 %  62 %   
* Variants were grouped for primary screening; given %’s are for groups not individual variants. 
 
 From the three libraries, none of the variants had activity greater than the DLH-A6 variant. 
The 85 + 88 library required secondary screening of the best groups from the primary screen to 
obtain this information. The ten variants with the greatest activity from the site 38 SSM library were 
isolated and sequenced. All of these sequenced variants encoded leucine at position 38; nine using 
the original CTT codon, one with a single base change to a CTG codon. All the variants from the site 
145 SSM library with activity equal to the DLH A-6 variant were sequenced. All encoded cysteine at 
position 145 but similarly to the 38 library, one of the variants contained a silent mutation using a 
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TGT codon instead of the original TGC codon. The best sixteen variants of the 85 + 88 SSM library 
from the secondary screen were sequenced; all had activity within error of the DLH A-6 variant. 
One variant contained an amino acid mutation of Y85L, all others were unchanged at both sites. 
However, as with the last two libraries, two silent mutations occurred both changing the original 
codon for Y85 from TAC to TAT. 
 
 It is only possible to speculate on the reason for not finding alternative beneficial mutations 
for the four sites. The previous F38L mutation was beneficial due to the reduced size of leucine in 
comparison to phenylalanine. It was initially thought that valine or alanine could provide further 
benefit under the same premise this however, was not the case. Thus it was presumed that mutating 
residue 38 to a smaller amino acid disrupted packing and interactions within the active site. 
  
 The DLH A-6 variant contains five active site mutations, three of which are contained in the 
DLH A-2 variant (Q35H, F38L and Y145C) and were proven to be destabilising. The other two are to 
the loop containing H202 of the catalytic triad (E199G and S208G) and were shown to drastically 
increase the flexibility of the loop. The Y145C mutation was thought to enhance catalysis since 
removal of the bulky tyrosine residue opens space allowing greater movement of H202, which lies 
just above residue 145 in the active site. In the crystal structure of the DLH A-6 variant, the cysteine 
was oxidised, and appeared to form hydrogen bonds with the protein backbone of the active site 
loop (Figure 4.2). Since no beneficial mutations were found to replace cysteine in this position, it is 
likely that these hydrogen bonds were necessary to maintain the stability and integrity of the active 
site. Under this notion serine would have been an appropriate replacement for cysteine had the SSM 
been carried out using the DLH S-2 variant as template, but not in the A-6 variant as was the case. 
 
 
Figure 4.2 Hydrogen bonding and change to residue 145 during the directed evolution 
  
 The substrate binding residues Y85 and W88 unchanged during the SSM, presumably due 
to interaction with the aromatic ring of the substrate. Evidently there was no benefit to be gained 
from mutation to an alternative residue(s). It is possible that a tandem mutation was missed due to 
a slight deficiency in the number of variants screened. However, all single mutations were covered 
and none were found to be beneficial, only Y85L which was neutral.  
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4.5. Long-term Goals and Future Work 
The initial motivation for this work was to not only change the substrate specificity of DLH, as 
achieved in the published work, but also to change its function from a simple hydrolase to a 
transesterase. The enzyme-facilitated synthesis of esters is of interest in the areas such as 
pharmaceutics, organic synthesis in a laboratory setting and biofuel production.134  
 
 The first step in achieving these long-term goals was to change the substrate specificity of 
DLH to an enzyme capable of catalysing the hydrolysis of ester and lipase substrates. This has been 
achieved in the work presented in this current chapter. Subsequent work towards enabling DLH 
catalysed transesterification reactions is discussed in Chapter 6. 
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The Role of Compensatory Surface Mutations in 
Directed Evolution  
 
The article “Compensatory stabilising role of surface mutations during the directed evolution of 
dienelactone hydrolase for enhanced activity” published in The Protein Journal forms the basis for 
this chapter. 
 
 
5.1. Introduction 
The publication presented in this chapter (Section 5.2) arose from the work discussed in Chapter 4. 
The previous work consisted of three sequential directed evolution experiments yielding a series of 
variants with enhanced activity, stability and altered substrate specificity. During the second stage 
of the evolution process the DLH-S2 variant was identified with increased thermal stability (Tm = 
55.1 ± 0.5 °C). This variant contained a large number of active site mutations – Q35H, F38L, C123S, 
Y145C, E199G, S208G and G211D – that contributed to an increase in catalytic activity and 
specificity. However, active site mutations are often observed to be destabilising but three surface 
mutations – Q110L, Y137C and N154D (Figure 5.1) – were thought to provide stabilising effects and 
not only compensate for the destabilising nature of the active site mutations but exceed the stability 
of the DLH C123S enzyme (Tm = 53.7 ± 0.2 °C). 
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Figure 5.1 The DLH-S2 variant (A) mutations with the green circles around the surface mutations 
and (B) location of the surface mutations 
 
 Stability is an important factor in any directed evolution experiment, either directly where 
increased stability is the target of the evolution, or more applicably indirectly due to the high 
correlation between stability and evolvability.132, 133 
 
 In the publication presented in this chapter (Section 5.2) we constructed a series of variants 
containing these surface mutations individually and combined with a constant background of 
activity enhancing mutations. The variants were evaluated to assess and compare their thermal and 
chemical stability to identify the effects of the surface mutations and their roles during the directed 
evolution process. In doing this we aimed to show the potential benefit to concurrent monitoring of 
protein stability during directed evolution experiments.  
 
 
5.2. Reproduction of Published Article 
The following article is reproduced with kind permission from Springer Science and Business 
Media. (http://link.springer.com/article/10.1007/s10930-015-9600-7) 
License Number: 3636941349800 (May 27, 2015) 
 
J. L. Porter, C. A. Collyer, D. L. Ollis (2015) Compensatory stabilizing role of surface mutations 
during the directed evolution of dienelactone hydrolase for enhanced activity. The Protein Journal 34, 
82-89. 
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Abstract Directed evolution is a common tool employed
to generate enzymes suitable for industrial use. High
thermal stability is often advantageous or even a require-
ment for biocatalysts, as such the evolution of protein
stability is of practical as well as academic interest. Even
when evolving enzymes for new or improved catalytic
functions, stability is an important factor since it can limit
the accumulation rate and number of desired active site
mutations. Dienelactone hydrolase, a small monomeric
protein, has been previously evolved via a three-stage
process to possess enhanced activity and specificity toward
non-physiological substrates. In addition to seven active
site mutations there were three surface mutations that were
thought to increase the stability of the enzyme and com-
pensate for the destabilizing active site mutations. Here, the
individual influence of the three surface mutations—
Q110L, Y137C and N154D—on the thermal and chemical
stability of DLH has been assessed. While the Q110L and
N154D mutations improved the thermal stability, the
influence of the Y137C mutation was more complex.
Individually it was destabilizing both thermally and
chemically, but when in the presence of the Q110L and
N154D mutations its effect was neutralized in relation to
thermal but not chemical stability. In the context of a
directed evolution experiment, these compensatory surface
mutations play important roles. However, our results show
that detrimental mutations can arise, thus the simultaneous
monitoring of stability changes while evolving enzymes for
enhanced catalytic properties can be beneficial.
Keywords Protein stability ! Directed evolution !
Dienelactone hydrolase ! 310 helix ! Urea denaturation !
Protein evolvability
Abbreviations
DLH Dienelactone hydrolase
PCR Polymerase chain reaction
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel
electrophoresis
Tm Melting temperature
1 Introduction
Stability is a fundamental aspect of protein science and is
arguably one of the most important parameters dictating
the use of proteins in industrial applications such as med-
icine or bioremediation [1]. The ability of a protein to
maintain its structural integrity is reliant upon interactions
between its constituent amino acids. The combination of
these interactions—i.e. electrostatic interactions, hydrogen
bonding, salt bridges, disulfide bonds and hydrophobic
interactions—form a fragile balance that defines the sta-
bility of a protein. Slight perturbation of this balance,
whether by thermal or chemical means, can trigger protein
unfolding and irreversible degradation.
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In nature, enzymes exist in a tightly controlled envi-
ronment where their physical and catalytic properties have
evolved to align purely with the needs of the host
organism. As such, naturally available enzymes are often
not optimally suited for industrial applications [2–4].
Protein engineering and in particular directed evolution
provide a means of enhancing the catalytic or physical
properties of enzymes [5–7]. Increased thermal stability is
often the target of directed evolution studies but even
when it is not, stability is still an important feature in any
directed evolution experiment. This is due to the high
correlation between protein stability and evolvability; a
stable protein has a greater capacity to evolve as it can
more readily accept the often-destabilizing active site
mutations that provide new and improved catalytic func-
tions [8, 9].
Dienelactone hydrolase (DLH) is a small monomeric a/
b hydrolase fold enzyme [10, 11]. It has been previously
evolved to possess improved activity and specificity
toward p-nitrophenyl butyrate and larger p-nitrophenyl
esters via a three-stage process [12]. The native enzyme
contains a catalytic triad consisting of a cysteine (C123),
an aspartic acid (D171) and a histidine (H202). It is also
active with a serine as nucleophile (C123S) and since
unlike cysteine, serine is not prone to oxidation, the serine
mutant (DLH C123S) was used as a starting point for the
aforementioned directed evolution study. The second
stage of the evolution involved improving the thermal
stability of DLH to generate variants with the potential to
accommodate the often-destabilizing active site mutations
that are necessary for the acquisition of enhanced cata-
lytic properties [8, 9]. During this evolution the DLH-S2
variant (Q35H, F38L, Q110L, C123S, Y137C, Y145C,
N154D, E199G, S208G and G211D) was identified with
an elevated melting temperature of 55.1 ± 0.5 "C. Most
of the mutations in this variant contributed directly to
increased activity toward the non-physiological substrates
but were observed to be destabilizing. However three of
the mutations in DLH-S2—Q110L, Y137C and N154D—
are surface mutations away from the active site and were
thought to provide increased stability, enough to not only
compensate for the destabilizing nature of the active site
mutations but to surpass the stability of the native enzyme
(Tm = 53.7 ± 0.2 "C). In the present study, we con-
structed the DLH-S0 variant that contains the activity
enhancing mutations of the DLH-S2 variant but not the
three surface mutations. We also made a series of variants
containing these surface mutations individually and in
combination to identify the contribution each makes to
the stability of the enzyme and thereby investigate the
possible roles they served in the directed evolution
process.
2 Materials and Methods
2.1 Plasmid Construction
The DLH-S2 variant [12] was the starting point to design
the mutants for this study by reverting combinations of the
mutations Q110L, Y137C and N154D back to native. This
was done using pairs of mutagenic primers (Table 1) to
generate fragments. These were then recombined in a
second PCR using the M13 universal flanking primers to
reassemble the appropriate full-length genes. The genes
were digested using DpnI, NdeI and EcoRI restriction
enzymes then gel purified and ligated into the plasmid
pJWL1030 [13]. All mutations were confirmed by
sequencing over the entire coding region before expression
and purification. DNA sequencing was performed on an
AB 3730xI DNA Analyzer (Applied Biosystems) at the
ACRF Biomolecular Resource Facility, JCSMR at the
Australian National University.
2.2 Expression and Purification
DLH variants were expressed as previously described [12].
Cells were harvested then resuspended in 20 mM HEPES,
1 mM EDTA, pH 7.5 and lysed using a combination of
rlysozyme (Novagen) and BugBuster (Novagen). The sol-
uble fraction was purified using anion exchange chroma-
tography on a DEAE Fractogel column (Merck) and eluted
between 60 and 100 mM NaCl using a step-wise gradient.
Proteins were concentrated using a 10,000 molecular
weight cut-off filter (Millipore). Enzyme concentration was
determined by UV absorbance at 280 nm on a NanoDrop
1000 (Thermo Scientific) using an extinction coefficient
estimated by the PROTPARAM program on the ExPASy
Proteomic Server [14]. Protein molecular weight was
confirmed by mass spectrometry. Protein solutions were
directly injected into a LCT premier XE oa-TOF mass
spectrometer (Waters). Masses are given in Table S1.
2.3 Structural Analysis
B-values were normalized to enable accurate comparison
between the DLH C123S (PDB 4U2B) and DLH-S2 (PDB
4U2D) variant structures. This was achieved by dividing
the individual B-values for whole residues, side chain or
main-chain atoms by the average value for that particular
structure. A normalized B-value lower than one means a
lower level of flexibility while a B-value higher than one
means a higher level of flexibility than the average for that
structure. Structures were aligned using SUPERPOSE [15]
in the CCP4 suite of programs [16].
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2.4 Kinetic Characterization
Spectrophotometric assays were used to determine kinetic
constants for the DLH catalysed hydrolysis of p-nitro-
phenyl acetate to p-nitrophenol and acetic acid. The
initial velocity of the reaction was monitored using the
change in intrinsic absorbance of p-nitrophenolate at
405 nm (extinction coefficient 12,341 M-1 cm-1 and
path length 0.52 cm) using a Spectramax M2e plate-
reader (Molecular Devices) with temperature control at
25 "C. The reaction was initiated with the addition of
20 lL of enzyme to a solution containing substrate dis-
solved in acetonitrile—used at 1 % v/v—and 20 mM
HEPES, 1 mM EDTA, pH 7.5 to a final assay volume of
200 lL. The final enzyme concentration was kept con-
stant at 0.5 lM, while the substrate concentration was
varied at 5, 10, 25, 50, 100, 250, 500 and 750 lM. Data
were obtained in triplicate and errors are the standard
deviation between the data sets. The kinetic parameters
Vmax and Km were calculated by fitting the experimental
data to the Michaelis–Menten equation [17] using Kale-
idaGraph 4.1.
2.5 Thermal Denaturation
Residual activity measurements and subsequent extraction
of melting temperatures were done as previously described
[12]. Overall protein unfolding was monitored using the
change in fluorescence caused by binding of the fluoro-
phore SYPRO Orange (Sigma-Aldrich) to hydrophobic
residues exposed upon protein denaturation. Fluorescence
was measured at 605–610 nm with a 7900HT Fast Real-
Time PCR system (Applied Biosystems) at the ACRF
Biomolecular Resource Facility within the JCSMR at the
Australian National University with the temperature
increased linearly from 10 to 90 "C at a rate of
1 "C min-1. Samples were run in triplicate, consisting of
5 lM enzyme and 59 SYPRO orange dye with 5 % v/v
DMSO, 75 mM NaCl in 50 mM HEPES at pH 7.5.
Melting temperatures were determined by fitting the data
to the Boltzmann equation [18] using SciDAVis version
0.2.4 where errors are the standard deviation.
2.6 Urea Initiated Unfolding
Protein stability in the presence of a chemical denaturant was
assessed by monitoring activity in the presence of varying
urea concentration. Samples of 0.5 lM enzyme were incu-
bated for 30 min with 0–6 M urea increasing in 0.5 M
increments in a buffered solution of 20 mM HEPES, 1 mM
EDTA, pH 7.5 to a final volume of 198 lL. The reaction was
initiated with the addition of 2 lL of 25 mM p-nitrophenyl
acetate to give a final concentration of 250 lM and was
monitored in the same manner as the kinetic assays.
3 Results
The DLH-S0 variant (Q35H, F38L, C123S, Y145C,
E199G, S208G and G211D) was generated from the DLH-
S2 variant [12] by reverting the Q110L, Y137C and N154D
mutations back to native. A series of DLH variants were
created in the same manner, using the DLH-S2 variant and
converting individual or combinations of the surface
mutations back to native, each with a constant background
of activity enhancing mutations. See Table 2 for the name
and amino acid mutations for each variant.
3.1 Kinetic Characterization
Kinetic characterization for the hydrolysis of p-nitrophenyl
acetate showed that changes in kinetic parameters between
the variants are minimal (Fig. 1; Table 3). The surface
mutations Q110L, Y137C and N154D do not influence the
kinetic properties of DLH as shown by the Km and kcat
values that are within error.
3.2 Crystal Structure Analysis
Crystal structures of native DLH (PDB 4U2B) and the
evolved DLH-S2 variant (PDB 4U2D) were solved as part
of a previous study [12]. Comparison of these structures for
the purposes of this current study showed differences
caused by the respective surface mutations. In particular
comparison of the B-values showed significant differences
in electron density spread and positional disorder
Table 1 Mutagenic primers
used for generation of PCR
fragments
The codon in bold encodes the
amino acid mutation
Primer Sequence
110F 50-CGC TAT GCG CGA CAC CAA CCC TAC AGC-30
110R 30-CGC GCT GTG GTT GGG ATG TCG TTG CCG TTC-50
137F 50-CTA GTG GCC GCC AAA GGA TAC GTG GAC CG-30
137R 30-GG TTT CCT ATG CAC CTG GCG CGG CAT C-50
154F 50-G CTG GAG AAG CAG CTC AAC AAG GTC CCG-30
154R 30-C TTC GTC GAG TTG TTC CAG GGC CTC CAG-50
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indicating changes in flexibility at two of these surface sites
(Supporting Figs. S1, S2). The Q110L mutation resulted in
a reduction in flexibility, conversely the Y137C mutation
caused partial localized disorder and consequently
increased flexibility while there was no significant differ-
ence caused by the N154D mutation in relation to B-value.
Residue 110 lies in loop 8 (residues 108–116) on the
exterior of the enzyme away from the opening of the active
site cleft. In the native enzyme this loop is highly flexible
with an average normalized B-value of 1.54. Incorporation
of the Q110L mutation stabilized not just the single residue
(normalized B-value lowered from 1.60 to 0.93) but also
the entire loop lowering the average B-value to a normal-
ized value of 1.04 from the previous 1.54 (Fig. 2).
Although the loop is solvent exposed the side chain of
residue 110 from the Ca–Cb bond is oriented towards the
core of the enzyme. In the native enzyme the side chain of
Q110 is orientated away from the buried region from the
Cc–Cd bond such that the amide is solvent exposed, with
leucine at this position the side chain is partially buried.
The solvent accessible surface area for residue 110 is
42.0 A˚2 for glutamine and 21.6 A˚2 for leucine in this
position.
The effect of changing tyrosine to cysteine at position
137 is not clear from the crystal structure. The B-values
show the change causes a localized increase in flexibility,
this is the opposite effect expected of a stabilizing muta-
tion. Regardless this mutation was fully conserved
throughout the remaining stability evolution and the fol-
lowing evolution for increased specificity toward p-nitro-
phenyl butyrate [12].
3.3 Quantifying the Effect of Individual Mutations
on Protein Thermal Stability
Thermal denaturation was measured in two ways, the first
by measuring residual activity after heat exposure and the
second, by monitoring the change in fluorescence caused
Table 2 Amino acid mutations in the series of constructed DLH variants
DLH variant Amino acid mutations
S0 Q35H F38L C123S Y145C E199G S208G G211D
Q110L Q35H F38L Q110L C123S Y145C E199G S208G G211D
Y137C Q35H F38L C123S Y137C Y145C E199G S208G G211D
N154D Q35H F38L C123S Y145C N154D E199G S208G G211D
Q110L & N154D Q35H F38L Q110L C123S Y145C N154D E199G S208G G211D
S2 Q35H F38L Q110L C123S Y137C Y145C N154D E199G S208G G211D
The mutations in bold are the surface mutations
Fig. 1 Kinetic characterization of variants with a showing Km values
and b showing kcat values. The data was obtained in triplicate and the
errors are the standard deviation
Table 3 Kinetic constants for the DLH variants
Km (lM) kcat (s
-1) kcat/Km (M
-1 s-1)
S0 13 ± 1 0.59 ± 0.01 4.6 ± 0.2 9 104
Q110L 14 ± 1 0.60 ± 0.01 4.3 ± 0.2 9 104
Y137C 13 ± 2 0.57 ± 0.03 4.3 ± 0.5 9 104
N154D 12 ± 1 0.58 ± 0.02 4.9 ± 0.2 9 104
Q110L & N154D 13 ± 2 0.58 ± 0.02 4.4 ± 0.5 9 104
S2 14 ± 1 0.61 ± 0.01 4.5 ± 0.3 9 104
Data was obtained in triplicate and the errors are the standard
deviation
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by binding of the fluorophore SYPRO Orange to unfolded
protein. The residual activity plots and the fluorescence
monitored denaturation curves are given in Supporting
Figs. S3 and S4 respectively. Melting temperatures
extracted from each data set are displayed graphically in
Fig. 3 and in full in Supporting Table S2.
Melting temperatures determined by residual activity
show the Q110L and N154D mutations have stabilizing
effects but the Y137C mutation alone is destabilizing. The
sum of the changes in melting temperature determined by
residual activity due to the individual mutations (0.6 - 1.9 ?
2.7 = ?1.4 "C) was significantly lower than when they were
present together in the same protein (?3.4 "C). In other
words the increase in melting temperature observed in the
DLH-S2 variant does not equal the sum of its parts. This
observation prompted construction and testing of the Q110L
& N154D combined variant. The change in melting tem-
perature of this variant was similar and within error of the
DLH-S2 variant (?3.1 "C) suggesting that although the
Y137C mutation is destabilizing alone, when coupled with
the Q110L and N154D mutations the negative effects are
neutralized.
The melting temperatures determined based on residual
activity were within error but lower than the melting
temperature determined based on the overall protein
unfolding. This was unsurprising since residual activity
measurements rely purely on the integrity of the active site
and slight perturbation would disable catalysis. The overall
unfolding monitored by SYPRO orange fluorescence gave
Fig. 2 Changes to loop 8 caused by the Q110L mutation
Fig. 3 Comparison of melting temperatures determined by residual
activity and thermal denaturation monitored using SYPRO orange.
Residual activity was measured after heating 0.5 lM enzyme aliquots
between 30 and 70 "C for 15 min, followed by 15 min at 4 "C to
allow for possible refolding. SYPRO orange thermal denaturation was
monitored using 5 lM enzyme solutions that were heated to 90 "C at
a rate of 1 "C min-1. All data was obtained in triplicate and the errors
are the standard deviation
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consistent values for the breakdown of the individual
mutations. The sum of the changes in melting temperature
observed in the single mutants (1.0 - 0.7 ?
2.9 = ?3.2 "C) is equivalent to the change observed for the
three mutations jointly in the DLH-S2 variant (?3.1 "C).
The Q110L & N154D variant has the highest melting tem-
perature, 3.3 "C greater than the DLH-S0 variant, this is
within error of the values observed for the Q110L and
N154D single mutants.
3.4 Changes in Response to Chemical Denaturation
Here we studied the unfolding of the DLH variants in the
presence of increasing concentrations of urea to assess the
effect of the surface mutations on the overall chemical
stability of the enzyme. The six variants conformed to three
different unfolding profiles (Fig. 4). Unfolding of the
DLH-S0, Q110L and S2 variants was virtually identical,
the Y137C variant began unfolding at a lower urea con-
centration, while the N154D and Q110L & N154D variants
were more resistant to denaturation. Put simply, two of the
three surface sites affected the chemical stability of DLH.
The Q110L mutation had no observable effect, while the
Y137C mutation had a negative effect and the N154D
mutation had a positive effect on the resistance of the
enzyme to the chemical denaturant.
Although when measuring residual activity in response
to heat treatment it was observed that the Q110L and
N154D mutations neutralized the destabilizing effect of the
Y137C mutation, with chemical denaturation that was not
the case. Here, the negative effect of the Y137C mutation
and the positive effect of the N154D mutation are of
equivalent magnitude, such that when present together in
the DLH-S2 variant, the effects were balanced.
4 Discussion
Crystal structure analysis showed changes in structure and
flexibility caused by the respective surface mutations.
Structural evaluation of the Q110L mutation showed a
drastic reduction in B-values for loop 8 resulting from
more hydrophobic interactions introduced with leucine at
position 110. Efficient packing and reduced flexibility of
loops, especially those that are solvent exposed, is a
characteristic of thermophilic enzymes [19–21]. Here we
conclude that the Q110L mutation had a stabilizing effect
on the enzyme due to more efficient packing of loop 8.
Residue 154 is part of a single 310 helix in DLH. These
helices are less stable and therefore less favorable than the
more common a-helices due to the dipoles being less well
aligned [22]. Usually 310 helices only extend for three to
four residues [23], the one in DLH is unusual since it is
twelve residues in length (148–159) [10], although there is
a slight break in the hydrogen bonding between main chain
atoms so it is more accurate to describe it as two conjoined
310 helices of six residues each. Comparison of B-values
between the native enzyme and the DLH-S2 variant
showed little change. Residue 154 is on the solvent
exposed side of the 310 helix and the side chain is highly
flexible with either the native asparagine or mutated
aspartic acid. Intuitively we can deduce that the N154D
mutation exerted its stabilizing effect through increased
hydrophilic interactions enabled by the change to aspartic
acid, a charged hydrophilic residue, at this highly solvent
exposed position.
The Y137C mutation was predicted to be destabilizing
based on the increased local disorder, and indeed stability
testing proved this was the case in isolation. What was
unclear, was why this mutation was found during the
evolution and why it was subsequently conserved
throughout a further seven rounds of library generation and
screening [12], if it was in fact destabilizing.
Several techniques were employed to determine the
effect of the individual mutations on the overall structure of
DLH. These all involved assessing the stability of the
enzyme in response to either thermal or chemical dena-
turation by monitoring the integrity of the active site or the
overall folded state. Residual enzyme activity following
heat treatment—or thermal inactivation—is often used to
determine melting temperatures and assess enzyme stabil-
ity [24]. It is a quick and relatively simple method. It
assumes that the active site unfolds proportionally to the
rest of the enzyme and although this is usually presumed to
be the case, our results indicate that the Y137C mutation
causes earlier disruption of the active site (Fig. 3).
The thermal stability of the DLH-S2 variant containing
all three surface mutations and the Q110L & N154D var-
iant with the Y137C mutation omitted was highly similar
Fig. 4 Protein denaturation in response to increasing urea concen-
tration. The activity of 0.5 lM enzyme solutions in the presence of
varying urea concentrations was measured following 30 min
incubation
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and within error when measured by residual activity. Thus,
the Y137C mutation shows epistatic interactions with the
Q110L and N154D mutations since they neutralize the
destabilizing effects it exhibits alone. It therefore stands
that the Y137C mutation was carried through the evolution
with the N154D mutation since both appeared simulta-
neously in the evolution with the Q110L mutation already
established [12]. The nucleotides encoding the amino acids
at positions 110, 137 and 154 are in relatively close linear
proximity (Supporting Fig. S5). Although shuffling to omit
the Y137C mutation would have occurred during the
combined shuffling/error-prone PCR in the library gener-
ation step of the directed evolution experiment, the prob-
ability of this variant being selected would have been very
low. This is due to the much higher abundance of variants
possessing all three mutations and especially since under
the screening conditions selecting for increased residual
activity, the Y137C mutation was neutral.
Themechanism for the thermal denaturation of proteins is
well understood, heat increases the kinetic energy causing
protein molecules to vibrate and rapidly denature to form
molten globules. However the molecular basis for protein
denaturation in the presence of urea is still widely debated
[25]. Initial studies favored an indirect mechanism, whereby
the urea infiltrates the water hydrogen bond network altering
the solvent environment although, there is scarce experi-
mental data supporting this hypothesis. Alternatively, urea
could exert its effect directly by binding to and stabilizing
protein in its denatured state [26–29]. Irrespective of
mechanism, previous results have shown that increased
thermal stability likely corresponds to increased chemical
stability [30], this is consistent with the observation that
thermophilic enzymes are often highly tolerant of chemical
denaturants and organic solvents [31, 32]. Our results to an
extent contradict this, the Q110L mutation gave improved
thermal stability but no change in resistance to urea, while
the N154D mutation gave improved stability in both
instances. Influence of Y137C epistatic mutation was more
complex, it gave reduced stability in response to thermal and
chemical denaturation. However, when present with the
Q110L and N154D mutations it was not thermally destabi-
lizing but was chemically destabilizing. We postulate that
the increased flexibility—a destabilizing feature—of loop 9
(residues 135–138) caused by the Y137C mutation was
nullified in terms of thermal stability when present with the
other stabilizing mutations due to the more global nature of
thermal denaturation.
5 Conclusions
The Q110L, Y137C and N154D mutations to the surface of
DLH were identified during a previous directed evolution
study and thought to contribute to the thermal stability of
the DLH-S2 variant [12]. The mutations were fully con-
served in the rounds following their identification. These
types of compensatory stabilizing mutations play an
important role enabling directed evolution; without them,
stability would be a crucial factor limiting the number of
accumulable active site mutations. Here, the stabilizing
roles of the Q110L and N154D mutations were proven,
while the Y137C mutation was shown to be destabilizing.
However, under conditions matching those of screening
during the directed evolution—residual activity in the
presence of the Q110L and N154D mutations—it had a
neutral effect, explaining why it was not eliminated in
subsequent rounds of evolution. Thus, this work shows the
potential benefit to simultaneous monitoring of protein
stability over the course of a directed evolution experiment.
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Improving Enzyme Stability in Organic Solvents 
  
6.1. Introduction 
As previously discussed (Chapter 1, Section 1.7 and Chapter 4, Section 4.5), the motivation for most 
of the work presented in this thesis was to achieve the ultimate goal of engineering DLH from a 
simple hydrolase into a transesterase. It is not possible to achieve this using a purely aqueous 
reaction medium (Scheme 6.1).  
 
 
 
Scheme 6.1 DLH catalysed (A) hydrolysis and (B) potential transesterification in ethanol 
 
 In aqueous solution DLH catalyses the hydrolysis of p-nitrophenyl acetate to p-nitrophenol 
and acetic acid through the addition of water. For transesterification to occur an alcohol must be 
provided to replace water in the reaction. For example in the presence of methanol or ethanol 
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instead of water, providing the reaction proceeds, methyl- or ethyl acetate would replace acetic acid 
as the second product with transesterification across the ester bond. 
 
 Enzymes typically operate under mild aqueous conditions, akin to those within the cell. The 
concept of using enzymes in reaction media other than their natural aqueous reaction media took 
off in the mid 1980’s and was pioneered by Alexander Klibanov.135-137 This chapter details 
experiments testing the stability, solubility and activity of DLH in organic solvents. Directed 
evolution has been used to evolve DLH for greater stability in water-ethanol co-solvent mixtures. 
Interestingly mutations found during the evolution align with those predicted to be stabilising 
using bioinformatic techniques.  
 
 
6.2. Enzyme Catalysis in Organic Solvents 
Enzymes present a desirable alternative to synthetic catalysts, which often operate under harsh 
conditions. Hydrolases and in particular lipases have applications ranging from the synthesis of 
organic compounds, especially chiral compounds, and pharmaceutical intermediates to the 
production of biofuels and uses in bioremediation.29, 50, 138, 139 These industrial biocatalysts have the 
potential to promote specified and controlled reactions with exceptionally enhanced reaction rates. 
Furthermore the use of enzymes generally circumvents the need for the protection and de-
protection steps that are required in traditional organic synthesis. Unfortunately, despite the many 
advantages to the use of enzymes in industry, they are often intolerant of required industrial 
process conditions that deviate from those within the cellular environment (Section 1.1.1).  
  
 Most industrial chemical syntheses are performed in non-aqueous reaction media since 
water is a poor solvent for hydrophobic substrates and can facilitate undesired side reactions. As 
such organic solvents are often a desired reaction medium for biocatalysis. Organic solvent systems 
can be classified into three main types. These are water plus water miscible co-solvent (i.e. ethanol) 
systems, water plus water immiscible biphasic solvent systems and anhydrous organic solvent 
systems (Figure 6.1). 
 
 
Figure 6.1 Enzyme catalysis in the three main types of organic solvent systems 
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6.2.1. Advantages 
As already eluded to, there are many advantages to using enzymes in organic solvents that are 
cannot be gained using purely aqueous reaction media.140, 141 These include the following: 
 
 New enzyme reactions !
 Increased solubility of non-polar substrates !
 Suppression of water dependent side reactions !
 Easier recovery and recycling of enzymes !
 Aided separation and improved product yields !
 Elimination of microbial contamination  !
 
 The primary motivation for carrying out enzyme catalysed reactions in organic solvents is 
the accessibility of new reactions. In organic solvents the thermodynamic equilibrium shifts in 
favour of synthesis over hydrolysis. For example, in water esterases catalyse the hydrolysis of esters 
to the corresponding acids and alcohols but in anhydrous solvents the addition of a nucleophile (i.e. 
an alcohol or amine) leads to transesterification or aminolysis rather than hydrolysis. 
  
 In synthetic organic chemistry water is considered a poor solvent and is incompatible with 
many rections. Thus the use of organic solvents would expand the range of, otherwise insoluble, 
substrates and in doing so also increase the suitability of enzymes for industrial applications. The 
easier recovery and recycling of enzymes as well as aided separation and improved product yields 
apply especially when reactions are conducted using biphasic or anhydrous solvent systems. 
Although there are many important advantages to the use of enzymes in organic solvents, 
particularly in an industrial setting, there are also some severe limitations.  
 
 
6.2.2. Limitations 
The primary limitation is the propensity of enzymes for denaturation and inactivation upon 
exposure to non-aqueous solutions. Enzymes have evolved to function within aqueous cellular 
environments and as such are not equipped to function in non-physiological environments such as 
those provided by organic solvents. Interestingly enzymes from thermophilic organisms have been 
observed to generally exhibit greater stability in organic solvents than their mesophilic 
counterparts.142-144 Thermodynamic stabilisation of hydrophobic substrates in organic solvents can 
also be problematic. In aqueous solutions, hydrophobic enzyme active sites provide an energetic 
incentive for non-polar substrates to bind. However, in organic solvent systems hydrophobic 
substrates will be more stable than in water, thereby disfavouring catalysis.   
 
 These limitations are not unsurmountable and the benefits to be gained from the use of 
enzymes in organic solvents have the potential to expand the current scope for industrial 
!"&!
biocatalysis. Therefore alongside a high level of solubility and good thermostabilty, stability in 
organic solvents is a desirable physical trait for enzymes.141  
 
 
6.2.3. Strategies for the Stabilisation of Enzymes in Organic Solvents 
Strategies for stabilisation of enzymes in non-aqueous reaction media can be placed into two more 
general categories. The first includes strategies involving modification of the solvent environment, 
while the second includes strategies for modification or immobilisation of the enzyme. Strategies 
that fall within the first category include the use of additives such as salts, sugars or surfactants that 
can reduce the denaturing effect of the solvent on the enzyme. The second category contains a more 
diverse range of strategies including; protein engineering, chemical modification, cross-linking and 
various methods of immobilisation.141, 145  
 
 Chemical modification of proteins through covalent binding of polyethylene glycol (PEG) to 
the protein surface (PEGylation) is commonly used in therapeutic medicine since the protein-
polymer conjugates often possess favourable stability and pharmacokinetic properties.146 With 
conjugation, the size of the protein is increased while the solvent accessible surface area of the 
protein is decreased. In addition to its use in therapeutics, PEGylation is also commonly used to 
enhance protein stability in the presence of organic solvents.147, 148 The immobilisation of enzymes is 
also a common approach to improving the stability of enzymes in organic solvents. Enzymes can be 
immobilised onto solid support matrices by adsorption or covalent binding, they can be 
immobilised into gel matrices, films or polymers or they can be cross-linked to form insoluble 
crystals or particles.149  
  
 Although these methodologies have been proven successful, we wanted to use directed 
evolution to engineer an enzyme to possess in-built increased stability toward ethanol. The work 
presented in this chapter investigates the solubility and activity of DLH in various organic solvents 
and uses directed evolution to enhance its stability in the presence of ethanol. The reason being that 
for transesterification to occur an alcohol must be present in high concentration to favour 
transesterification over hydrolysis. The candidate enzyme must therefore be stable in the presence 
of high concentrations of the chosen alcohol. Ethanol was chosen as the solvent since it is cheap and 
less toxic than methanol. 
 
 
6.3. Experimental Methods 
 
6.3.1. Lyophilisation and Solubility in Organic Solvents  
The DLH-S2 variant was divided into 20 µL aliquots with 0.25 mg of purified protein in each then 
lyophilised using a FreeZone 4.5 freeze dry system (Labconco). Resuspension of each 0.25 mg 
aliquot of dried protein was attempted in various organic solvents. Those that did not solubilise 
DLH were diluted to 75, 50 or 25 % with water and re-evaluated.   
! "'!
 
6.3.2. Directed Evolution 
The DLH-S2 variant (Chapter 4) was used as a starting point to evolve DLH toward greater stability 
in ethanol. Libraries were generated by error-prone PCR with 0.1 mM MnCl2 to achieve an average 
mutation rate of one amino acid per variant. At low error-rates it has been shown that error-prone 
PCR libraries follow the Poisson distribution.150, 151 Thus, although the average amino acid mutation 
rate is one, almost 40 % of the library will contain no amino acid mutations. This would necessitate 
some level of oversampling to ensure full library coverage during screening. Library and screening 
statistics are listed in Table 6.1 and Figure 6.2 shows the overall workflow for the directed evolution 
process.    
 
Table 6.1 Library and screening statistics for the directed evolution of increased ethanol stability 
Primary screen Secondary Screen 
Theoretical library size Actual size of library screened Number of variants screened 
1416 ~ 2160 50 – 100 
* Triple the theoretical library size should generally be screened achieve 95 % library coverage 
 
 Mutations that provide new or improved catalytic functions are rare since they need to fulfil 
very specialised roles in the active site and often require synergistic mutations. Thus, when 
evolving an enzyme for enhanced or altered catalytic properties, the percentage of the theoretical 
library covered during screening can be a crucial factor to identifying rare positive variants. This is 
not so crucial when evolving the physical properties (i.e. solubility or stability) of an enzyme since 
these types of mutations are not so specific. More importantly mutations are generally additive and 
could occur at any residue, particularly those that are solvent exposed. Here the library and 
screening sizes were kept small to allow more rapid screening and a larger number of rounds than 
more comprehensive screening would feasibly allow. 
 
 
Figure 6.2 Experimental workflow for the directed evolution of DLH for increased ethanol stability 
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 Amplified PCR products were digested and ligated into pCY76 at the NdeI and EcoRI 
restriction sites then transformed into DH5! E.coli (Section 2.3). The transformed libraries were 
distributed into 96-well microtitre plates with approximately 3 CFU per well (see Supporting 
Information for Publication 1 in Appendix A). Cells were grown for 24 hours then 40 µL aliquots 
were transferred to a separate 96-well assay plate containing 10 µL of a solution of 20 mM HEPES, 1 
mM EDTA at pH 7.5 and BugBuster (Novagen) for cell lysis. The lysate was incubated for 30 min 
after addition of 148 µL of ethanol diluted with buffer (Table 6.2) then assayed for activity towards 
p-nitrophenyl acetate as described in Publication 1 reproduced in Chapter 4. The wells exhibiting 
the greatest activity (approximately the top 5% of wells) were streaked onto ampicillin 
supplemented agar plates and grown overnight. Six individual colonies from each streaked well 
were inoculated into 96-well plates and grown overnight then subjected to a secondary screen. The 
secondary screen was identical to the first only the activity of the individual variants was assessed 
with and without ethanol. This measure was to ensure that any mutations giving a positive result in 
the primary screen due to improved activity rather than the desired stability could be distinguished 
in the secondary screen – these were to be included in subsequent rounds provided they were not 
drastically destabilising.  
 
Table 6.2 Concentration of ethanol used for incubation in each round of screening 
 Rd 1 Rd 2 Rd 3 Rd 4 Rd 5 Rd 6 Rd 7 Rd 8 
Ethanol 
(v/v) 30 % 30 % 32.5 % 32.5 % 35 % 35 % 35 % 37.5 % 
 
 
 
6.3.3. Preliminary Characterisation 
The DLH-S2 variant and the best variants from generations 2 (E2), 4 (E4), 6 (E6) and 8 (E8) of the 
ethanol evolution were preliminarily characterised using cell lysate. Characterisation comprised of 
the assessment of the activity and stability of the variants in ethanol. All preliminary and final 
characterisation results were obtained in triplicate and the error is the standard deviation.  
 
 
6.3.3.1. Activity 
Single colonies of DLH-S2, E2, E4, E6 and E8 variants were inoculated into a 96-well plate and 
grown at 37 °C overnight. Cells were lysed with BugBuster (Novagen) then 30 µL of lysate was 
diluted to 200 µL with 20mM HEPES, 1mM EDTA pH 7.5 and assayed for activity toward p-
nitrophenyl acetate (250 µM). The reactions were monitored at 405 nm on a SpectraMax M2e plate 
reader (Molecular devices) at 25 °C.  
 
 
 
! ""!
 
6.3.3.2. Stability in Ethanol 
The ethanol stability of the DLH-S2 variant and the evolved ethanol tolerant enzymes were 
preliminarily evaluated using cell lysate. Single colonies were inoculated into a 96-well plate and 
grown overnight. The cell cultures were distributed into assays plates with 30 µL in each well and 
lysed by adding 10 µL of 5 % (v/v) BugBuster (Novagen). Ethanol diluted to various concentrations 
with buffer (20mM HEPES, 1mM EDTA pH 7.5) and was added to each sample to give final ethanol 
concentrations of 0 – 50 % (v/v) and a final volume of 200 µL. Samples were incubated for 30 min 
then assayed for activity toward p-nitrophenyl acetate as described above. 
 
 
6.3.4. Final Characterisation 
The DLH-S2 and DLH-E8 variant enzymes were expressed and purified for characterisation as 
described in the Publication 2 reproduced in Chapter 5. Kinetic characterisation, thermal stability – 
monitored by residual activity and SYPRO Orange fluorescence – as well as chemical stability 
experiments were also performed as described in the same publication and solubility was accessed 
by SDS-PAGE (Section 2.4). 
 
 
6.3.4.1. Activity in the Presence of Organic Co-solvents 
The activity of the DLH-S2 and DLH-E8 variants were tested in the presence of various organic co-
solvents. The variants (0.5 µM) were incubated in 20 mM HEPES, 1 mM EDTA at pH 7.5 with 20 % 
(v/v) co-solvent for 30 minutes. Following incubation, 2 µL of 25 mM p-nitrophenyl acetate 
dissolved in acetonitrile was added (giving a final substrate concentration of 250 µM with 1 % (v/v) 
acetonitrile) and activity was monitored as previously described (Section 6.3.3.1).  
 
 
6.3.4.2. Stability in Ethanol 
The ethanol stability of the DLH-S2 and DLH-E8 variants was measured similarly to the urea 
initiated unfolding. The enzymes were incubated for 30 minutes in 20 mM HEPES, 1 mM EDTA at 
pH 7.5 in the presence of different concentrations of ethanol from 0 – 55 % (v/v) increasing in 5 % 
increments to give a total of 12 data points, which were each obtained in triplicate. The enzyme 
concentration was held constant at 0.5 µM and following incubation activity was measured using 
250 µM p-nitrophenyl acetate as previously described (Section 6.3.3.1).  
 
 
6.3.5. Prediction of Stabilising Mutations Using Rosetta 
The calculations to predict stabilising point mutations were done by Prof. Thomas Huber. The 
crystal structure of native DLH (PDB code 1ZI6) was relaxed using Rosetta 3.5 relax application to 
minimise internal clashes and find the lowest energy state.152 Point mutations to all twenty amino 
!")!
acids (including the native) were assessed for each DLH residue excluding the three C-terminal 
residues that are perpetually disordered in crystal structures. A total of 4660 structures of single 
point mutant proteins were generated and the change in energy was calculated for each.153 It was 
noted that the large aromatic residues (Tryptophan, Tyrosine and Phenylalanine) were 
overrepresented among the stabilising mutations. To removed bias due to the residue type of the 
mutation, results were normalised each amino acid. For example, if a mutation to serine was 
destabilising, but less so than other mutations to serine, then this mutation would be ranked higher 
than a stabilising mutation to tryptophan that is less so than all other tryptophan mutations. 
  
 The mutations were analysed, ranked and filtered to find the surface mutations most likely 
to improve the stability of DLH. The best 910 of the 4660 mutations – in regard to lowest energy 
folded state – were filtered first to remove active site residues and then to select only mutations at 
sites with a relative accessible surface area (ASA) greater than 44 Å2, which is approximately 25 % of 
DLH residues (see Section 3.2.5 for calculation of relative ASA). The mutations were further filtered 
to include only mutations at positions with variable residues, and all residues with a ConSurf154 
conservation score larger than 1 were omitted. This method of data analysis resulted a final list of 
223 mutations covering 28 different surface sites. 
 
 
6.4. Results and Discussion 
 
6.4.1. DLH solubility in Organic Solvents 
Lyophilised protein was resuspended in different solvents to assess solubility (Table 6.2). These 
results were conducted using the DLH-S2 variant prior to the directed evolution for improved 
stability in ethanol.  
 
 Of the solvents tested, the more polar ethylene glycol and dimethyl sulfoxide (DMSO) were 
the only ones to completely solubilise DLH when used at 100 % (v/v). The water immiscible 
solvents ethyl acetate and cyclohexane were not able to solubilise DLH at this concentration. 
Dioxane, methanol, ethanol, isopropanol and dimethylformamide (DMF) were able to solubilise 
DLH at ratios of 75 to 50 % while acetonitrile had to be diluted to 25 % (v/v) with water in order to 
resuspend the lyophilised protein.  
 
 
 
 
 
 
 
 
 
! "*!
Table 6.2 Solubility of lyophilised DLH in organic solvents   
  100 % 75 % 50 % 25 % 
Methanol  ! ! " " 
Ethanol  ! ! " " 
Isopropanol  ! ! " " 
Ethylene glycol  " " " " 
Acetonitrile  ! ! ! " 
Dimethyl sulfoxide  " " " " 
Dimethylformamide 
 
! ! " " 
Dioxane  ! " " " 
Ethyl acetate 
 ! water immiscible 
Cyclohexane  ! 
 
 
 The activity of the DLH-S2 variant toward p-nitrophenyl acetate was tested after 
lyophilisation and subsequent resuspension in water. Interestingly, it was found that if the enzyme 
was lyophilised from a buffered solution (20 mM HEPES, 1 mM EDTA, pH7.5) then the enzyme 
was active but when lyophilised from just water with no buffer, the enzyme was inactive. These 
were single experiments so would need to be repeated in order to investigate this further. 
   
 
6.4.2. Directed Evolution for Improved Stability in Ethanol 
Directed evolution was used to improve the stability of DLH in the presence of ethanol. A total of 
eight rounds of library generation and screening were conducted using libraries in excess of 2000 
variants generated by error-prone PCR (Table 6.4). The ethanol concentration for screening was 
increased over the course of the evolution to maintain a constant screening pressure (Table 6.2).  
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 At the conclusion of eight rounds of screening DLH variants for increased ethanol stability 
several beneficial mutations were identified, all of which occurred at exterior surface sites (Figure 
6.3). The S7T and S210P mutations were first identified individually in round one and were 
combined through shuffling in round two then fully conserved throughout the remainder of the 
evolution. The A134T mutation was identified in round three and present in all variants from round 
six. Although these were the only mutations to be fully conserved in the final round, there were 
several others that featured prominently over the course of the evolution. It is likely these mutations 
– S22L, R45Q, D53N, K116R and G187S – would have continued to feature and been conserved had 
the evolution extended beyond the eight rounds.  
 
 
Figure 6.3 Location of prominent stabilising mutations where the colours reflect order in which the 
mutations appeared prominently (blue: gen 1-2, orange: gen 3-4, green: gen 5-6 and red: gen 7-8) 
  
 It is only possible to speculate on the role of the mutations in aiding the stability of DLH in 
the presence of ethanol. Ethanol is a relatively polar solvent but less so than water, thus surface 
mutations to large hydrophobic amino acids (i.e. F, W) would not be expected and indeed were not 
observed. Most of the mutations are relatively subtle in relation to size and see a modest decrease in 
polarity (i.e. S7T, S22L, R45Q, D53N and S210P). The S210P mutation is likely stabilising due a 
reduction in flexibility of loop 14 since efficient packing and reduced flexibility of surface loops is a 
characteristic often observed in thermophilic enzymes.142-144 There is no structural data (B-values) 
available to validate the hypothesis at this stage, however obtaining a crystal structure is among the 
intended future work for this project. 
 
 The best variants (! Table 6.4, Table 6.5) from generation 2 (E2 variant), generation 4 (E4 
variant), generation 6 (E6 variant) and generation 8 (E8 variant) along with the DLH-S2 variant, 
underwent preliminary characterisation to determine their stability profiles in the presence of 
increasing ethanol concentrations. 
S7T 
S210P 
E78D 
R45Q 
K25R 
K116R 
G187S 
A134T 
D53N 
S22L 
Active Site Cleft 
!)$!
 
Table 6.5 Mutations present in selected evolved DLH variants 
Generation Variant ID Amino acid mutations 
2 E2 S7T, S210P 
4 E4 S7T, S22L, A134T, S210P 
6 E6 S7T, S22L, K25R, A134T, S210P 
8 E8 S7T, S22L, D53N, E78D, A134T, G187S, S210P 
 
 
 
6.4.3. Preliminary Characterisation of Evolved Variants 
The evolved variants underwent a preliminary characterisation using cell lysate to evaluate their 
activity in aqueous solution with no co-solvent present (Figure 6.4). The activity and stability of the 
variants in aqueous reaction media with the addition of different concentrations of ethanol as a co-
solvent was also assessed at this preliminary stage (Figure 6.5).  
  
 The activity of the variants toward the non-physiological substrate p-nitrophenyl acetate 
was measured using cell lysate. No significant change in activity was observed; the activity of the 
evolved variants and the DLH-S2 variant were all within error. 
 
 
Figure 6.4 Lysate activity of the DLH-S2 and ethanol tolerant evolved variants 
 
 The residual activity displayed by the variants in increasing concentrations of ethanol shows 
their stability – ability to maintain their structure, which is crucial for activity. Predictably in all 
cases the activity decreased with increasing ethanol concentration (Figure 6.5). Although the error 
associated with the data is significant due to the use of lysate, the differences between the variants 
are large enough to see the trend of consistent improvement over the course of the evolution. The 
E2 and E4 variants showed slight increases in activity in the presence of ethanol over the DLH-S2 
variant that was used as the starting point for the evolution. Similarly the E6 variant displayed 
further improvements courtesy of the K25R mutation that is the only additional mutation contained 
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by the E6 variant (S7T, S22L, K25R, A134T and S210P) but not the E4 variant (S7T, S22L, A134T and 
S210P). The E8 variant exhibited the greatest stability with an improvement in residual activity of 
approximately 30% over the S2 variant at a concentration of 30 % (v/v) ethanol (Figure 6.5A). 
 
 
Figure 6.5 Residual activity in the presence of ethanol of (A) all variants, (B) DLH-S2, (C) E2, (D) E4, 
(E) E6 and (F) E8 variant 
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6.4.4. Final Characterisation of the DLH-E8 variant 
The DLH-S2 variant (the enzyme used as template for this evolution for improved stability in 
ethanol) and the DLH-E8 variant (the best variant from the evolution) were purified and 
systematically characterised.  
 
 
6.4.4.1. Kinetic Characterisation 
Kinetic constants for the enzyme catalysed hydrolysis of p-nitrophenyl acetate were determined 
(Table 6.6). The values for Km, kcat and kcat/Km for the S2 and E8 variants were within error allowing 
the conclusion that the surface mutations in the E8 variant had no effect on the catalytic properties 
of the enzyme.  
 
Table 6.6 Kinetic characterisation of DLH-S2 and DLH-E8 variants   
 Km (µM) kcat (s-1) kcat / Km (M-1 s-1) 
DLH-S2 13.7 ± 0.7 0.61 ± 0.01 4.5 ± 0.3 x 104 
DLH-E8 11 ± 2 0.58 ± 0.03 5.2 ± 0.6 x 104 
 
 
 
6.4.4.2. Stability and Activity in Ethanol 
The stability of the S2 and E8 DLH variants was measured in the presence of ethanol in the same 
way as the preliminary characterisation (Figure 6.5), the only difference being the use of purified 
protein rather than cell lysate (Figure 6.6). 
 
 
Figure 6.6 Residual activity of DLH variants in the presence of ethanol 
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The unfolding profiles differ slightly to those obtained using crude lysate suggesting that the 
cellular debris has an effect on the interaction between the co-solvent and enzyme. There appears to 
be two stages of unfolding (- - - Figure 6.6) with an intersection at 30 % v/v ethanol that is more 
distinct for the E8 variant. One of these is due to protein denaturation and the associated loss of 
function and is hence the desired stability measurement. The other is likely not due to unfolding but 
instead a decrease in activity due to displacement of water with ethanol in the active site. From this 
experiment alone is it not possible to conclude whether this is because the transesterification (with 
ethanol replacing water as a nucleophile) is slower than or non-existent compared to the hydrolysis 
or whether DLH cannot catalyse the transesterification (Scheme 6.1).  
 
 
6.4.4.3. Activity in the Presence of Organic Co-solvents 
The activity of the purified enzymes in the presence of 20 % (v/v) organic co-solvent was evaluated. 
Figure 6.7 shows the activity expressed as a percentage of the activity exhibited when measured 
after incubation in a purely aqueous solution. In all instances the activity retained by the DLH-E8 
variant was greater or equal to the activity retained by the S2 variant. The directed evolution 
produced a DLH variant with improved stability and activity in the presence of not only ethanol 
but also other solvents including isopropanol, acetonitrile, acetone and DMSO. 
 
 
Figure 6.7 Activity of DLH in the presence of organic solvents compared to activity in water 
 
 
6.4.4.4. Solubility 
SDS-PAGE was used to identify any significant changes to the expression or solubility of the 
evolved DLH-E8 variant (Figure 6.8). Increases to expression or solubility would have provided 
improved activity in ethanol during the screening through the presence of more enzyme and not 
necessarily because of increased ethanol stability. However, there was no significant change to 
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expression or solubility of the DLH-E8 variant compared to either the native enzyme or the DLH-S2 
variant.  
 
 
Figure 6.8 SDS-PAGE of native DLH and the S2 and E8 variants expressed in pCY76 
 
 
6.4.4.5. Thermal and Chemical Stability 
There is a correlation between the properties governing protein thermal and chemical (solvents or 
denaturants) stability. This is evidenced by the observation that thermophilic enzymes often have 
increased resistance to chemical denaturants and organic solvents.142, 143 As such it was suspected 
that the mutations to the DLH-E8 variant – S7T, S22L, D53N, E78D, A134T, G187S and S210P – 
providing increased stability in ethanol, could also offer benefits in regards to thermal stability and 
resistance to denaturants such as urea or guanidine hydrochloride.  
  
 Thermal stability was determined in two ways; firstly by monitoring deterioration of the 
active site through residual activity measurements and secondly using the fluorophore SYPRO 
orange to monitor the overall unfolding of the enzymes (Figure 6.9). Melting temperatures for the 
DLH-S2 and E8 enzymes measured by residual activity were 54.3 ± 0.2 °C and 57.3 ± 0.2 °C 
respectively. When measured using the increase in fluorescence caused by binding of SYPRO 
orange to exposed hydrophobic upon protein denaturation, the melting temperatures were 54.6 ± 
0.1 °C and 57.7 ± 0.2 °C. The difference in melting temperature between the DLH-S2 and E8 variants 
was 3 °C when measured by either method. However, as observed in Publication 2 reproduced in 
Chapter 5, the melting temperatures determined by overall unfolding were slightly higher than 
those determined by residual activity but in both cases were within error.  
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Figure 6.9 Thermal denaturation (A) residual activity plot, (B) change in SYPRO orange 
fluorescence and (C) corresponding melting temperatures extracted from the data 
 
 The DLH-S2 variant was evolved for increased thermal stability (Chapter 4) so is itself more 
stable than the native and more active variants identified in previous chapters. Figure 6.10 and 
Table 6.7 show the change in melting temperature of the DLH variants from not just this evolution 
but also those discussed in Chapters 4 and 5. 
 
 
Figure 6.10 Comparison of melting temperatures of different DLH variants determined by residual 
activity 
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 The DLH-A2 variant has the lowest melting temperature on account of the three 
destabilising active site mutations (Q35H, F38L and Y145C). The three mutations to the active site 
loop (loop 14, discussed in Chapter 4) (E199G, S208G and G211D) provide enhanced stability to the 
DLH-S0 variant. The surface mutations (Q110L, Y137C and N154D) discussed in Chapter 5, 
contribute to a further increase in thermal stability. The mutations unique to the DLH-E8 variant 
(S7T, S22L, D53N, E78D, A134T, G187S and S210P) give additional increased thermal stability, 
making it the most thermally stable engineered DLH variant.  
 
Table 6.7 Amino acid mutations and comparison of melting temperatures 
Variant Chapter Mutations Tm (°C) 
Native 4 C123S 53.7 ± 0.2 
DLH-A2 4 Q35H, F38L, C123S, Y145C 48.7 ± 0.2 
DLH-S0 5 Q35H, F38L, C123S, Y145C, E199G, S208G and G211D 51.2 ± 0.3 
DLH-S2 4 & 5 Q35H, F38L, Q110L, C123S, Y137C, Y145C, N154D, E199G, S208G and G211D 54.3 ± 0.2 
DLH-E8 6 S7T, S22L, Q35H, F38L, D53N, E78D, Q110L, C123S, A134T, Y137C, Y145C, N154D, G187S, E199G, S208G, S210P and G211D 57.3 ± 0.2 
  
 
 The activity of the DLH-S2 and E8 variants was measured following incubation in the 
presence urea to assess their resistance to chemically induced denaturation (Figure 6.11). The DLH-
S2 variant unfolded at lower concentrations of urea than the E8 variant. Where the DLH-S2 variant 
exhibited negligible activity at concentrations greater than 4.5 M, the E8 variant still retained almost 
50 % of its original activity at the same concentration.  
 
 
Figure 6.11: Urea initiated denaturation measured using residual activity  
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 As with the similar assays conducted to assess ethanol tolerance (Section 6.4.4.2), activity 
loss occurred in two stages. These were presumably due to unfolding of the protein and 
replacement of water molecules within the active site thereby disrupting generation of the 
hydroxide nucleophile during catalysis and reducing substrate turnover rate. 
 
 
6.4.5. Attempts to Detect Transesterification 
Attempts to detect DLH catalysed transesterification were subject to time constraints and technical 
difficulties. Liquid chromatography – mass spectrometry (LC-MS) was the preferred method of 
detection over gas chromatography – mass spectrometry (GC-MS). The GC-MS available for use 
within the Research School of Chemistry used electron impact mass spectrometry and required 
higher sample concentrations compared to the available LC-MS, which was able to detect samples 
in the µM range and therefore more suitable for enzyme assays.  
 
 Brief attempts were made to detect standards of p-nitrophenol, butyric acid (hydrolysis 
product) and methyl butyrate (transesterification product) using a 6120 quadrupole LC-MS system 
(Agilent) with the assistance of Dr. Bradley Stevenson. Standards corresponding to the larger 
p-nitrophenyl butyrate substrate were used instead of the smaller p-nitrophenyl acetate due 
predicted difficulties with detection of the low molecular weight products acetic acid and methyl 
acetate. The negative ion of p-nitrophenol [M-H]-: 138.1 and the positive ion of butyric acid [M+H]+: 
89.1 were detected but no appropriate positive or negative ion was detected for methyl butyrate. 
Due to time constraints no further attempts were made.  
 
 
6.5. Bioinformatic Prediction of Stabilising Mutations  
Computational prediction of mutations stabilising to DLH was done by Prof. Thomas Huber using 
Rosetta. The 4660 mutations covering the full range of amino acid substitutions across the entire 
protein sequence were ranked based on the change in free energy then normalised and filtered to 
consider ASA and variability.  
 
 There were 182 mutations predicted to be stabilising at sites that adhered to the applied 
ASA and variability restrictions. Multiple stabilising mutations were predicted at most sites, such 
that the 128 mutations covered just 28 sites on the surface of DLH. The 28 sites and the predicted 
stabilising amino acid changes are listed in Table 6.8, along with B-values and relative ASAs. It 
should be noted that the B-values and relative ASAs are for the native enzyme (PDB ID 4U2B) since 
the stability predictions were for the native enzyme. However, the DLH-S2 and E8 variants contain 
activity enhancing mutations, several of which – E199G, S208G and G211D – are on loop 14 
(residues 198 – 212) and significantly increase the flexibility and thus the B-values. 
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Table 6.8 Residues where stabilising mutations were predicted 
Site Native  Amino Acid B-Value (Å
2) Relative  ASA (Å2) Stabilising Mutations 
4 E 23.0 98.4 G, S, A, D, K, P, T, Q, N, R, C 
7 S 18.9 61.8 T, C, V, K, D, E, R, I, Q 
9 Q 17.7 64.2 T, K, R, E 
11 Y 33.5 95.4 S, G, A, C, D, K, N, E, T, R, Q, P, H, V 
15 T 18.1 49.0 K, C, Q, R, A, E, G, S 
22 S 18.3 59.3 G, K, T, C, Q, E, R, A, M, P, L 
25 K 32.4 71.2 T, Y, E, R, Q, C, V, F, S, N, D 
26 A 25.7 49.1 C, T, K, S, V, R, P, G, I 
27 P 25.1 57.4 K, E, L, Q, N, S, R, C, D, T, G 
42 A 11.9 47.0 E, K, G, Q, D, R, N, S, T 
78 E 18.5 77.7 G, K, D, A, P, N, R, S, T, C 
82 E 15.0 66.7 K, A, R, D, G, N, Q 
86 K 17.6 61.6 R 
105 R 24.6 58.0 K, A, E, G, Q, N, D, C, Y 
109 H 34.3 66.8 G, N, K, D, Q, C 
158 E 21.8 44.0 K, Q, N, D, R 
160 K 24.8 67.0 D, T, N, R, G, S 
170 Q 16.2 60.7 K, R 
180 Q 18.4 56.1 K, E 
187 G 20.8 74.2 A, S, D, N, E, K, Q, R, T 
188 A 19.9 76.1 S, G, K, D, C, N, T, E, Q, R 
190 P 16.9 88.8 S, G, D, N, K 
207 T 13.6 63.6 S, K, A, G, P, E, Q, R, C 
210 S 16.3 100.4 G, D, K, N, E, P 
215 S 12.6 72.9 G, A, D, K, T, E, N, Q, C, V, R, I, L, W 
218 A 11.4 47.2 K, R, G, D, Q, E, T, N 
222 E 12.1 55.8 K, A, N, D, S, G, Q, R, C, M 
230 P 15.7 54.9 D, G, N, K, C, A, E 
Note: Sites in bold text and the underlined amino acids show the mutations identified as stabilising 
during the directed evolution of DLH. 
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 Ten mutations were identified during the directed evolution of DLH for increased stability 
in ethanol. Seven of these were predicted as stabilising using the unmodified data but all were 
predicted as stabilising when the data was normalised based on amino acid type. Six of the ten sites 
remained as candidates when taking into account the filters applied to reduce the volume of data 
(Table 6.8). These six mutations that were predicted to be stabilising by lowering the free energy of 
the folded state of the protein, were shown experimentally to be both thermally and chemically 
stabilising. The high consensus between mutations predicted to be stabilising and mutations 
determined to be stabilising experimentally provides promise for future work. Based on the results 
of this and previous directed evolution experiments (Chapter 3 and 4) as well as knowledge of DLH 
structure, it is suggested that residues E4, Y11, A188, S215 and E222 should be considered first 
targets for future mutagenesis. These residues all have a large number of stabilising mutations 
predicted, additionally they have high solvent ASA’s and, with the exception of E222, they all have 
large B-values.  
 
 
6.6. Conclusion 
Directed evolution was used to improve the stability of DLH in solutions containing ethanol as a co-
solvent. The best variant after eight rounds of evolution was the E8 variant that encompassed seven 
surface mutations – S7T, S22L, D53N, E78D, A134T, G187S and S210P. In addition to these 
mutations several others were identified during the course of the evolution that appeared multiple 
times, these include the K25R, R45Q, and K116R mutations. It was suspected that these mutations 
would have become conserved in future rounds had the directed evolution been continued. Due to 
the successful prediction of the mutations obtained during the evolution using the Rosetta software, 
it is hypothesised that further mutations selected based on these predictions would achieve more 
rapid improvements.  
  
 There were no significant changes to activity or solubility between the starting DLH-S2 
variant and the E8 variant. The mutations did enhance the stability of the enzyme both thermally 
and chemically. A 3 °C increase in melting temperature was observed while the difference in 
denaturing urea concentration was 1 M in favour of the E8 variant. Stability in the presence of 
ethanol increased consistently throughout the course of the evolution culminating in the DLH-E8 
variant. The DLH-S2 variant possessed 40 % of its original activity in a 30 % (v/v) ethanol-water 
solvent system where the evolved DLH-E8 variant was able to retain almost 70 % activity under the 
same conditions.  
 
 In order to obtain the transesterification product in reasonable yield, the ratio of ethanol to 
water in the reaction media would ideally be in favour of ethanol since both the hydrolysis and 
transesterification products would be obtained. Although the DLH-E8 variant has increased 
stability in ethanol it was not sufficient for these conditions to be met. Nevertheless, brief attempts 
were made unsuccessfully to monitor the reaction by LC-MS.  
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6.7. Future Work 
The current results provide promising options for future work to rationally increase the stability of 
DLH in the presence of ethanol. For DLH to be active in solutions consisting of predominantly 
ethanol, further protein engineering is necessary. It is suggested that 1H NMR spectroscopy using p-
nitrophenyl acetate as substrate be use for future detection of transesterification. The methyl or 
ethyl ester of the transesterification product would have a unique chemical shift. Integration of this 
signal compared to p-nitrophenol would provide a ratio of transesterification to hydrolysis. This 
reaction could be conducted in methanol or ethanol however, it is suggested that methanol be used 
in the first instance since methyl acetate would produce less signals on the NMR spectrum and thus 
allow easier integration of the relevant peaks. This work is being continued in collaboration with 
Prof. Charles Collyer’s Laboratory at the University of Sydney.  
 
 Using Rosetta predictions to improve the stability of an enzyme in organic solvents is of 
interest not just to turn DLH into a transesterase but also to establish an rapid and efficient protocol 
that could be applied to engineer lipases and other industrially relevant enzymes. Additional future 
work could include obtaining a crystal structure of the DLH-E8 variant for comparison with the 
DLH-S2 structure that was solved and published in the article reproduced in Chapter 4. 
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Structural Changes Caused by Crystal Packing 
 
The article “Crystallisation of dienelactone hydrolase in two space groups: Structural changes 
caused by crystal packing” published in Acta Crystallographica Section F is the basis for this chapter. 
 
 
7.1. Introduction 
Protein structure determination is an important aspect of structural biology. Knowing the specific 
configuration of protein atoms is essential to be able to fully understand the function of these 
macromolecules. There are many techniques employed for this purpose including circular 
dichroism,155 electron microscopy, mass spectrometry,156 nuclear magnetic resonance (NMR) 
spectroscopy,157-160!small angle X-ray scattering (SAXS)161 and X-ray crystallography (Table 7.1).  
   
Table 7.1 Techniques in structural biology and the information they can provide 
Circular dichroism Information on secondary structure 
Electron microscopy Overall shape 
Ion-mobility mass spectrometry Assembly formation and protein dynamics  
NMR spectroscopy Local conformation of residues 
Small angle X-ray scattering  Shape and complex formation 
X-ray diffraction Atomic configuration 
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 Of these techniques, X-ray crystallography is the most widely used with almost 90 % of all 
protein and protein-nucleic acid complex structures in the Protein Data Bank (PDB) solved by X-ray 
crystallography.162 Methods for the study of protein complex assemblies and protein dynamics are 
designed to complement structural data and cannot replace X-ray crystallography or NMR 
spectroscopy in providing three-dimensional structures at atomic resolution.163, 164  
 
 
7.1.1. X-ray Crystallography 
Macromolecular X-ray crystallography has advanced significantly over the years since the first 
structure of myoglobin was solved in 1958.165 Previously the practical aspects of data collection and 
subsequent calculations were very laborious and could take up to a year, now this process is 
automated and can be performed within hours.166 A recurrent criticism of X-ray crystallography 
throughout this time period has been the potential for distortion of structure occurring as a result of 
packing in the crystalline environment. In some instances it has been shown that the crystal 
environment does affect molecular structure. For example, different crystal forms of T4 lysozyme 
exhibit large differences in the hinge-bending angle between the amino and carboxyl terminal 
domains.167 However, other studies have found only minor differences at crystal interfaces with no 
significant changes to the protein backbone – particularly studies dealing with monomeric 
proteins.168, 169 Furthermore it was demonstrated early in the crystallography era that the enzyme 
carboxypeptidase-A retained activity in the crystalline state, inferring an unchanged active site from 
that in solution.170 
   
 In the publication presented in this chapter (Section 7.2) we crystallised DLH in two space 
groups and analysed the resulting structures to identify differences that arose due to changes in the 
crystallographic environment. In doing this we aimed to add to the evidence that crystal contacts 
cause only minor changes at crystallographic interfaces and typically do not alter the protein 
backbone and overall structure.  
 
 
7.2. Reproduction of Published Article 
The following article is reproduced with permission of the International Union of Crystallography. 
(http://dx.doi.org/10.1107/S2053230X1401108X) 
 
J. L. Porter, P. D. Carr, C. A. Collyer, D. L. Ollis (2014) Crystallization of dienelactone hydrolase in 
two space groups: Structural changes caused by crystal packing. Acta Crystallographica Section F 70, 
884-889.  
 
Author Contributions: I expressed, purified and crystallised DLH. The C2 structure was solved by 
P.D.C. I refined and analysed the structures and wrote the manuscript under the guidance of both 
P.D.C and D.L.O with academic contribution from C.A.C. 
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Dienelactone hydrolase (DLH) is a monomeric protein with a simple !/"-
hydrolase fold structure. It readily crystallizes in space group P212121 from
either a phosphate or ammonium sulfate precipitation buffer. Here, the
structure of DLH at 1.85 A˚ resolution crystallized in space group C2 with two
molecules in the asymmetric unit is reported. When crystallized in space group
P212121 DLH has either phosphates or sulfates bound to the protein in crucial
locations, one of which is located in the active site, preventing substrate/inhibitor
binding. Another is located on the surface of the enzyme coordinated by side
chains from two different molecules. Crystallization in space group C2 from a
sodium citrate buffer results in new crystallographic protein–protein interfaces.
The protein backbone is highly similar, but new crystal contacts cause changes in
side-chain orientations and in loop positioning. In regions not involved in crystal
contacts, there is little change in backbone or side-chain configuration. The
flexibility of surface loops and the adaptability of side chains are important
factors enabling DLH to adapt and form different crystal lattices.
1. Introduction
Dienelactone hydrolase (DLH) is a 25.5 kDa monomeric protein
belonging to the !/"-hydrolase fold class of enzymes. It was first
identified in Pseudomonas knackmussii and forms part of the "-
ketoadipate pathway that is used by bacteria to degrade otherwise
toxic aromatic compounds (Schmidt & Knackmuss, 1980; Ngai et al.,
1987). The initial structure of native DLH was determined at 2.8 A˚
resolution more than 20 years ago (Pathak et al., 1988). It contains
236 amino acids forming seven helices and eight strands of "-sheet;
seven of the strands are parallel with strand "2 antiparallel to the rest.
The "-sheet is in the core of the enzyme and is surrounded by the !-
helices. Six of the !-helices lie on the outer solvent-accessible
domains of the enzyme, while the other lies within the inner core
(Pathak & Ollis, 1990). As is characteristic of !/"-hydrolase fold
enzymes, DLH contains a catalytic triad consisting of a nucleophilic
cysteine (Cys123), a histidine (His202) and an aspartic acid (Asp171)
(Pathak et al., 1991). The enzyme is also active with a serine replacing
the nucleophile (C123S; Cheah, Ashley et al., 1993; Cheah, Austin et
al., 1993).
In the years since the first structure was published, DLH has been
studied both mechanistically and from an engineering perspective
(Kim et al., 2005; Walker et al., 2000, 2012), with most studies resulting
in crystallization and structural analysis. There are currently ten DLH
structures in the Protein Data Bank, nine of which are obtained from
isomorphous crystals in space group P212121 with a single DLH
molecule in the asymmetric unit. The one with different morphology
(although still in space group P212121) is attributed to the presence of
2-propanol and the bound PMS moiety of the protease inhibitor
phenylmethylsulfonyl fluoride (PMSF). Crystals isomorphous to
those previously reported were initially grown but dissolved with the
addition of PMSF in 2-propanol only to reform in situ with new cell
dimensions (Robinson et al., 2000).
DLH has been shown to readily crystallize in space group P212121
using either phosphate or sulfate precipitating agents. Here, we
report the crystallization and structure of DLH, using citrate as
precipitating agent, in space group C2 with two molecules in the
asymmetric unit. Differences between the new and old structures
# 2014 International Union of Crystallography
All rights reserved
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highlight the effects of precipitating ions and the crystal lattice on the
molecular structure.
2. Materials and methods
2.1. Expression, purification and crystallization
DLH was expressed and purified as described previously (Kim et
al., 2005). Both the P212121 and C2 crystal forms were obtained using
hanging-drop vapour diffusion. The P212121 crystals were grown
using conditions similar to those previously reported (Kim et al.,
2005). The hanging drop consisted of 5 ml of 12 mg ml!1 protein
solution and 3 ml of 0.1M sodium citrate, 1.2M ammonium sulfate
pH 5.8 over an 800 ml reservoir. Crystals were harvested after 5–10 d
growth at 277 K. The C2 crystals were grown in an 8 ml hanging drop
with a 1:1 ratio of protein to precipitant solutions, where the preci-
pitant was 0.8M sodium citrate pH 5.8 and the reservoir volume was
again 800 ml. Crystals were harvested after 3–5 d growth at 291 K and
were then stored at 277 K. Prior to data collection, crystals were
transferred to a cryobuffer consisting of the crystallization buffer with
the addition of 30% glucose and 5% glycerol.
2.2. Data collection and processing
Data for both crystal forms were collected using Cu K! radiation
at a temperature of 100 K. Data were recorded as a contiguous
sequence of 1" rotations using a MAR345 detector mounted on a
Xenocs GeniX 3D Cu HF micro-beam X-ray generator, with cooling
supplied by an Oxford Cryostream 700 series. 160 frames were
collected for the C2 crystal and 180 for the P212121 crystal. The C2
crystal required 60 min exposure per frame, whereas the P212121
crystal required 5 min exposure per frame. Data-collection statistics
are listed in Table 1.
2.3. Structure determination and refinement
The C2 crystal structure (PDB entry 4p93) was solved by molecular
replacement using Phaser (McCoy et al., 2007) as implemented in the
CCP4 suite of programs (Winn et al., 2011). PDB entry 1zi6 (Kim et
al., 2005) was used as a search model. The search yielded a single
correct solution (rotation function Z-score = 23.5, translation func-
tion Z-score = 59.9, log-likelihood gain = 4031). Further refinement
was undertaken using REFMAC5 (Murshudov et al., 2011). The final
refinement statistics are listed in Table 1. The P212121 structure (PDB
entry 4p92) was simply refined against the same known structure
(PDB entry 1zi6). Crystal contacts for both crystal forms were
identified using CONTACT (Tadeusz Skarzynski, Imperial College
London), the structures were superimposed using SUPERPOSE
(Krissinel & Henrick, 2004) and the difference in accessible surface
area due to crystal contacts was calculated using AREAIMOL (Saff
& Kuijlaars, 1997) in CCP4.
3. Results and discussion
3.1. Crystal packing and overall structure
The new C2 crystal form was found to contain two copies of DLH
in the asymmetric unit, designated A and B. These molecules have
different crystal environments and are related by a noncrystallo-
graphic twofold axis perpendicular to the unique axis (Fig. 1). The
solvent content of the C2 crystals was 41%, while the corresponding
value for the P212121 crystals was 47%. The C2 crystals did not
diffract as well as the P212121 crystals, but data of sufficient quality
could be collected to enable determination of an accurate structure.
The average error in the C2 coordinates was found to be 0.13 A˚ as
determined by the diffraction-component precision index (DPI)
value for the model (Cruickshank, 1999), while the corresponding
error for the P212121 structure was 0.08 A˚.
The overall DLH structure was very similar in either the P212121
(4p92) or C2 (4p93) crystal forms. The r.m.s. displacements after
superimposing the two chains of the C2 structure with the P212121
structure were 1.02 A˚ for chain A and 0.85 A˚ for chain B. When the
superposition was limited to main-chain atoms, the r.m.s. displace-
ments were 0.43 and 0.41 A˚ for the A and B chains, respectively. The
r.m.s. difference obtained when superimposing molecule A on
molecule B was 0.96 A˚ for all atoms and 0.37 A˚ for main-chain atoms.
The differences between the three structures were not uniform and
were concentrated principally in the loop regions and at crystal-
lographic interfaces.
The conditions used to obtain either crystal morphology were
similar in two important aspects: the pH was the same (pH 5.8) and
the crystallization buffers were both high in salt (1.2M ammonium
sulfate and 0.8M sodium citrate). Ionic strength and pH are two of
the most important variables affecting crystal growth (Zeppezauer,
1971; Feher & Kam, 1985); this being the case, it is surprising that
isomorphous crystals were not obtained. It should be noted that
although the C2 crystals were initially grown at a slightly higher
temperature, they were subsequently stored at the same temperature
as the P212121 crystallization with no change in morphology.
3.2. Crystal contacts and the role of sulfate ions in the P212121
crystal
In the P212121 crystals each molecule interacts with six others
through three interfaces (Supplementary Fig. S11). The interface
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Table 1
Summary of diffraction data and refinement statistics.
Values in parentheses are for the highest resolution shell.
DLH P212121 DLH C2
Data collection
Unit-cell parameters (A˚, ") a = 48.2, b = 71.0, c = 77.5,
! = " = # = 90.0
a = 100.2, b = 49.1, c = 89.6,
! = # = 90.0, " = 94.3
Wavelength (A˚) 1.5418 1.5418
Resolution range (A˚) 77.46–1.65 (1.70–1.65) 89.36–1.85 (1.90–1.85)
Observed reflections 224333 (14494) 113253 (7865)
Unique reflections 31176 (2138) 35229 (2484)
hI/$(I)i 50.6 (20.8) 16.9 (5.1)
Completeness (%) 95.6 (91.0) 94.0 (88.9)
Rmerge 0.030 (0.102) 0.063 (0.303)
Refinement statistics
Resolution (A˚) 19.67–1.65 (1.70–1.65) 19.66–1.85 (1.90–1.85)
No. of reflections 29557 (1894) 33459 (2299)
No. of free R reflections 1578 (98) 1770 (117)
R factor 0.158 (0.145) 0.173 (0.201)
Free R factor 0.172 (0.185) 0.205 (0.263)
No. of non-H atoms 1766 3542
No. of water molecules 246 184
No. of sulfate ions 3 0
Model quality
R.m.s. deviations from ideal geometry
Bond lengths (A˚) 0.007 0.008
Bond angles (") 1.090 1.087
Average B factors (A˚2)
Overall 10.38 22.12
Main-chain atoms 8.34 20.11
Side-chain atoms 12.11 24.22
Ramanchandran plot, residues in (%)
Favoured regions 97.0 97.4
Allowed regions 3.0 2.6
Disallowed regions 0 0
1 Supporting information has been deposited in the IUCr electronic archive
(Reference: SW5074).
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containing the most interactions is between the residues of helices 2
and 7 of neighbouring molecules. Arg81, Glu82 and Gln89 of helix 2
form hydrogen bonds to Ser215, Glu222 and Arg223 of helix 7 as well
as parallel %–% stacking between His172, which lies on a loop
protruding over the active site, and Trp50 located in helix 1. In
addition, there is a sulfate ion that is ligated by side chains from both
molecules. It lies between the N-terminal end of helix 6, 2.84 A˚ from
the peptide backbone of Ala176, where it is likely to be stabilized by
the !-helix dipole and the exterior side of helix 1 from the neigh-
bouring molecule, where it forms hydrogen bonds with the side chains
of Arg45 and Ser49. The remaining interfaces are minor, involving
only two to three residues. One involves Gln9 of strand "1 and Glu78
and Gln76 of loop 6; the other involves Ser22 of loop 3 and Ala188 of
loop 13.
DLH crystallized in space group P212121 has sulfate ions that form
crystal contacts between protein molecules within the lattice frame-
work. In crystals obtained using a phosphate precipitation buffer,
phosphates replace sulfates in these positions. There are three
coordinated sulfate molecules in the lattice. One forms part of an
interface, as described above. The second and third sulfate molecules
are coordinated by a single DLH molecule rather than at interfaces.
One is positioned near the start methionine with an O atom (O4)
2.72 A˚ from the N-terminus. The final sulfate ion is positioned at the
opening of the enzyme active site and is coordinated by Arg81,
Ser203, Arg206 and Ser209 (Fig. 2). The latter residues reside on a
loop containing the His202 of the catalytic triad. This loop functions
as a cover for the active site, creating a crevice inaccessible to bulk
solvent. The location of this sulfate ion causes problems when trying
to soak substrates into the enzyme active site.
3.3. New crystallographic interfaces in the C2 crystal
In the C2 crystal lattice each molecule interacts with eight others,
giving rise to eight unique interfaces that involve 21 chain A residues
and 21 chain B residues (Supplementary Fig. S2). The main interface
involves residues Gln67, Glu70, Thr71 and Ala72 from loop 6 and
Arg79, Gln80, Gln83 and Lys86 for helix 2 hydrogen bonding to the
same residues from a neighbouring molecule. This interface is
between a chain A and a chain B molecule; therefore, although the
hydrogen-bonding residues involved are the same, the bond distances
are different. For example, the distance of the hydrogen bond
between Thr71 from chain A and Gln83 from chain B is 3.22 A˚,
whereas the bonding distance when the chains are reversed is 3.78 A˚.
Similarly, the distance between Ala72 from chain A and Arg79 from
chain B is 3.16 A˚ compared with 2.65 A˚ between Arg79 from chain A
and Ala72 from chain B. These differences are significantly larger
than the error as determined by the DPI value.
There are two interfaces that lie along the crystallographic twofold
symmetry axis, one between chain A molecules and one between
chain B molecules. The crystallographic interface between chain A
molecules involves hydrogen bonding between Gln89 and Ala176;
additionally, parallel-displaced %–% stacking is observed between
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Figure 1
Crystal packing of DLH in space groups P212121 (a), (b) and (c), and C2 (d), (e) and (f ) shown along the a, b and c axes of the unit cells.
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Tyr85 and His172. The crystallographic interface between chain B
molecules consists of a weak hydrogen bond of 3.25 A˚ between Gln89
and Glu184. The interactions at the interface of molecules A and B in
the asymmetric unit involve Arg105 and His109 from helix 3 of
molecule A with Ser49 from helix 1 as well as Thr207 of molecule B.
The first of the four remaining interfaces has hydrogen bonding
between Glu184 and Arg223 from helices 6 and 7 as well as His195
from strand "8 of chain A, with residues Glu4, Ser7 and Thr15 near
the N-terminus of chain B. The second consists of hydrogen bonds
between Thr15 and Ser7 of chain A and Glu184 and Gly187 of chain
B. The third interface involves hydrogen bonding between Arg45 and
Ser49 of helix 1 and Ser22 from chain A and Arg105, His109 and
Pro111 of helix 3 and loop 8 of chain B. The final interface involves a
single interaction between Lys160 and Asp226 of neighbouring chain
B molecules.
3.4. Structural changes
The r.m.s. displacement plot for residues of the P212121 structure
superimposed with molecule A of the C2 crystal highlights regions
with the most variation (Fig. 3a). Similar differences were noted
between molecules A and B of the C2 crystal. The backbone segment
that has the most variation for both chains of the C2 structure is the
section between residues 22 and 27 that comprise loop 3. Ser22 is
involved in hydrogen bonding to a different residue in the C2 crystal
form than in the P212121 crystal form. In the P212121 crystal it
hydrogen bonds to the backbone of Ala188 at a distance of 2.97 A˚,
while in molecule A of the C2 crystal it interacts with Arg105 of
molecule B at a distance of 3.18 A˚. Another significant region of
difference is between residues 169 and 185 that comprise loop 12 and
helix 6. As mentioned previously, the DLH interface involving helix 6
is along the crystallographic twofold symmetry axis for the C2 crystal.
Residues His172 and Ala176 are involved in interactions at this
interface and the change in side-chain orientation to establish
hydrogen bonds and accommodate the new interface is reflected in
both the main-chain and side-chain difference values. Overall, where
the difference is in side-chain orientation, it is observed that most
differences are for charged residues that are involved in interactions
at the protein–protein interfaces within the crystals.
Fig. 3(b) shows a temperature-factor analysis for the main-chain
atoms of the P212121 structure and each chain of the C2 structure.
Individual residues have been identified where the B factor is large in
all structures or there is a significant difference in the value between
structures. For example, Gln76 has a large B factor in both chains of
the C2 structure (33.0 and 39.0 A˚2) but not in the P212121 (13.2 A˚
2).
In the latter Gln76 is involved in hydrogen bonding to Gln9 of a
neighbouring molecule, while in the C2 structure it does not form
crystal contacts. Similarly, Ala176 forms crystal contacts in chain A of
the C2 crystal but not in chain B or in the P212121 structure. The high
flexibility of solvent-exposed surface loops (3, 6, 8, 12 and 14) is
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Figure 2
Overlay of structures and active site with and without a sulfate ion bound.
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confirmed with peaks in the observed B factors. Fig. 3(c) shows the
loss in accessible surface area (ASA) per residue as a result of crystal
packing. The different interfaces are reflected here; for example, loop
6 is at a crystallographic interface in both chains of the C2 crystal but
not in the P212121 crystal. The total loss in ASA for the enzyme is
greater for the C2 crystal, with a difference of 3106 A˚2 for chain A
and 2747 A˚2 for chain B compared with 2303 A˚2 for the enzyme when
in the P212121 crystal form.
Studies into the influence of the crystal environment on protein
structure have identified aspects that are most likely to vary with a
changing environment (Zhang et al., 1995). The orientations of side
chains on the surface of proteins have been observed to differ among
proteins crystallized in multiple space groups, and this is especially
true for polar residues (Jacobson et al., 2002). Flexible loop regions
have also been observed to exhibit different conformations when in
different crystallographic environments (Kishan et al., 1994). The
changes observed for DLH are consistent with these previous
observations.
4. Conclusion
This is the first report of DLH crystallizing in a space group other
than P212121. The new C2 crystal form can be attributed to the
absence of a significant concentration of sulfate or phosphate. In the
P212121 crystals one sulfate ion binds to cause a minor shift in the
backbone conformation of a loop that forms part of an interface in
both crystal forms. More importantly, a second sulfate ion forms an
structural communications
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Figure 3
(a) R.m.s. distance difference plot showing the distance between the P212121 and chain A of the C2 structure for both the main-chain and side-chain atoms. Note that some
side-chain r.m.s. difference values are zero; occupancy was set to zero during structure refinement because of high flexibility shown by poor electron density. (b) Average B
factors of main-chain atoms for each residue of the P212121 and both chains of the C2 structure. (c) The difference in accessible surface area caused by crystal contacts.
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important part of an interface. The crucial location of this sulfate in
the lattice explains the necessity for a high ammonium sulfate
concentration in the crystallization buffer for formation of the
orthorhombic P212121 crystals. Subsequently, it also explains why, in
the absence of sulfate or phosphate ions despite a similar ionic
strength and pH, the P212121 lattice previously reported cannot form
and DLH crystallizes in a new space group.
The overall structures of a single DLH molecule crystallized in
either the P212121 or C2 space groups are very similar. The secondary
and tertiary structures can be easily aligned with minimal discrepancy,
and this is also the case for both molecules in the C2 asymmetric unit.
The main differences are in the side-chain orientations, more speci-
fically for surface residues at protein–protein interfaces within the
crystal lattice. In regions of the protein where there are no crystal
contacts in either crystal form (i.e. between residues 110 and 140),
there are only very slight differences in residue side-chain orientation
and main-chain position. This highlights the fact that the differences
in structure caused by crystal contacts as a result of crystal packing
are minor. One of the frequent criticisms of crystallography is that
crystal contacts distort molecular structure. In the case of DLH, the
effects of crystal packing are small.
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Conclusion 
 
Directed evolution is a powerful tool and can be used not only to engineer enzymes for specific 
industrial tasks but also to generate variants and pathways for the study of enzyme evolution. The 
work contained within this thesis uses directed evolution to study protein solubility, activity, 
substrate specificity and stability.  
 
An initial aim of the work was to evolve DLH separately for improve solubility and 
stability. The distinction between the factors governing these two properties is unclear and for 
practical purposes they are often considered to be the same. However difficulties arose down both 
avenues of directed evolution. The DHFR fusion system was adapted such that it could be used to 
select for improvements to enzymes with a pre-existing level of solubility (Chapter 3). Three rounds 
of evolution were carried out using the modified system with promising results. Two variants were 
identified that appeared to have increased levels of expression and solubility over the native 
enzyme. Unfortunately this work was ceased prematurely since it appeared that the selection 
generated a lot of false positives, instead other projects were favoured. However after 
reconsideration, most of the mutations identified were in appropriate locations to enhance solubility 
and the evolution, with only minor modification to the selection protocol, could have been 
continued. Nevertheless the groundwork has been laid for future continuation of the work or use of 
the modified selection system.  
 
Improving the stability of DLH required an appropriate screening method. Measurement of 
residual activity is commonly used for such purposes and was employed here once the activity of 
DLH had first been improved toward the easily assayable p-nitrophenyl acetate (Chapter 4). In this 
case it was used for the purpose of increasing the evolvability of DLH. The evolution of DLH over 
! "$!
multiple directed evolution experiments to increase substrate range (p-nitrophenyl esters with acyl 
chains from C2 to C12) became of interest for the insight it could provide on the evolution and 
diversity of !/" hydrolase fold enzymes. DLH is a simple hydrolytic enzyme that has been turned 
into an enzyme capable of hydrolysing ester and lipid substrates. The stability of DLH was 
monitored during the course of the evolution and selectively improved in order to compensate for 
destabilising active site mutations. This strategy allowed the rapid acquisition of seven active site 
mutations without stability as a limiting factor. Three surface mutations were identified as 
potentially stabilising and their individual roles in the directed evolution process were investigated 
(Chapter 5).  
 
A recurring long-term goal of this work was to investigate the use of enzymes in organic 
solvents (Chapter 6). Some lipases and thermophilic enzymes have been shown to be active in 
organic solvents but DLH is not a typical candidate for this kind of use. However, it was thought 
that the ability to evolve an enzyme such as DLH to be stable in non-aqueous reaction media would 
open more prospects for utilisation of other enzymes in this way. Directed evolution was used to 
identify ten surface mutations, seven of which were present together in the DLH-E8 variant, and 
shown the proving stabilising effects in the presence of a range of organic solvents. These mutations 
increased not only the chemical stability but also the thermal stability. It appears multiple stability 
parameters can be evolved simultaneously, at least in the early stages of evolution, it is likely later 
stages would produce more specific stability enhancements (i.e. chemical or thermal). Interestingly 
the evolved mutations were predicted as stabilising using computational methods. It is proposed 
that the set of predictions, after filtering and analysis, be used in the future to more rapidly increase 
enzyme chemical stability as well as thermal stability. This would be a more efficient and a more 
cost effective method.     
 
 Finally, the structure of DLH crystallised in space group C2 was solved and compared to the 
structure of DLH crystallised in the space group P212121 (Chapter 7). The crystallographic 
environments of the DLH molecules were different in the two crystal forms. However, there were 
only minor differences observed between the structures, these were mainly differences in side chain 
orientation focused at crystallographic interfaces and flexible surface loops. The minimal differences 
in DLH structure caused by the crystalline environment further highlight the significance of the 
structural changes caused by the evolved activity enhancing mutations discussed in Chapter 4.  
 
 Overall the work presented in this thesis has shown the evolution of DLH under multiple 
selection pressures. It has highlighted the importance of monitoring stability to the rapid acquisition 
active site mutations that are often destabilising. It has also provided a foundation for use of the 
modified DHFR fusion system for selection of highly soluble enzymes and provided preliminary 
results for the use of DLH in organic solvents. 
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SDS-PAGE Analysis for Expression and Solubility Testing 
SDS-PAGE analysis of native and evolved DLH variants was done to access any noticeable changes in 
enzyme solubility or expression. Plasmid DNA (pCY76) carrying the genes was transformed into DH5a cells 
then a single colony was inoculated into 5 mL of ampicillin supplemented LB media and grown overnight. 
Cells were pelleted then resuspended in 20 mM HEPES, 1 mM EDTA pH7.5 and lysed using BugBuster 
(Novagen). Lysate samples were set aside and the remainder was centrifuged at 16000 rpm for 5 minutes. 
The supernatant (soluble fraction) was decanted and the pellet (insoluble fraction) was resuspended using 9 
M Urea. 
 
 
Figure S1: SDS-PAGE of native DLH and variants from evolution one. 
 
 
 
Figure S2: SDS-PAGE of native DLH and variants from evolution two. 
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Figure S3: SDS-PAGE of native DLH and variants from evolution three. 
 
 
Amino Acid Mutations Accumulated During Each Evolution 
The amino acid mutations obtained over each round of directed evolution are shown in tables S1-S3. Table 
S1 shows the mutations in evolution one – p-nitrophenyl acetate activity, table S2 shows mutations in 
evolution two – thermal stability and table S3 shows mutations in evolution three – p-nitrophenyl butyrate 
activity. For simplicity, some mutations that only appeared once have not been shown. 
 
Improvements in activity during evolution one shown by the crude lysate assays and the actual improvements 
measured by kinetic characterization using purified enzyme are on a similar scale (Table S4). This is 
consistent with the observation from the solubility and expression tests by SDS-PAGE that show changes in 
expression and solubility are slight. If there were significant improvements in either then the indicated 
activity based on crude lysate would overestimate the actual activity and vice versa.  
 
The changes in activity during the third evolution are significant but the fold improvements are smaller than 
for the first two evolutions. As a result the calculating the fold improvements based on lysate activity has 
more associated error. Lysate assays were done once as part of the secondary screen, so percentage 
improvements were calculated from a single experiment whereas all enzyme kinetics were done in triplicate.  
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Table S4: Comparison of changes in activity measured from crude lysate and purified protein 
 
 
Residual Activity of Native and Evolved DLH Variants 
Protein stability was determined using residual activity. This was measured using purified protein as 
described in the methods section of the main text. 
 
Figure S4: Residual activity plot of native DLH and (A) variants from evolution one (B) variants from 
evolution two and (C) variants from evolution three 
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Gene Structure and Regulation 
The genes encoding the four enzymes of the modified ortho-cleavage catechol branch of the !-ketoadipate 
pathway are located together and referred to as the clc gene cluster (Figure S7). The clcD gene encoding 
DLH is the third of these genes and is immediately followed by the clcE gene encoding maleylacetate 
reductase. The ribosome binding site sequence necessary for translation of maleyacetate reductase is 
contained within the clcD gene.  
 
 
Figure S5: The clc gene cluster encoding the four enzymes of the modified ortho-cleavage catechol branch 
of the !-ketoadipate pathway 
 
 
Library Generation by Error-prone PCR  
Error-prone PCR was used for library generation and the MnCl2 concentration was varied from 0.1 to 0.2 
mM to obtain the desired mutation rate for each of the evolutions (Table 1). PCR is inherently biased due to 
the exponential nature of the amplification process. For example, a mutation introduced in the first 
amplification cycle will be significantly more abundant in the final library than mutations introduced in the 
later stages. To partially combat this bias, four reactions were carried out in separate tubes (50 !L each) at 
each library generation stage and then combined to construct the final working library. The average amino 
acid mutation rate was determined by random selection and sequencing of ten variants.  
 
clcA 
clcB 
clcD clcE 
Gene Size (bps) Enzyme encoded 
clcA 780 chlorocatechol dioxygenase II 
clcB 1110 chloromuconate cycloisomerase II 
clcD 708 dienelactone hydrolase 
clcE 1056 maleylacetate reductase 
clcD clcE 
RBS and possible  
proteolytic  
cleavage site 
! ! "+!
Table S5: Error-prone PCR set up for library generation 
Component Volume (!L) 
Template DNA (50 !M) 1 
M13 Forward primer (10 !M) 5 
M13 Reverse primer (10 !M) 5 
PCR buffer (without additional MgCl2) 5 
MgCl2 (50 mM) 5 
MnCl2 (5 mM) 1-2 
dNTPs (40 !M combined) 1 
Taq polymerase (5 U !L-1) 0.5 
Water 25.5-26.5 
Total 50  
 
The PCR conditions were 30 cycles of 96°C for 10 s, 55°C for 10 s and 72°C for 20 or 5 s. The longer 
extension time (20 s) was used for first round library generation in the directed evolution process. For 
subsequent rounds, when shuffling was required in addition to the introduction of new mutations, then the 
shorter extension time (5 s) was used.  
 
Library Plating 
Primary screening in microtiter plates was done with 2-3 colony forming unit (CFU) per well to increase 
throughput.1, 2 This approach has been described previously but here the methods differ. The transformed 
library was pelleted then resuspended in 1 mL of 10% (v/v) glycerol and 1% NaCl (sterilized). Aliquots of 
the resuspended cells were diluted both 1:10 and 1:100 with the same glycerol solution. Small 40 !L aliquots 
of the undiluted and diluted solutions were plated on LB agar plates supplemented with ampicillin and grown 
overnight, while the remaining solutions were stored at 4 °C. Multiple dilutions were made to ensure one of 
the agar plates contained between 50-250 colonies (a countable number). The transformed colonies were 
counted and this information was used to calculate the number of CFU per !L. The appropriate stock library 
was diluted to 2-3 CFU per 200 !L with LB ampicillin and plated into 96 well microtiter plates. 
 
Expression and Purification 
For expression, the gene encoding native or a variant DLH was first cloned into the constitutive expression 
vector pJWL1030 (par+, bla+, lacZpro, T7!10tir+) and transformed into Escherichia coli DH5" strain.3 Cells 
were grown overnight at 37°C in LB media supplemented with kanamycin. Cells were harvested then 
! ! "#,!
resuspended in 20 mM HEPES, 1 mM EDTA, pH 7.5 and lysed using a French Press. The soluble fraction 
was loaded onto a DEAE Fractogel anion exchange column (Merck) and eluted between 60 and 100 mM 
NaCl using a step-wise gradient. Enzyme elution was determined by SDS-PAGE analysis and the appropriate 
fractions were combined and concentrated using a 10,000 molecular weight cut-off centrifugal filter 
(Millipore). Concentrated protein was applied to a Sephadex-G75 superfine size exclusion column (GE 
healthcare) and eluted with 20 mM HEPES, 1 mM EDTA, pH 7.5. Enzyme elution was again determined by 
SDS-PAGE and pooled fractions were concentrated. Enzyme concentration was determined by UV 
absorbance at 280 nm using an extinction coefficient estimated by the ProtParam program on the ExPASy 
Proteomic Server. 
 
Data Collection, Processing and Refinement Statistics for Native and Variant DLH Crystals 
Statistics for the data collection, processing and refinement of the native and five DLH variants crystals (A-6, 
S-2, S-3, B-1 and B-4) are shown in table S4. The structure for the S-3 variant was obtained due to the 
possibility of the three C-terminal residues being ordered. It was thought that since the K235N mutation 
seemed to have a stabilizing effect, although minimal, those residues would be ordered whereas in the native 
and other variants this was never the case. However, the residues were disordered regardless of the mutation 
as a result this structure is not referenced in the main text since the other mutations are identical to the S-2 
variant. 
 
PDB Codes: Native  – 4U2B 
  A-6  – 4U2C 
  S-2  – 4U2D 
  S-3  – 4U2E 
  B-1 – 4U2F 
  B-4  – 4U2G 
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Table S1 Calculated and experimentally determined masses of DLH variants 
 Calculated Mass (Da) Experimental Mass (Da) 
S0 25255.6 25254.9 
Q110L 25240.6 25240.4 
Y137C 25195.5 25195.1 
N154D 25256.6 25255.5 
Q110L & N154D 25241.6 25241.0 
S2 25181.5 25180.9 
 
 
 
 
 
Fig. S1 Changes in B-value for the native (A) and DLH-S2 (B) structures 
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Fig. S3 Residual activity plots of the DLH variants with (A) S0, (B) Q110L, (C) Y137C, (D) N154D, (E) 
Q110L & N154D and (F) S2. Errors are the standard deviation between three replicates.  
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Fig. S4 Thermal denaturation plots of the DLH variants monitored by SYPRO orange fluorescence with 
(A) S0, (B) Q110L, (C) Y137C, (D) N154D, (E) Q110L & N154D and (F) S2. Three replicates are 
shown for each and quoted errors in the melting temperatures are the standard deviation. 
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Table S2 Melting temperatures determined by residual activity and overall denaturation.  
 Residual activity Overall thermal denaturation 
 Tm (°C) Change (°C) Tm (°C) Change (°C) 
S0 51.2 ± 0.3  51.5 ± 0.5  
Q110L 51.8 ± 0.2 0.6 52.5 ± 0.4 1.0 
Y137C 49.3 ± 0.4 - 1.9 50.8 ± 0.4 - 0.7 
N154D 53.9 ± 0.2 2.7 54.4 ± 0.3 2.9 
Q110L & N154D 54.2 ± 0.2 3.1 54.8 ± 0.2 3.3 
S2 54.6 ± 0.4 3.4 54.6 ± 0.2 3.1 
Values are the average from three replicates and the errors are the standard deviation. 
 
 
 
 
 
Fig. S5 Scale and spacing of mutations during combined shuffling/error-prone PCR 
 
DNA shuffling in the previous directed evolution study was done by PCR, combining shuffling with the 
introduction of new genetic diversity in a combined shuffling/error-prone PCR protocol [1]. The genes 
are amplified from the vector primers (M13F and M13R) at the 5 and 3’ ends. The extension step is kept 
short (5 s) such that only a portion of the gene is amplified in each extension step. 
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Figure S1: The three protein interfaces of the P212121 crystal. 
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Figure S2: The eight protein interfaces of the C2 crystal 
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